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SUMMARY
The ultraviolet A (UVA) radiation component of sunlight has been shown to be a source 
of oxidative stress to skin via generation of reactive oxygen species. Recently it has 
been shown that the exposure of human primary foreskin fibroblast cell line, FEK4, to 
UVA radiation causes immediate release of ‘free’ iron in the cells via proteolytic 
degradation of ferritin. Since the rapid release of potentially harmful ‘free’ iron to the 
cytosol could be a major factor in UVA-induced damage to the skin, this phenomenon 
was investigated in more detail in both cultured human skin fibroblasts and 
keratinocytes following single or repeated exposure to UVA radiation at natural 
exposure levels. The results demonstrated that immediately following single or repeated 
UVA irradiation of both fibroblast and keratinocyte cells, the intracellular labile iron 
pool (LIP) concentration increases in a dose-dependent maimer. The level of LIP returns 
to basal level only 6 h after a single irradiation and does not change further for the next 
48 h. Furthermore, the basal and UVA-induced level of LIP was 2-4 fold higher in 
fibroblasts when compared to keratinocytes. The low level of LIP in keratinocytes is 
likely to be an important factor for their higher resistance to UVA-induced membrane 
damage. Indeed, it appears that there is a direct relationship between the basal level of 
LIP in cells and the extent of UVA-induced LIP release and lysosomal and plasma 
membrane damage. Overall these findings indicate that UVA-mediated immediate 
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1.1 Ultraviolet (UV)-General introduction
The electromagnetic spectrum includes wavelengths that range from very short (10'15 
m), high energetic to longer (103 m), less energetic radiowaves. Ultraviolet (UV) is a 
part o f non-ionising electromagnetic radiation, including wavelengths from 10 nm to 
400 nm. Exposure to UV occurs from both natural and artificial sources. The sun is the 
major source of UV radiation. The sun emits radiation extending from infrared (760- 
3000 nm), visible (400-760 nm) to UVA band (320-400 nm, near-UV) through UVB 
(290-320 nm, mid-UV) down to the high energy UVC band (190-290 nm) and vacuum 
UV (10-190 nm). UV undergoes absorption and scattering as it passes through the 
Earth’s atmosphere with absorption by ozone, molecular oxygen and other molecules. 
Variation in UV intensity reaching the Earth depends on solar zenith angle, atmospheric 
ozone, cloudiness and aerosol load etc. Due to the absorption of the wavelengths below 
310 nm by ozone, only infrared, visible, UVA and a part of UVB can reach the Earth’s 
surface. Therefore the effects of solar UV radiation on biological systems concern only 
UVA and UVB wavebands. Only UVA will be investigated in this thesis. UVA 
comprises the major part (90%) of solar UV at noon (Pathak et al., 1997). It can be 
further divided into the UVA-II (320-340 nm) and UVA-I (340-400 nm) regions. UVA- 
II and UVB radiations have similar effects. Classification of the solar spectrum reaching 
the Earth’s surface is shown in the Table 1.1.
Table 1.1 Classification of the solar spectrums that reach the Earth’s surface
Type UVB UVA Visible Infrared
Wavelength/nm 290-320 320-400 400-760 760-3000
l
UV radiation must be absorbed by biomolecules to produce damage. The interaction of 
UV with biological material changes as a function of wavelength. At short wavelengths, 
the UVB region overlaps with the tail of DNA absorption so that direct absorption by 
molecules such as nucleic acid (e. g. DNA) dominates. At longer wavelengths including 
the UVA region, different chromophores absorb and this can lead to oxidative stress. 
Hence, organisms on the Earth’s surface have to be well adapted, e.g. by forming UV- 
absorbing surface layers (skin or fur), by antioxidant defences to quench UV-generated 
reactive oxygen species (ROS) or by efficiently repairing damaged DNA (reviewed by 
de Grujil, 2000).
In recent decades, there has been a substantial decrease in the ozone layer and a 
consequence is that the earth is exposed to more UV radiation. Furthermore life styles 
have been changed leading to increased personal sunlight exposure: e. g. changes such 
as holidays in the sun, cosmetic tanning, minimal clothing outdoors, insufficient use of 
sunscreens and photo therapy used for medical reasons.
In humans, the major targets for UV are the skin and the eyes and it is important to 
emphasise that the transmission of UV through these tissues and cells increases with 
increase in wavelength, so that longer wavelengths penetrate much deeper and can 
cause effects on targets which differ from those of short wavelengths. Both acute and 
chronic exposure to sunlight are associated with various physiological and pathological 
states. The acute response involves immediate effects including erythema, heat, 
swelling, sunburn, pigmentation, hyperplasia, immune suppression and vitamin D 
synthesis (Gasparro et al., 1998). The chronic response involves delayed effects such as 
cataract and skin ageing (also called photo-ageing), which is the result of morphological
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changes such as wrinkling, elasticity loss, uneven pigmentation due to general alteration 
of all the epidermal and dermal components of skin. Chronic exposure of skin to UV 
radiation may lead to skin cancer (reviewed by Tyrrell, 1994).
1.2 Oxidative stress and reactive oxygen species (ROS)
Oxygen is the most abundant element in the Earth’s crust. All animals and plants 
require oxygen for the efficient production of energy, except those organisms that are 
especially adapted to live under anaerobic conditions. Although oxygen is essential to 
life, it can give rise to a variety of ROS as a part of normal metabolism.
The term “oxidative stress” describes a situation in cells in which the equilibrium 
between prooxidant and antioxidant species is broken in favour of prooxidant state, due 
to ROS. Toxicities and pathologies associated with the oxidation of nucleic acids, 
proteins, lipids and carbohydrates have been collectively termed ‘oxidative stress’. 
ROS, referred to as oxidative stress, can be generated both exogenously (e. g. 
xenobiotics, pesticides, ozone, photochemical smog, ultraviolet light, ionising radiation) 
and endogenously (e. g. mitochondrial respiration, microsomal and nuclear membrane 
electron transfer and phagocytic oxidative burst).
ROS is a collective term that includes not only oxygen-based radicals (see below) but 
also non-radical derivatives of oxygen such as singlet oxygen (l0 2 ) and hydrogen 
peroxide (H2 O2), which are capable of forming radicals. ROS have been implicated in 
inflammation, ageing, some diseases (including cancer), drug action, drug toxicity and 
recently apoptosis.
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Free radicals are species capable of independent existence and contain one or more 
unpaired electrons in an orbital in the outermost electron shell. They are able to take an 
electron from or donate an unpaired electron to another molecule. Free radicals are very 
active intermediates and are potentially powerful damaging agents in vivo. Organic free 
radical species are numerous, but oxygen-based free radicals that occur in biological 
systems are limited. Here, discussion will be restricted to oxygen-based free radicals 
included superoxide anion (O2’’), hydroxyl radical (OH#), peroxyl radical (ROO#) and 
alkoxyl radical (RO#), which can oxidise protein, lipid and carbohydrate. The primary 
target of free radicals is the lipid bilayer of the membrane. Free radicals may be 
involved in the initiation and propagation of free radical chain reactions which 
potentially damage cells (Riley, 1994). Free radicals can kill bacteria, damage 
biomolecules, modify genomic and cellular structures, provoke immune responses, 
activate oncogenes, cause artherogenesis and enhance the ageing process.
UVA radiation generates ROS in cultured skin cells (see section 1.7). Free radicals are 
generated in skin exposed to UVA (Black, 1987; Trenam et al., 1992; Yasui et al., 
2000). Uncontrolled production of ROS leads to damage to biomolecules and may cause 
diseases because ROS have been implicated in many inflammatory skin disorders 
(Trenam et al., 1992).
1.3 Human skin
Skin, the largest organ of the body, keeps internal systems intact. It is not only a barrier 
to protect the body from chemical and physical (e. g. ultraviolet light) agents and micro 
organisms, but is also involved in defence mechanisms and other important functions. 
The skin thickness varies according to the site of the human body, but the average is
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0.3-0.4 mm. The skin composes two layers - the upper epidermis and inner dermis (see 
Fig. 1A and IB). The epidermis is beginning at the outer surface and working inwards. 
There are four clear layers that can be observed in the epidermis under a light 
microscope. They are defined as:
1) Comified layer - stratum comeum
2) Granular layer -  the zone where epidermal nuclei disintegrate
3) Germinative or prickle cell layer- the bulk of the living epidermal keratinocytes
4) Basal layer- the only keratinocytes in normal epidermis that undergo cell division
The epidermis is mainly composed of keratinocytes with some Langerhans cells and 
melanocytes. Keratinocytes produce the protein keratin (which provides a strength and 
flexibility to the epidermis) and a low level of a wide range of cytokines so that 
keratinocytes can influence immunologic function. These cytokines include interleukins 
(ILs), chemokines, tumour necrosis factors (TNF), colony-stimulating factors (CSF), 
transforming growth factors and growth factors. Keratinocytes in the basal layer divide 
(on average every 4 weeks) and the daughter cells undergo changes as they move 
upward to the skin surface. At the final stage, these cells lose their nuclei and then die, 
dehydrate and flatten out to form a comified external layer (stratum comeum). Dead 
cells are constantly being shed, while new cells are continuously being produced in the 
basal layer. Langerhans cells are antigen-presenting cells and play a major role in the 
immune surveillance system of the skin. Melanocytes synthesise melanin, which 
matures into melanosomes and are delivered to the keratinocytes in the outermost layer 
of the epidermis. They are uniformly distributed to form an UV-absorbing barrier, 










Fig. 1A Penetration of solar UV radiation into the skin 







The dermis is a connective tissue matrix that is between the epidermis and the 
subcutaneous layer. The upper dermis contains capillaries to nourish the epidermis. The 
lower thicker layer is reticular dermis. Fibroblasts are the major cells in the dermis. 
They synthesise collagen, elastin and glycosaminoglycans (GAG). Collagen fibres 
provide strength and resilience while elastin fibres provide elasticity to the skin. GAG 
provides viscosity, hydration and allows the dermis limited movement. Other cells 
embedded in the reticular layer including fat cells and dermal dendrocytes, mast cells, 
macrophages and lymphocytes as well as many blood and lymphatic vessels, nerves and 
nerves endings, oil glands and hair roots.
The solar energy reaching the skin is quite different for the epidermis and dermis so that 
damage to epidermal and dermal cells is very different. The epidermis is the primary 
target for oxidative stress generated not only by solar radiation, but also by other 
physical and chemical agents in the environment. When the two major skin cells, the 
epidermal keratinocytes and the dermal fibroblasts are exposed to UVA radiation, they 
receive different amounts of radiation. The epidermal keratinocytes are exposed to both 
UVA and UVB radiation while the dermal fibroblasts are shielded from UV radiation to 
a considerable extent by the overlying epidermis and will be mostly received by UVA 
radiation. A major part of UVA can penetrate quite deeply into the skin. Indeed, 35- 
50% of UVA radiation may reach the dermis of Caucasian skin (Bruls et al., 1984. see 
Fig. 1A). A small amount of UVA radiation can reach below the surface of the skin and 
penetrate blood vessels.
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1.4 Cellular defence against UVA
The epidermal keratinocytes and underlying fibroblasts are protected to some extent by 
the stratum comeum, a physical absorption barrier. It reflects, scatters and absorbs 
incident UV radiation. Melanin can act as an additional defence of the epidermis. It 
provides some physical protection and attenuates UV radiation by scattering and 
dissipation of absorbed energy. Since most cellular components are susceptible to 
potentially deleterious oxidation, the cellular antioxidant systems are cmcial to the 
prevention or removal of the damage caused by the oxidising component of UV 
radiation. Cellular antioxidant defence mechanisms include non-enzymatic and 
enzymatic systems, which sometimes act in synergy. DNA repair and inducible 
protection pathways also contribute to cellular defence.
1.4.1 Non-enzymatic defence-antioxidant molecules
Glutathione (GSH): GSH is an endogenous tripeptide (y-glutamyl-cysteinyl-glycine) 
that is the most abundant thiol found in most tissues. The ubiquitous non-protein free 
thiol is present at high concentration (3-5 mM) in most the cell types and therefore is 
considered as a major constitutive component in the maintenance of cellular reducing 
equivalents (reviewed by Tyrrell, 1991). It is an effective reductant, and a powerful 
radical scavenger. GSH reacts with LOOH or quenches ROS (such as H2 O2 , 02*~ and 
OH#) by hydrogen atom donation resulting in the formation of GSH disulphide (GSSG 
or oxidised glutathione).
ppv
LOOH + 2GSH LOH + GSSG + H20
2GSH + H2Q2 GPX > GSSG + 2H2Q
So GSH acts as a radical scavenger itself and also as a cofactor (hydrogen donor) for 
protective enzymes such as GSH peroxidase (GPX), GSH transferases, trans- 
hydrogenases and also for several other antioxidants such as ascorbate, which in turn 
regenerate a-tocopherol (reviewed by Tyrrell, 1994). GSSG is reduced to GSH by 
glutathione reductase (GR) in the presence of NADPH as the hydrogen donor.
GSSG + H+ + NADPH GR > 2 GSH + NADP+
The populations of cultured human skin fibroblasts or epidermal keratinocytes that have 
been depleted of GSH by treatment with low concentration of BSO (buthionine 
sulfoximine: a specific inhibitor of y-glutamyl-cystein synthesis) are strongly sensitised 
to the lethal action of both UVA and UVB radiation and visible light, so GSH provides 
a major line of defence against the cytotoxic effects of both UVA and UVB radiation 
(Tyrrell and Pidoux, 1986 and 1988).
Pre-mutagenic damage induced by UVA radiation in human lymphoblastoid cell (TK6) 
is lower in the presence of GSH when compared with cells depleted of GSH (Applegate 
et al., 1992). GSH has also been shown to protect calf thymus DNA and Chinese 
hamster ovary cell (CHO) against 7,8-dihydro-8-oxo-2’deoxyguanosine (8-oxo-dG) 
formation after UVA exposure (Fischer-Neilsen et al., 1992 and 1993). UVA radiation
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decreased GSH and GSH depletion strongly enhanced both basal levels and 
UV A/peroxide enhanced expression of (and threshold of UVA-induced) HO-1. It may 
lead to enhance gene expression either as a result of the potential accumulation of ROS 
or as a result of the direct influence of GSH on a critical target involved in signal 
transduction (Lautier et al., 1992). GSH depletion by BSO in HaCaT cells also leads to 
enhance UVA-induced damage (Tobi et al., 2000). Experiments with murine skin have 
demonstrated that glutathione levels in both dermis and epidermis are depleted by UVA 
or UVA plus UVB treatment (Connor and Wheeler, 1987; Shindo et al., 1993).
Vitamin E: Vitamin E refers to at least eight isomers of tocopherol. Among these, a- 
tocopherol (TOC-OH) is the best-known isomer and possesses the most potent 
antioxidant activity. High levels of tocopherol are found in selected mammalian tissues. 
It is a major lipophilic antioxidant, which acts as a scavenger and chain breaking 
antioxidant during lipid peroxidation by donating labile hydrogen to terminate 
propagating LO* and LOO* groups and other radicals O2*’, OH*, in turn producing a- 
tocopheryl radical (TOC-O*) which is insufficiently reactive to abstract hydrogen 
atoms. This process can be written as:
LOO* + TC O -O H  >LOOH + T 0 C -0 *
a-tocopherol has been shown to be a physical quencher and chemical scavenger of ’0 2 , 
with the irreversible oxidation of a-tocopherol to its a-tocopheryl quinone (reviewed by 
Fryer, 1993). Tocopherol can be regenerated by reduction of the tocopheryl radical by 
GSH or vitamin C (ascorbic acid) (Niki et al., 1987). Vitamin C and vitamin E (a-
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tocopherol) have complementary roles in preventing lipid peroxidation induced by 
oxidative stress (reviewed by Tyrrell, 1994).
There are reports that a-tocopherol protects against UVA-induced lipid peroxidation in 
cultured human fibroblasts (Morliere et al., 1991; Gaboriau et al., 1993; Coulomb et al., 
1996; Clement-Lacroix et al., 1996; Skoog et al., 1997) and keratinocytes (Djavaheri- 
Megny et al., 1996). The main in vivo function of a-tocopherol is to prevent lipid 
peroxidation. There is evidence that vitamin E, at least when applied topically to skin, is 
able to protect particularly against ozone-mediated lipid peroxidation (Thiele, 1997). 
UVA-induced cytotoxicity could be inhibited in the case of fibroblasts derived from the 
patient with photosensitive disease using the water-soluble vitamin E analogy, Trolox C 
(Kralli and Moss, 1987).
Vitamin C (ascorbate): Vitamin C is a hydrophilic antioxidant and reacts with a wide 
range of ROS (Halliwell and Gutteridge, 1999). It is able to quench ]02 (Chou and 
Khan, 1983), which could be an important mode of protection of biological systems 
where l02 is generated in aqueous-phase. In addition, it has a strong reduction potential 
and therefore has the ability to restore the antioxidant properties of a-tocopherol (Niki 
et al., 1987; Njus and Kelley, 1991). Such a reduction can be expressed as follows:
TOC-O* + AH" > TOC-OH + A*"
AH" is the ascorbate anion and A*" is its product. Vitamin C therefore may prevent 
oxidative damage in skin by acting synergistically with vitamin E. Tebbe and co­
workers in 1997 found that vitamin C inhibited UVA-induced lipid peroxidation in 
cultured human keratinocytes. A dietary antioxidant mixture (vitamin E, vitamin C and
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glutathione) clearly reduced the UVB-induced tumour multiplicity and increased the 
tumour latent period in mouse studies (Black et al., 1985). Using vitamin C topically 
also protected porcine skin from ultraviolet radiation-induced damage (Darr et al., 
1992). Vitamin C was reported to increase ferritin mRNA translation in cultured cells in 
response to iron (Toth et al., 1995), which may increase storage of harmful iron inside 
cells. However, ascorbate (> ImM) may also act as a prooxidant since it can efficiently 
reduce Fe3+ to Fe2+, marking it available for Fenton-type reactions. For example, 
ascorbate stimulates iron-dependent peroxidation of membrane lipids in cultured skin 
fibroblasts (Basu-Modak et al., 1996) and release iron from ferritin thus induced DNA 
damage in neuroblastoma cells (Badder et al., 1994).
Carotenoids: Carotenoids such as vitamin A can protect against photosensitised 
reactions in several ways including quenching *02 (Krinsky et al., 1982). P-carotene 
itself is a precursor of vitamin A and is a member of the carotenoid family of 
antioxidants. P-carotene has been shown to inhibit UV-induced epidermal damage and 
tumour formation in mouse models (Mathews-Roth and Krinsky, 1987). In humans, 
high doses of P-carotene are effective in certain photosensitivity diseases (Epstein, 
1977; Mathews-Roth et al., 1982). However, there is still a controversy about P- 
carotene as a photoprotectant. It may be reasonable to suggest that p-carotene itself is 
limited in its protection unless it co-operates with other antioxidants.
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1.4.2 Enzymatic defence-antioxidant enzymes
The enzymatic system of the skin functions by catalysing the decomposition of oxidants 
and free radicals into less reactive species. The major antioxidant enzymes are catalase 
(which destroys H2 O2), superoxide dismutase (SOD, which converts (V - to H2 O2), 
GPX and associated enzymes (which in addition to metabolising H2O2 , also reduce 
LOOH such as those that result from lipid peroxidation).
Glutathione peroxidase (GPX) is a selenium dependent enzyme, located in the cytosol 
and mitochondrial matrix. It acts on H2 O2 and lipid peroxides by coupling the reduction 
of these compounds with the oxidation of GSH, forming water and an alcohol 
respectively (see 1.4.1). This is important because the central role of glutathione in 
protection of cells against damage by UVA radiation (Tyrrell and Pidoux, 1986 and 
1988; Lautier et al., 1992). Selenium deficient cultured human fibroblasts were found to 
have a lower GPX activity and were sensitive to UVA and H2O2 cytotoxicity and lipid 
peroxidation (Moysan et al., 1993 and 1996; Bertling et al., 1996). Selenium 
supplementation increased GPX and decreased UVA-induced lipid peroxidation in 
human skin fibroblasts (Leccia et al., 1993). Emonet (1997) also found that thiols and 
selenium protected human skin fibroblasts against UVA-induced toxicity. Recently, it 
has been shown that single or repetitive low dose UVA radiation (200 kJ/m2) to human 
skin fibroblasts led to a substantial up-regulation of GPX activity, which protects cells 
against subsequent challenge with high dose of UVA radiation (Meewes et al., 2001). 
Previously, the same group reported that Mn-SOD was induced by UVA radiation 
(Poswig et al., 1999). The adaptive responsive involving GPX protection clearly 
depended on the irradiation interval and a sufficient selenium concentration. Normally
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no changes or only a slight decrease in GPX activity has been observed upon UVA 
radiation in fibroblasts (Shindo et al., 1997; Moysan et al., 1993)
Catalase: Catalase locates in peroxisomes. The catalase (a heme protein) is an enzyme 
that primarily scavenges H2O2 (another is GPX). Unlike other peroxidases, catalase 
catalyses the direct decomposition of H2O2 to ground state oxygen and water without 
the use of another substrate as GPX does. In cultured human fibroblasts and 
keratinocytes, catalase activity is strongly reduced after UVA exposure (Punnonen et 
al., 1991; Moysan et al., 1993; Tirache et al., 1995; Shindo et al., 1997). This is 
probably due to oxidative damage to the enzyme (Giordani et al., 1997). Comparing the 
protection of GSH against UVA, catalase is less important because catalase deficient 
(cells treated with amino-triazole, a catalase inhibitor) fibroblasts did not show 
decreased survival after UVA radiation (Tyrrell and Pidoux, 1989; Peak et al., 1990a), 
although they were more sensitive to H2O2 induced cytotoxcity. On the contrary, 
Bertling in 1996 found that H2O2 played a major role in broad-spectrum (310-400 nm) 
cytotoxicity of selenium deficient murine cells. Although catalase may not be a major 
protective enzyme of fibroblasts following UVA radiation, it may reduce the damage of 
other antioxidant enzymes (GPX and SOD) (Tirache et al., 1995).
Superoxide dismutases (SODs): SODs include Cu/Zn-SOD, Mn-SOD and Cu-SOD, 
located in cytosol, mitochondria and plasma membranes, respectively. They catalyse the 
reduction of O2*- to less reactive H2O2 . The trace element zinc (Zn) is thought to 
maintain the configuration of SOD whereas Cu is involved in the catalytic activity for 
Cu/Zn SOD. Zn, like selenium (Se), when added to cultured human skin fibroblasts, 
resulted in a reduction in UVA-induced lipid peroxidation and an increase in cell
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survival, but no increase in Zn-SOD activity (Leccia et al., 1993). Richard in 1993 
observed the same phenomenon and also found that the Zn protection was not mediated 
by antioxidant activity. Similarly, the addition of manganese (Mn, the metal in the 
active site of Mn-SOD) into cultured human fibroblasts protected these cells from 
oxidative injury by UVA radiation but this was not accompanied by an increase in Mn- 
SOD activity (Parat et al., 1995). Zn supplementation can protect against both DNA 
strand breakage and apoptosis in human skin fibroblasts (Leccia et al., 1999). It was 
found that SOD activity was decreased by solar simulated UV radiation in human skin 
fibroblasts (Shindo et al., 1997) and human skin keratinocytes (Punnonen et al., 1991). 
However, inactivation of this enzyme was considered to occur indirectly by ROS rather 
than directly as has been found with catalase (Shindo et al., 1997).
Recently, cultured fibroblasts repetitively exposed to UVA radiation (200 kJ/m2 per day 
for three days) actually developed an adaptive response marked by an increase in Mn- 
SOD mRNA levels and Mn-SOD activity after the third exposure (Poswig et al., 1999). 
Since SOD dismutates 02~  to H2O2 , the increase in SOD activity is accompanied with 
an increase in catalase and/or GPX (Amstad et al., 1991; Yohn et al., 1991) to prevent 
H2O2 toxicity. Studying SOD and catalase content of human fibroblasts from different 
normal cell lines and the efficiency of lipid peroxidation after UVA radiation, it was 
found that the extent of lipid peroxidation was correlated with the ratio of SOD to 
catalase. Furthermore when this ratio increased, by increasing SOD or decreasing 
catalase before UVA radiation, the peroxidation of lipid increased (Leccia et al., 1993). 
If SOD activity exceeded that of H2O2 scavenger, accumulation of H2 O2 by SOD could 
lead to toxicity.
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It was shown that both enzymatic (catalase, GR, SOD, GPX, HO-2) and non-enzymatic 
(GSH, vitamin E and ascorbate) antioxidant capacities of the epidermis are higher than 
those of the dermis, when measured in vivo in mouse and human skin and in vitro in 
fibroblasts and keratinocytes (Shindo et al., 1993 and 1994; Applegate et al., 1995).
Immediately after UV radiation (UVB and UVA), some of the enzymatic and non- 
enzymatic antioxidant of the mouse and human skin or cultured cells decreased (Fuchs 
et a l, 1989; Shindo et al., 1993 and 1997; Lautier et al., 1992), especially catalase 
(Moysan et al., 1993). However, there is still no clear relationship established between 
higher antioxidant level and cellular resistance to UVA radiation.
Thioredoxin/thioredoxin reductase: Thioredoxin/thioredoxin reductase may also play 
a role in the defence of skin against oxidative stress including UV radiation. 
Thioredoxin is a small protein that, in its reduced form, has a protein disulfide reductase 
activity as a consequence of its two reactive thiol groups. The protein reacts with free 
radicals in human keratinocytes in vivo (Schallreuter and Wood, 1986).
Repair processes, such as excision of damaged DNA bases, can prevent the effects of 
UVA-mediated oxidative processes. DNA enzymes responsible for excision, repair of 
the damaged DNA strand, all aid in reducing the carcinogenic action of UV radiation 
(de Laat et al., 1996). If this antioxidant defence is not enough, cells can no longer 
divide and will die (either by apoptosis or necrosis) or may be left with apparently 
mutagenic /carcinogenic persistent lesions (reviewed by Tyrrell, 1994).
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1.4.3 The inducible defence pathway in FEK4 cells-The role of HO in UVA- 
mediated oxidative stress
Heme oxygenase (HO) catalyses the initial steps of heme degradation in eukaryotic 
cells, leading mainly to the formation of biliverdin (biliverdin is reduced to bilirubin by 
biliverdin reductase) and carbon monoxide (CO), with the release of iron. Three 
isoforms of HO have been identified in mammalian cells: HO-1, HO-2, HO-3. They are 
the products of separate genes. HO-1 is widely distributed in tissues (highest in livers 
and spleens) and highly inducible in virtually all cells. HO-2 is expressed constitutively 
but is unresponsive to any of the inducers of HO-1. HO-2 levels are the highest in the 
brain and testes of mammals. HO-3 is nearly devoid of catalytic activity and may act 
mainly as a heme-sensing or heme-binding protein or both (Elbirt and Bonkovsky, 
1999).
HO-1 gene expression is inducible both in vivo and in vitro by numerous chemicals and 
oxidative stress including UVA (Keyse et al., 1989 and 1990; Applegate et al., 1991). It 
was found that the induction of expression of the HO-1 occurs at the transcriptional 
level. The induction of HO-1 is a general response to oxidative stress in cells cultured 
from a variety of human tissue and mammalian species. Induction of HO-1 leads to a 
reduction in the cellular pool of heme and heme-containing proteins and thereby 
removes potential pro-oxidant catalysts. The liberated iron acts as an inducer of ferritin 
(Vile et al., 1994). In vivo and in vitro studies demonstrated that biliverdin/bilirubin act 
as antioxidants (Stocker et al., 1987). The other product of HO is CO, appears as a 
potential regulator of neural processes and vascular tone (reviewed by Ryter and 
Tyrrell, 2000). Since high levels of HO-1 are induced in cells from a tissue (skin) which 
are clearly not important in haemoglobin metabolism, a second function of HO-1 has
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been proposed. Its induction may protect cells against oxidative stress (Keyse et al, 
1990; Balia et al., 1992; Elbirt and Bonkovsky, 1999).
Poss and Tonegawa (1997) proposed that HO-1 is required for mammalian iron 
reutilization: mice lacking the functional HO-1 developed an anaemia associated with 
abnormally low serum iron levels, yet accumulated hepatic and renal iron that 
contributed to macromolecular oxidative damage, tissue injury and chronic 
inflammation because they lack the functional HO-1 to metabolise heme iron to 
extracellular spaces. Ferris et al (1999) showed that in murine fibroblast cells, HO-1 
activity regulated iron accumulation and efflux. In experiments where 55Fe was added to 
cells over-expressing HO-activity, iron uptake was reduced and iron efflux was 
increased compared to normal cells or HO-1 deficient cells. This preventing of cell 
death by regulation of cellular iron, suggested another possible cytoprotective role for 
HO-1, attributed to the augmentation of iron efflux. However, there is also evidence to 
suggest that HO can act as prooxidant (reviewed by Ryter and Tyrrell, 2000). Human 
Hela (HtTA-1) cells which overexpress HO-2 protein actually displayed a lower 
intracellular heme concentration and a higher level of chelatable iron than the parent 
strain HtTA cells shortly after hemin treatment and are more sensitive to high doses of 
UVA radiation (500 kJ/m2). This hypersensitivity does not occur 24 h after removal of 




Iron is the second most abundant metal, after aluminium and the fourth most abundant 
element in the Earth’s crust (5%). It is the most abundant transition metal in living 
organisms. An adult human has a total 4g of iron present in the body. One percent of 
tissue iron (i.e. 40mg) is mobilised by macrophages of the reticuto-endothelial system to 
the erythroid bone marrow for hemoglobin synthesis per day. Humans absorb 1-2 mg 
from the diet and excrete 1-2 mg of iron per day to maintain the balance of body iron. 
Living organisms such as mammals appear to have selected iron for achieving a large 
number of essential biological processes, since it is involved as a part of, or as a 
cofactor of many protein and enzymes. Its bioavailability is generally limited and higher 
species often exhibit deficiency, such as anaemia. Although iron is essential to all the 
cells because of its role in catalysing reactions of oxidation and reduction by virtue of 
its ability to change valence states, it could be potentially toxic. Iron overload 
conditions also occur, such as genetic or acquired iron overload (Hemochromatosis) or 
the delocalisation of intracellular iron such as the inflammatory response (some skin 
conditions: psoriasis, venous ulceration, atopic eczema) or atherosclerosis (Trenam et 
al., 1992). Another danger of iron is its ability to favour neoplastic cell growth. The 
metal is carcinogenic due to its catalytic effects on the formation of OH*, suppression of 
the activity of host defence cells and promotion of cancer cell multiplication (Weinberg 
et al., 1996). Iron may have a role in the carcinogenic process of other transition metals 
such as copper and nickels, or other kinds of carcinogens (Toyokuni et al., 1996). Iron 
also contributes to the skin inflammation by ROS in the rat (Trenam et al., 1992).
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Iron in the form of ferrous (Fe2+) is readily soluble at neutral pH but the polymeric 
oxides and hydroxides of ferric (Fe3+) precipitate at neutral pH as Fe(OH) 3  unless the 
metal is suitably chelated (Crichton et al., 1987). Iron’s biochemical activity reflects its 
dual ability to co-ordinate electron donors and to participate in redox processes 
(capacity to reduce or to oxidise a molecule). Most of the iron in organisms is found in a 
complex in proteins (reviewed by Richardson and Ponka, 1997) because of the low 
solubility of the metal in biological milieu. Of the proteins, ferritin allows the cells to 
deposit a pool of bio-available iron in a form which is soluble under physiological 
conditions and is non-toxic (see section 1.5.3 Iron homeostatasis).
The largest pool of iron (about 75%) presents in heme of hemoglobin and myoglobin 
where they transport oxygen. Other iron-containing proteins comprise cytochromes and 
iron-sulphur proteins transferring electrons in the respiratory chain, and various 
enzymes involved in oxygen-dependent reactions like oxygenases, hydroxylases, 
peroxidases and catalase, among them are the detoxifying P450 cytochromes, iron 
regulatory proteins and aconitase. Finally the enzymatic activity of ribonucleotide 
reductase requires iron. All of these together may account for no more than 10% of the 
total iron pool. The other 15% of body iron is present in ferritin, the iron storage 
compartment (reviewed by Kuhn, 1994). There is also a small part (0.1-1 %) of labile 
iron pool (LIP) (see section 1.5.5) that can catalyse the formation of ROS, if not 
appropriately shielded due to its extreme reactivity towards oxygen.
Under normal physiological conditions, 02*' and H2 O2 interact with organic substrate 
slowly. However, in the presence of transition metals such as iron or copper, the 
reaction will be accelerated. It is generally assumed that there is a small intracellular 
pool of free iron that can react with O2 *’ and H2O2 , giving rise to the reactive OH* via
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the Haber-Weiss reaction (1) or Fenton reaction (2). Much of the biological damage 
attributed to those species (O2’, H2O2 and OH*) is dependent on the presence of iron 
(Aust, 1985; Halliwell and Gutteridge, 1999). These processes can be expressed as 
follows:
O 2  "b F e  > F e  +  O 2  ( 1)  (Haber-Weiss reaction)
H 2 O 2  "b Fe > OH + OH +  Fe (2) (Fenton reaction)
Net:
0*2 + H 20 2 —-r- - - > OH*+ OH' + 0 2 (3)
(Source: Halliwell and Gutteridge, 1999)
The net effects are DNA damage; impaired synthesis of proteins, membrane lipids and 
carbohydrates; induction of proteases; and altered cell proliferation. Iron is an essential 
component in redox-driven lipid peroxidation systems. Iron plays an important role in 
damage to lipids, by catalysing lipid peroxidation, to produce ROOH, which split to 
form of RO* and ROO* radicals (Aust et al, 1995). These reactions can be described as 
follows:
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ROOH+ Fe^ + complex----- »RO*+ OH" + Fe^+ complex (4)
ROOH+ Fe^+ complex----- »ROO*+ H+ + Fe^ + complex (5)
ROOH -------> RO*+ OH* (6)
Transition metals other than iron, notably copper, are also able to catalyse the above 
reactions, but the best candidate in vivo is iron. Several iron complexes can also catalyse 
the Haber-Weiss reaction in cell-free systems, including Fe2+-EDTA (McCord and Day, 
1978; Halliwell and Gutteridge, 1999). In cells, however, the true catalyst in Fenton 
chemistry is more likely to be the low-molecular weight (LMW) free iron pool, or iron 
made available from other cellular sources under conditions of oxidative stress. This 
pool provides the cell with a relatively accessible form of iron for incorporation into 
cytosolic enzymes and proteins. The iron which can be extracted from proteins by 
ligands into a LMW form has been termed the ‘labile iron pool’ (LIP) by Jacobs (1977); 
White et al. (1976) (see section 1.5.5).
Iron has been involved in UVA-mediated damage to biomolecules, both in vitro and in 
cell cultures. UVA-mediated cytotoxicity in primary human fibroblasts was 
significantly reduced by pre-treatment of the cells with iron chelators, e. g. DFO, which 
chelated both Fe2+ and Fe3+, preferentially Fe3+ (Keyse and Tyrrell, 1989). Similarly, 
UVA-mediated protein oxidation measured by sulfhydryl loss was strongly reduced by 
pre-treatment of cells with iron chelators (Vile and Tyrrell, 1995). UVA-induced lipid 
peroxidation in membranes of cultured human primary fibroblasts was shown to occur 
via pathways involving iron and ^  (Vile and Tyrrell, 1995). Solar UV radiation-
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mediated generation of LO* in mouse and human skin is significantly decreased by 
topical application of the iron chelator DFO (Jurkiewwicz and Buettner, 1996), also 
indicating a role for iron in lipid peroxidation. Iron treatment significantly increased 
lipid peroxidation, while DFO significantly decreases lipid peroxidation in human 
fibroblasts irradiated with UVA (Morliere et al., 1997). Fe2+, in conjunction with H2O2 , 
can also catalyse the oxidation of protein sulphydryl group and cause the inactivation of 
protein function in vitro (Hu et al., 1992; Vile and Tyrrell, 1995). Because of the 
dangerous nature of ‘free’ or ‘catalytic’ iron, the free iron level is tightly maintained 
within cells by feed-back mechanisms that lead to “ iron homeostasis” (see section 
1.5.3).
1.5.2 Ferritin
Ferritin is the iron storage protein. The protein must maintain its iron in a soluble, bio- 
available and non-toxic form. The ubiquitous protein ferritin (450 kDa) is a cytosolic, 
hollow protein and consists of 24 subunits of polypeptides. The heteropolymeric 
components (light chain, L, 19 kDa; and heavy chain, H, 21 kDa) form a shell around 
an inorganic iron oxyhydroxide core [FeOOH]x. The sequestered iron is maintained in
-1 L
an oxidised Fe state by the ferritin H-chain, which has ferroxidase activity which is 
necessary for iron uptake by the ferritin molecule. The L-chain facilitates iron core 
formation within the protein shell and has more iron storage capacity. The proportion of 
H to L varies depending upon the tissue source as well as the level of iron loading. The 
mammalian H-ferritin and L-ferritin polypeptide show 50% homology and have the 
same ancestral gene (Ponka et al., 1998).
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A ferritin molecule can sequester up to 4500 iron atoms. Normally, ferritin is only about 
20% iron-saturated (Reif, 1992) and as much as one third of ferritin iron may turn over 
daily as a result of degradation and synthesis. Ferritin is slowly degraded to a non­
specific complex containing iron, which becomes the component of hemosiderin. 
Hemosiderin is lipoprotein found in lysosomes, which appears to be a dead end in the 
metabolism of iron and ferritin (reviewed by Bridges, 1996).
In cells, most of the iron is sequestered in ferritin as a crystalline core of ferric Fe 
ions. Ferritin has high capacity to chelate iron and convert it to the ferric state in which 
it is relatively safer. Thus ferritin is able to restrict the availability of Fe to participate 
in the Fenton reaction. Ferritin therefore appears to play an important role as a 
cytoprotective protein. In this way iron is limited in its capacity to catalyse oxidative 
reactions in the presence of H2 O2 (Ollinger and Roberg, 1997). It is generally considered 
that the chelation of the intracellular iron with exogenous chelators or increased levels 
of the endogenous iron storage ferritin will protect mammalian cells in culture against 
oxidative stress generated by a variety of agents such as H2O2 and UVA radiation (Balia 
et al., 1992; Vile et al., 1993 and 1994).
Although ferritin’s iron-scavenging property is well known, it may also be a potentially 
hazardous molecule under pathological conditions or in cells exposed to oxidative stress 
(Reif, 1992; Pourzand et al., 1999). Ferritin photoreduction could trigger peroxidation 
of lipoproteins such as low density lipoprotein LDL (Aubailly et al., 1994). Reductive 
release of iron from ferritin may catalyse cytotoxic radical reactions like the Haber- 
Weiss reaction. O2 ** may mobilise iron from ferritin, although the ability of O2*' to do 
this is very limited (Bolann et al., 1990). Ferritin may also exert a prooxidant role
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because o f ferrous ions released from the ferritin protein by a variety of reducing agents 
(Reif, 1992).
1.5.3 Iron Homeostasis
Because of the ambivalent role of iron in cells, it is essential for living organisms to 
maintain iron homeostasis in order to ensure the iron supply but prevent accumulation 
of excess iron. Cellular iron metabolism which comprises pathways of iron uptake via 
transferrin receptor (TfR) and storage in ferritin is co-ordinately regulated through a 
feedback control mechanism mediated at the post-transcriptional level by cytoplasmic 
factors known as iron regulatory proteins (IRPs). In response to fluctuations in the level 
of LIP, IRPs act as major regulators of these pathways (see below).
Transferrin (Tf): Tf, the plasma iron-binding glycoprotein which is the major vehicle 
for transfer of iron in the body, provides most of the iron for the physiological needs of 
iron-requiring cells, and is normally the only source of iron for hemoglobin synthesis. It 
binds and transports iron, hence reduce the toxic side effect of iron. The 80 kDa Tf has 
high affinity for Fe3+. Each Tf molecule consists of two globular domains and each 
domain contains a high-affinity binding site for one iron molecule. Fe3+ attaches to these 
sites extremely tight at physiological pH. Although Tf can also bind to other metals 
such as aluminium, manganese, copper and cadmium, the affinity is much lower than 
iron. Tf exists as a mixture of iron-free (apo Tf), one iron (mono Tf) and two iron 
(diferric Tf) forms of the molecule. The primary function of Tf is to bind iron in plasma 
and to transport iron into various cells and tissues. Tf is bound to membrane receptors 
and that are found in many cells. The Tf is then internalised by endocytosis and releases 
its iron at acidic pH in late endosomes.
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Transferrin receptor (TfR): TfR is a homodimeric glycoprotein with a molecular 
weight of approximately 180 kDa. Its two identical subunits are joined by two disulfide 
bonds. Because each domain contains a binding site for the Tf molecule, a homodimer 
of TfR can bind up to two molecules of Tf simultaneously. TfR is expressed in all cells 
except mature erythrocytes and other terminally differentiated cells. There are two 
forms of TfR, TfRl and TfR2 which have distinct cell-and tissue-specific expression 
pattern. TfR is expressed at high levels in rapidly dividing cells. Expression of TfR in 
non-erythroid cells is regulated at the post-transcriptional level by the interaction of 
IRPs and 5 x iron responsive element (IREs) in 3’-untranslated regions (UTR) of TfR 
mRNA. TfR linked to the cell surface and binds diferric iron-loaded Tf with high 
affinity. TfR complex is formed that is then endocytosed within an acidic endosomal 
compartment where the TfR iron is released from Tf in a pH dependent manner. The 
TfR complex is subsequently cycled back to the cell surface and Tf is released from the 
receptor to the plasma as apotransferrin (reviewed by Eisenstein, 1998). Dissociation of 
apotransferrin from its receptor takes place at neutral pH at the cell surface, making 
both the ligand and receptor available for further rounds of iron absorption. Apart from 
this T f dependent pathway, several cell types also have other efficient mechanisms of 
iron uptake that includes a process consistent with non-specific uptaken, pinocytosis 
and a mechanism that is stimulated by a LMW-Fe complex (see section 1.5.5).
Iron regulatory proteins (IRPs): IRPs include IRP1 (90 kDa) and IRP2 (105 kDa), 
which are cytosolic mRNA-binding proteins that bind to a stem loop (hairpin) RNA 
structure known as the IRE. IREs are located in either the 5’or 3’-UTRs of specific 
mRNAs encoding proteins involved in iron and energy homeostasis. IRPs expressed in
26
all tissue but in most cells IRP2 has less abundant expression than IRP1. IRP1 was 
shown to be the cytosolic counterpart of aconitase (Ac), which is a (4Fe-4S)-containing 
Krebs cycle enzyme that catalyzes the isomerization of citrate to isocitrate. Although 
IRP1 and Ac are only 30% identical, IRP1 contains all the Ac active sites. A (4Fe-4S) 
cluster assembly/disassembly leads to the switch between the forms. High iron levels 
convert apo-IRP into the active (4Fe-4S) Ac, non RNA-binding form. RNA binding and 
Ac activities are mutually exclusive and the switch between these activities occurs 
without changes in the IRP1 protein level. IRP2 shares about 60% identity with IRP1. 
Despite sequence similarities, IRP2 is thought not to form a (4Fe-4S) cluster and 
consequently lacks Ac activity. IRP2 is controlled at the level of protein stability and 
the regulation involves proteolysis by the proteasome (reviewed by Hentze and Kuhn,
1996).
When cellular iron is high, it will cause inactivation of IRP-1, which has an intact [4Fe- 
4S] cluster (holo-protein) and high Ac activity and cannot bind IRE of 5 -UTR or 
ferritin mRNA so that ferritin is translated freely, and can sequester excess iron in the 
newly formed ferritin shell. It also leads to degradation TfR mRNA that inhibits iron 
uptake. Both bring down the level of intracellular ‘free’ iron. When cellular iron is low, 
the IRPs is in the form of the apo-protein without the Fe-S cluster, and no Ac activity. It 
binds EREs with high affinity leading to the inhibition of ferritin mRNA translation and 
also binds to the 3’-UTR of TfR mRNA, thus stabilises of TfR mRNA and induces of 
TfR protein synthesis (Ponka et al., 1998). The net result is an increase in iron uptake 
and availability within the cell. Iron can therefore be considered as a feed-back regulator 
of its own metabolism.
Although iron is the major regulator of IRP activity, other factors such as UVA, H2 O2 , 
nitric oxide (NO), protein kinase C phosphorylation and hypoxia/reoxygenation 
modulate the RNA binding activity of IRP1 and/or IRP2 besides iron (reviewed by 
Cairo et al., 2000). IRP1 is up-regulated by NO and H2 O2 , IRP2 is up-regulated by NO 
but not H2O2 , thereby may limit the pro-oxidant challenge of iron (Pantopoulos and 
Hentze, 1998, Lieu et al, 2001).
1.5.4 New genes contribute to iron homeostasis.
Recent identification and characterisation of the hemochromatosis protein HFE, the iron 
exporter ferroprotin 1 and the transferrin-independent transporter Nramp2 and SFT also 
been demonstrated to have important roles in maintaining iron homeostasis in the body.
The hemochromatosis gene and its product
Hereditary hemochromatosis (HH) is a common autosomal-recessive disorder of iron 
metabolism, with an inherited disorder that results from an accumulation of excess iron 
in many organs, which is manifested by liver, heart and skin dysfunction. More than 
80% of HH patients have mutation in a major histocompatibility complex (MHC) class I 
type protein (HFE). HFE has been identified, cloned and expressed. The missense 
mutation of HFE is responsible for most cases of hemochromatosis. HFE is a 
glycoprotein, which associates with p2-microglobulin at the cell surface. Lack of HFE 
expression may be associated with iron over-loading. HFE forms specific complexs 
with the TfR to decrease the affinity for Tf (the negative regulator of TfR; Feder et al., 
1998). Expression of HFE leads to activation of IRPs and results in decreased ferritin 
and iron uptake from diferric Tf in HeLa cells (Riedel et al., 1999).
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Nramp (natural resistance associated macrophage protein), comprises include Nrampl 
and Nramp2. Nramp2 was first identified as a divalent metal transporterl (DMT1) or 
divalent cation transporterl (DCT1). The mRNA of the protein has IREs at its 3’-UTR, 
and is expressed in many different tissues with high expression levels at the duodenum 
brush border, is consistent with its role in intestinal iron absorption and iron acquisition. 
Nramp2 is located on the plasma membrane as well as on subcellular compartments 
characterised as late endosomes or lysosomes. It stimulates divalent metal (such as Fe2+ 
and Zn2+, Mn2+, Ni2+, Co+2, Cu+2, Cd+2) uptake and its function is pH dependent at an 
optimum at low pH (pH < 6). Nramp2 is subcellularly colocalised with Tf, and may 
play a role in transporting Tf-bound iron exits from the endosome membrane, thus it is 
named iron importer also (reviewed by Lieu et al., 2001). Nrampl, regulates 
macrophage activation in infectious and auto-immune disease. It is located in late 
endosomes/lysosomes and delivers divalent cations from the cytosol to phagolysosomes 
(reviewed by Lieu et al., 2001).
SF T  (stimulator of iron (Fe) transporter) is a transmembrane protein that enhances 
uptake of both Tf-bound and non-Tf-bound iron in cultured cells. Its activity appears
• ^ -4- ^ -4-relatively selective for Fe and Fe transport, which is energy dependent and at neutral 
pH. Expression of SFT seems to be inversely regulated by cellular iron levels. SFT is 
localised to endosomes and its expression stimulates iron assimilation from Tf, 
however, the relationship between SFT and Nrampl is still not clear (reviewed by Lieu 
et al., 2001).
•51
IM P  (integrin mobilferrin pathway): Fe is bound to a cell surface P3-integnn and 
transferred to a calreticulin-like chaperone protein called mobilferrin in intestinal cells
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of normal rodents and non-intestinal K562 (human erythroleukemia) cells. This 
pathway is not shared by other metals (Conrad et al., 2000).
Paraferritin: The 520 kDa membrane complex called paraferritin contains P-integrin, 
mobilferrin, flavin mono-oxygenase and p-microglobulin. It participates in the mucin- 
mediated Fe uptake in the gut lumen. Following internalisation, ferric iron may reduce 
to ferrous iron, then available for incorporation into compounds such as ferritin and 
heme (Conrad et al., 1999).
The iron exporter: ferroprotinl. Ferroprotinl was identified recently in man. It has 
IREs at its 5’-UTR, which can bind IRP1 and IRP2, indicating ferroprotinl is regulated 
by intracellular iron levels. It resides at the basolateral surface of duodenal enterocytes 
and may mediate iron efflux across membranes to plasma by a mechanism that requires 
ferroxidase activity (reviewed by Lieu et al., 2001)
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1.5.5 The Labile iron pool (LIP)
It is generally accepted that there is a small amount (<1%) of iron not bound to iron 
proteins or loosely bound to ligands present in the cytosol. This cytosolic iron pool is 
often referred as the transit iron pool, based on the assumption that it represents iron in 
transit between Tf and ferritin (Crichton et al., 1987). It has been named LMW-Fe or 
LIP, which serves to provide the cell with a relatively accessible form of iron for 
incorporation into cytosolic enzymes or proteins (Breuer et al., 1996). Although the 
nature of the LIP is not fully understood, it probably consists of both Fe2+ or/and Fe3+ 
ligands, existing in dynamic equilibrium as Fe2+ and Fe3+ forms. The Fe2+ becomes 
oxidised and deposited within ferritin (reviewed by Harrison and Arosio, 1996). In cells, 
where the environment becomes even more reducing than plasma, one may expect Fe2+ 
LMW species to be predominant. Ligands such as pyrophosphates, phosphate ester, 
ATP, ADP, GTP, nucleic acids, lipids, glycogen, riboflavin, ascorbate, sugars, amino 
acids, polypeptides and uncharged growth factors have been proposed, but none of these 
ligands have been universally accepted as the major ligand for iron in the LMW-Fe pool 
(reviewed by Crichton and Ward, 1992). Evidence confirming the importance of 
nucleotides as ligands for the LMW-Fe pool was presented by the discovering of 
receptors for ATP-Fe2+ or/and ATP-Fe3+ in mitochondria or ferric citrate in the cells 
(Weaver and Pollock, 1989 and 1990) which could supply iron for heme biosynthesis. 
Gurgueira and Meneghini in 1996 reported that there was an ATP-dependent uptake 
system for iron-citrate and iron-ATP chelators from isolated rat liver nuclei and 
suggested that these may be the important ligands.
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In cells, the LIP constitutes the cytosolic fraction of iron, which is accessible to 
permeable chelators. It contains the metabolically and catalytically reactive iron of the 
cells. The LIP ultimately causes peroxidative damage to vital cell structures due to its 
catalytic action in one-electron redox reactions. Unlike ferritin bound iron, the LIP is 
loosely bound to macromolecular complexes and they are sensed by the cytosolic IRPs. 
The LIP is maintained by a balanced movement of iron from extracellular and 
intracellular sources, which can be increased by endocytosis of Tf bound iron or non-Tf 
bound iron and degradation of ferritin. The decrease of LIP may occur following protein 
and heme synthesis as well as during exposure of cells to chelators (Epsztejn et al., 
1997). The increased intracellular iron may bind to DNA and membranes, and make 
them a selective target for oxidative damage by forming OH* in close proximity.
Iron bound to LMW ligands constitutes a potential source of catalytic iron upon UVA 
radiation. In vitro, physiological doses of UVA radiation could reduce Fe3+ bound to the 
LMW intracellular chelator citrate (Vile and Tyrrell, 1995). Various conditions of stress 
including UVA radiation (Pourzand et al., 1999), O2** (Biemond et al., 1988), reducing 
agents (Baader et al., 1994) have been shown in vitro to induce iron release from 
ferritin. In rodent cell extracts, oxidative stress can release iron from ferritin (Cairo et 
al., 1995). LMW-Fe has been shown to be active in the cell damaging process caused by 
oxidative stress, promoting lysosome rupture and release of potent hydrolytic enzymes 
to the cytosol (Ollinger and Brunk, 1995). It has also been reported that UVA radiation 
leads to bacterial cell lethality, by creating a transit iron load, providing very favourable 
conditions for the production of highly deleterious free radical through a variety of 
mechanisms that lead to oxidative stress (Hoerter et al., 1996).
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Recently, it has found that UVA radiation causes an immediate release of “free” iron in 
FEK4 cells as a result of UVA induced lysosomal damage, that leads to ferritin 
degradation in the cytosol by lysosomal proteases (Pourzand et al., 1999). UVA 
radiation of FEK4 cells also induces immediate heme release from microsomal 
hemoprotein (Kvam et al., 1999), which provides another potential source of harmful 
iron. This UVA-mediated iron release is likely to play a major role in UVA-mediated 
damage. The key role of iron in biological radical formation offers the potential for 
protective intervention by iron chelators such as DFO, and these have been studied both 
in vivo and in vitro (reviewed by Cabantchik, 1999) for treatment of imbalance in iron 
homeostasis, such as iron overload disease.
1.5.6 Determination of LMW-Fe or LIP
The LIP is the available cellular iron and has at least four potential functions: a) cellular 
iron transport b) expression of iron regulatory genes (TfR and ferritin) c) control of the 
activity of iron containing proteins d) catalysis of Fenton reactions. Attempts to quantify 
and assess the LMW-Fe pool, in the past, relied on methods that homogenise cells and 
tissue and the iron content is then determined using electron paramagnetic resonance 
(EPR) with iron chelators (Kozlov et al., 1992) or DFO-chelatable 59Fe (Rothman et al., 
1992). All the physicochemical methods used either require cell disruption or relatively 
large amounts of tissue because of the low sensitivity of the methods. As a consequence 
of tissue homogenization, the equilibrium between free and bound iron, as well as its 
oxidation state, may be altered. So the dynamic changes in this iron pool can not be 
measured. One method developed by Lytton et al. (1992) used nitrobenzdiazole- 
desferrioxamine (NBD-DFO), which is a fluorescent probe that can enter cells and 
extract iron thereby causing physical disruption. Binding of iron to this fluorescent
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probe quenched its fluorescence, and subsequent removal restored fluorescence which, 
in turn, could be used to provide a quantitative determination of iron content. However, 
because o f the poor cell tolerance and low quantum yield of the probe, it was difficult to 
assess the amount of iron bound to this probe (Epsztejn et al., 1997). It was shown that 
the fluorescence calcein assay (CA-assay), developed by Cabantchik and co-workers 
(Epsztejn et al., 1997), can measure intracellular iron.
Fluorescence calcein assay (CA-assay):
CA loading and intracellular LIP estimation
CA (see Materials and Methods for structure) is a fluorescent probe with a relative 
high fluorescence quantum yield. It has ethylenediaminetetracetic acid (EDTA)-like, 
two metal binding moieties and high affinity for Fe2+ and Fe3+ (1014 and 1024 M '1 
respectively in aqueous salt solution), which are similar to those of EDTA (Epsztejn et 
al., 1997). The fluorescent probe CA binds readily, stoichiometrically (1:1), and 
reversibly with a fraction of Fe2+ associated with LIP, while forming fluorescence- 
quenched CA-bound iron complexes (CA-Fe). CA is an indicator for transition metal at 
neutral pH in solution. It is a hydrophilic-carboxylated compound, therefore 
impermeable to cells. It can serve as a metallo-sensitive probe for Fe2+ for the following 
reasons, i) Quenching of fluorescence ensues upon binding of iron and other metals, 
such as Cu2+, Ni2+, Co2+, but not Ca2+ and Mg2+, even at 1000-fold excess in 
physiological salt solutions because of their very low selectivity. However, the 
concentrations of Cu2+, Ni2+, Co2+, are negligible in physiological solution. Binding of 
CA to Fe2+ is considerably faster than Fe3+, reflecting the different chemical activity of 
the two forms of iron, ii) DFO which has a high affinity for Fe (1031 for Fe3+ and 1021 for 
Fe2+) but low affinity for other metals can abrogate the CA-detectable LIP. iii) By
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addition of Fe chelators, the fluorescence produced by CA in cells is kept unchanged.
i *y i
Furthermore, although in the presence of ascorbate, Fe can be reduced to Fe , there is 
only slight increase in the fluorescence in cells (Breuer et al., 1995). Consequently, the 
quenched fluorescence of the CA-Fe complex in solution is fully restored by addition of 
excess chelators such as salicyladehyde isonicotinoyl hydrazone (SIH) or divalent metal 
Ionophore + DTPA (Diethylenetriamine pentaacetic acid, affinity for Fe > 1027) (Breuer 
et al., 1995; Cabantchik et al., 1996) which can abstract iron from CA, so the CA 
fluorescence assay is based on the availability of fast permeating high affinity chelators 
(e. g. SIH which can chelate both Fe2+ and Fe3+ forms of iron and has a binding constant 
1029 M '1 for Fe3+ and 1020 M"1 for Fe2+ (Epsztejn et al., 1997) and their capacity to 
abstract iron from CA, causing a dequenching of its fluorescence signal within the cells. 
These fluorescence changes evoked by SIH addition provides a basis for the CA-Fe and 
the dynamic monitoring of cytosolic iron in living cells using spectrofluorometry.
Inside the cells, LIP is operationally defined as free iron [Fe] plus [CA-Fe]. CA-Fe, CA 
and Fe are quick to reach equilibrium whose reaction is expressed as 
[CA-Fe] <-> [CA] + [Fe] (1)
[CA-Fe] can determined by CA-assay. The rest is to gain the dissociation constant (Kd) 
of [CA-Fe] by iron titration of CA-loaded cells (see Materials and Methods). In 
quantitative terms, the formation of CA-Fe in cells depends on the relative 
concentrations of free CA and free iron and the apparent Kd of CA-Fe, which is 
governed by equation (2).
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The [Fe] can be calculated by this equation. After the development of this assay, a 
number of different studies were carried to assess changes in the LIP after various 
treatments. Breuer et al (1996) showed that brief exposure to both Fe salt, ferrous 
ammonium sulphate (FAS), and oxidative treatment (e. g. H2 O2) caused increases in the 
LIP whereas DFO treatment decreases the LIP of the cells.
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1.6 UVB
The short, more energetic solar UVB wavelengths (the most energetic in sunlight) 
readily cause erythema so it is also known as erythemal UV. UVB is mainly absorbed 
by the epidermis, but it also penetrates sufficiently into skin to cause damage in the 
dermis. The morphological and histological cellular changes that occur in skin include 
erythema, pigmentation and hyperkeratosis (thickening of the stratum comeum) (Pearse 
et al., 1987).
UVB is absorbed by most biological macromolecules (such as lipid, protein and nucleic 
acids). DNA is both the main absorbing chromophore and the target for critical 
biological effects in the UVB region. Epidemiological studies have shown that human 
skin cancer is linked to UVB exposure. UVB induces non-melanoma skin cancer (e.g. 
squamous cell carcinoma, SCC) in mice (reviewed by de Grujil et al., 2000). Only a few 
cases of experimental animal melanoma have been reported by UVB (reviewed by de 
Gruijl, 1999). Evidence exists that it is the direct absorption of UVB by DNA, which is 
potentially mutagenic and is linked to photocarcinogenesis in vivo in animal models 
(Ley et al., 1991). It is well established that UVB gives rise to mutations in proto­
oncogenes and tumour suppressor genes that initiate the molecular cascade towards skin 
cancer (Brash et al., 1991; Ziegler et al., 1993; Berg et al., 1996). Furthermore, 
stimulation of DNA repair leads to a decrease in the incidence of UV-induced skin 
tumours in mice (Yarosh et al., 1992), further demonstrating the importance of the 
mechanism of repair to DNA damage in the biological effects of short UV wavelengths.
The most frequent bulk lesion of DNA photoproduct formed after UVB exposure is the 
pyrimidine dimer (Freeman et al., 1989). This is either a cyclobutane ring at
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neighbouring bases which form a cyclobutane pyrimidine dimer (CPD), or binding at a 
position in one base to the adjacent base to form the 6-4 pyrimidine-pyrimidone 
photoproduct (6-4 PP). UVB also causes a limited number of strand breaks and induces 
base modifications such as 7,8-dihydro-8-oxo-2’deoxyguanosine (8-oxo-dG) formation 
(reviewed by de Gruijl, 2000), which is known to form a miscoding lesion which can 
cause G to T transversion after replication of the damaged DNA (Shibutani et al., 1990). 
UVB causes both local and systemic immunosuppression. UVB leads to decreased 
rejection of transplanted tumours in mice (Kripke et al., 1974). It has been demonstrated 
by using a sensitiser of contact hypersensitivity (CHS) that CHS is suppressed in murine 
models or humans after UVB radiation. This may be due to impaired antigen presenting 
ability of Langerhans cells or generation of suppressor T-lymphocytes. UVB radiation 
impaired Langerhans cells in the epidermis of mice (Greene et al., 1979) and humans 
(Cooper et al., 1992). DNA damage may also be an important initiating event in 
immunosuppression (reviewed by Tyrrell, 1994). Immounsuppression therapy (in renal 
transplant patients) increases skin cancer. UVB-induced immunosuppression may 
therefore contribute to sunlight-induced cancer.
UVB may also damage proteins. Protein absorption peaks in the ‘non-solar’ UVC range 
but extends through the UVB because aromatic amino acid residues (phenylalanine, 
tyrosine and tryptophan) absorb UV with a maximum around 280 nm. Although cell 
membranes are not primary targets of UVB, radiation of cultured human keratinocytes 
with biologically relevant doses of UVB has been shown to cause lipid peroxidation 
(Pounonen et al., 1991). In cultured human skin fibroblasts (FEK4), only lethal doses of 




UVA radiation comprises lower energy photons and higher doses are needed to cause 
the same damage (such as erythema, sunburn and pigmentation and carcinogenesis) as 
that induced by UVB radiation. UVA is approximately a thousand times less as 
erythemagenic as that UVB per photon, this ratio of efficiency is also true in cultured 
cell systems. However, UVA reaches the Earth's surface at incident energy estimated to 
be 10-100 times greater than UVB and the UVA penetrates much deeper into the dermis 
than UVB (see Fig. 1 A).
An action spectrum is a measure of the relative effectiveness of different wavelengths 
within the spectral region of study to produce a given response such as erythema and 
cytotoxicity. Action spectra, taken together with solar spectroradiometric measurements 
and the known transmission of human skin have led to the conclusion that the UVA 
component of solar UV is a major contributor (up to 80%) of the cytotoxic action of 
sunlight at the basal layer of the epidermis (Tyrrell and Pidoux, 1987).
Exposure of certain individuals to UVA radiation is actually increasing due, at least in 
part, to the longer exposure times permitted by the more widespread use of primarily 
UVB-absorbing sunscreens. Modem tanning technology also leads to UVA exposures. 
The absorption of UVA radiation leads to cellular oxidation (reviewed by Tyrrell, 1991) 
and there is considerable overlap between the types of cellular modification induced by 
UVA and those generated by oxidative pathways. Furthermore, it now appears that 
cellular defence against UVA damage involves antioxidant pathways.
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1.7.2 UVA-induced oxidative stress
UVA is oxidative in nature. Most biological effects of UVA, either on cultured cells 
(Danpure and Tyrrell, 1976) or in skin are oxygen-dependent. In vivo tests showed that 
UVA-induced erythema and pigment darkening (both immediate and delayed) are 
dependent on oxygen (Tegner et al., 1983; Auletta et al., 1986; Rorsman and Tegner, 
1988). GSH plays a major role in protection of cultured human skin cells from UVA 
radiation and this provide additional evidence that ROS generated by radiation are 
involved in UVA toxicity (Tyrrell and Pidoux, 1989). Studies in prokaryotic and 
eukaryotic cells both indicate that ROS may be generated in vivo by UVA radiation. 
The cytotoxicity action of UVA radiation on bacteria, fungi and yeast is known to be 
oxygen dependent (reviewed by Tyrrell, 1991). Further evidence that UV radiation 
generates ROS comes from studies utilising Salmonella typhimurium lacking the 
oxidative defence regulon (AoxyR). These strains are hypersensitive to UV radiation 
(Kramer and Ames, 1987).
The absorption of UVA by many cellular molecules can lead to the generation of ROS 
via interaction with endogenous chromophores such as porphyrins (reviewed by Tyrrell 
and Keyse, 1990). Photosensitised oxidation occurs as type I or type II reactions 
(Foote, 1991). The absorption of UV-photons by a sensitiser results in an electronically 
excited state. The excited sensitiser subsequently reacts directly with the target 
molecules, e.g. DNA (Type I reaction); or reacts with molecular oxygen (Type II 
reaction) to produce ROS, mainly singlet oxygen. The potential chromophores for UVA 
radiation including compounds such as quinones, steroids, flavins, porphyrins and 
heme-containing proteins such as cytochromes, peroxidases and catalase (reviewed by 
Tyrrell, 1991).
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Evidences that UVA radiation generate ROS
Hydrogen peroxide (H2O2): Both spontaneous and enzymatic (via SOD) dismutation of 
02*’ are important sources of intracellular H2O2 generation. O2 ' + H+ -> HOO', 
2H00* -> H2O2 + O2 . H2 O2 can be generated by UVA radiation of tryptophan in an 
oxygenated solution (McCormick et al., 1976). H2O2 may also be produced by UVA 
radiation of cysteine (Cunningham et al., 1985). There is evidence suggesting that H2O2 
can be generated in cultured human skin cells during UVA radiation (Peak et al., 1990a; 
Vile and Tyrrell, 1995) and that UVA-mediated lipid peroxidation and protein 
sulfhydryl loss in cultured human skin fibroblasts are related to the intracellular 
generation of H2O2 (Vile and Tyrrell, 1995), although H2 O2 did not appear to be an 
important component in UVA-mediated cytotoxicity (Tyrrell and Pidoux, 1989; Peak et 
al., 1990).
H2 O2 is a weak oxidising agent but in the presence of traces of transition metals, it is 
capable of inactivating proteins directly via oxidation of essential thiol (-SH) groups, or 
proteins containing iron-sulphur clusters, reduced heme moieties or copper prosthetic 
groups. Most of the damaging effects of H2O2 on biomolecules are thought to be the 
result o f the formation of the OH* in the Fenton reaction or the metal catalyzed Harber- 
Weiss reaction (Fenton, 1894; Haber and Weiss, 1934; see section 1.5.1). Unlike O2 
H2O2 crosses membranes readily and can therefore migrate within the cell and extends 
the area of potential damage.
Superoxide anion (O2 '*) is formed when molecular oxygen acquires an additional 
electron. That is O2 + e" -> O2*’. The most important sources of O2 ' in vivo in aerobic 
cells are probably the electron transport chains of mitochondria and the endoplasmic
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reticulum. However, phagocytic cells (e. g. macrophages, neutrophils) directly generate 
O2*' via the NADPH oxidase enzymatic system as a part of their defence against 
invading microorganisms (Babior, 1999). UVA radiation of NADPH and NADH in 
vitro generates H2O2 and O2 '* (Czochralska et al., 1984; Cunningham et al, 1985), O2 *' is 
then dismutated by SOD to give H2O2 . O2*" is relatively unreactive towards most 
biomolecules, including lipids and nucleic acids (Fridovich, 1978). However, it may 
react with certain proteins and inactivate them, notably proteins in the presence of 
transition metals prosthetic groups such as haem moieties or iron-sulphur clusters 
(Gardner et al., 1995). While several oxygen species act as biological oxidants, 02*’may 
act as a reductant as well. For example it is able to reduce ferritin iron (Fe3+) to its most 
reactive form Fe2+ (Biemond et al., 1988). As a consequence O2 ' toxicity to cells will 
depend largely on the availability of iron in the system. However, it has been suggested 
that 02*’ is not significantly involved in cellular effects mediated by UVA that include 
lipid peroxidation and protein oxidation (Vile and Tyrrell, 1995; Gaboriau et al., 1995).
Hydroxyl radical (OH*) is a product of the Fenton reaction that involves H2O2 and Fe2+. 
However, it can also be formed in the absence of any transit metal. It has been shown in 
vitro: in the reaction between O2 ' and NO’ or H2 O2 and endogenous NO’ (Nappi and 
Vass, 1998). OH’ is likely to be generated in cells following upon UVA irradiation (Vile 
and Tyrrell, 1995). OH* has also been detected in human skin biopsies irradiated with a 
UV source (mostly UVA) (Jurkiewicz and Buettner, 1996). OH’ generation, however, 
has not been linked to UVA cytotoxicity (Tyrrell and Pidoux, 1989), lipid peroxidation 
(Vile and Tyrrell, 1995; Morliere et al., 1997), protein activation (Giordani et al., 1997) 
or gene activation in cultured human skin fibroblasts (Basu-Modak and Tyrrell, 1993).
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Singlet oxygen ^O^); ^  is a derivative of molecular oxygen in which all valence 
electrons are spin paired. It elevates molecular oxygen to an excited “singlet” state. It 
may be generated via type II photodynamic process following absorption of with UVA 
radiation and/or visible light by cellular compounds (chromophores), or it may arise 
from non-photochemical sources such as the macrophage respiratory burst or membrane 
lipid peroxidation. * 0 2  is not a radical, yet it is a short-lived species and very active. lC>2 
may oxidise many organic molecules, including unsaturated membrane lipids, amino 
acids, thiols and nucleic acids (reviewed by Keyse and Tyrrell, 1998), at least in vitro. 
^ 2  has been implicated in several deleterious biological effects of UVA on cultured 
cells, including cytoxicity (Tyrrell and Pidoux, 1989) and lipid peroxidation (Gaboriau 
et al., 1995) and in cellular signalling events leading to the induced expression of a 
variety of proteins (reviewed by Keyse and Tyrrell, 1998). Finally ]02 has been 
proposed as by-product of lipid peroxidation and is also able to induce lipid 
peroxidation process via its direct reaction with PUFAs to form LOOH and to as 
damage DNA (Cadenas, 1989). The involvement of ]02 in UVA cytotoxity to 
mammalian cells has been confirmed by using either specific scavengers (sodium azide 
or histidine) of !02, or deuterium oxide (D2 O), which prolongs the lifetime of *02 
(Tyrrell and Pidoux, 1989).
Other ROS that may be produced intracellularly upon UVA radiation and have 
important effects include the lipid peroxidation chain intermediates i.e. L 0 ‘, LOO* and 
organic LOOH. Lipid alkoxyl radicals have been detected in human skin biopsies 
irradiated with solar UV (Jurkiewicz and Buettner, 1996). Other radicals like NO’ or 
related species such as peroxynitrite (ONOO*) may also participate directly or indirectly 
in cellular oxidative stress following UVA radiation (Kuhn et al, 1998a). Based on such
43
studies, the UVA component of sunlight is now considered as a generator of 
intracellular oxidative stress (Tyrrell, 1991 and 1994; Pourzand et a l, 1999a).
1.7.3 UVA induced DNA damage and skin cancer
Although DNA is a poor chromophore for the absorption of UVA radiation, the 
wavelengths produce ROS via photosensitisers and cause various types of DNA 
damage. UVA can induce 7,8-dihydro-8-oxo-2’deoxyguanosine (8-oxo-dG) and 
cyclobutane-type pyrimidine dimers, strand breaks and DNA-protein cross-links 
(covalent links between a protein and DNA) (reviewed by Tyrrell, 1994; Runger, 1999). 
Among them, 8-oxo-dG is the most studied type DNA lesion that occurs in the UVA 
range and has been shown in various mammalian cell types, notably human fibroblasts 
(Kvam and Tyrrell, 1997). Furthermore, this damage has been shown to depend on !02 
generation (Kvam and Tyrrell, 1997). Pyrimidine dimers, have been shown to occur in 
human skin in vivo following UVA radiation (Burren et al., 1998).
Like UVB radiation, UVA radiation proved to be a complete carcinogen in experiments 
in which skin carcinomas developed in (hairless) mice under chronic exposure (de 
Gruijl et al., 1993; Setlow et al., 1993). UVA radiation induced non-melanoma skin 
tumour in experimental animals was reviewed by de Grujil, (2000). UVA induced 
melanoma in fish (Setlow et al., 1993). UVA may be involved in human melanoma (de 
Grujil, 2000). But unlike UVB (exposure mainly induces a rapidly increasing number of 
squamous cell carcinomas (SCC) and keratoses as precursors), UVA radiation initially 
induces mainly benign papillomas (Kelfkens et al., 1992). UVB radiation appears to 
exert predominantly a “tumour initiating” effect, whereas “tumour promotion” is 
relatively more pronounced with UVA radiation. UVA radiation can be either
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immunosuppressive or immunoprotective, depending on irradiation conditions. It was 
shown that UVA abrogated the immunosuppressive effects of UVB in mice, by a 
mechanism that may involve heme oxygenase (HO) (Reeve and Tyrrell, 1999). In mice 
UVA treatment causes local suppression of contact hypersensitivity (CHS), Langerhans 
cell depletion and T suppressor activation (Bestak and Halliday, 1996).
1.7.4 UVA activation of genes in skin cells
UVA radiation is capable of inducing gene expression in mammalian cells, including 
epidermal keratinocytes and dermal fibroblasts from human skin. The UVA activation 
of genes in skin cells has been implicated in the acute inflammatory response of 
erythema and immune suppression and the chronic responses of photoageing and skin 
cancer. Among these genes are HO-1, matrix metalloproteinases (MMPs), an 
intercellular adhesion molecule (ICAM-1), a dual specific phosphatase (CL-100), the 
FAS-ligand molecule and various cytokines (reviewed by Tyrrell, 1999). The 
mechanism of UVA induction of genes differs from UVB induction and involves the 
generation of ROS. Among the ROS, appears to be the primary effector of UVA- 
mediated gene activation. Many transcription factors are also induced by UVA 
radiation, such as c-Fos, c-Jun and nuclear factor kappa B (NF-kB), and these have been 
induced in keratinocytes as well as fibroblasts (reviewed Tyrrell, 1997).
Keratinocytes: UVA-I (340-400 nm) induced genes include pro-inflammatory 
cytokines such as interlenkin (IL)-6 and IL l-a  in KB cells (an epithelial carcinoma 
derived cell lines) when depleted of cellular glutathione prior to radiation (Morita et al.,
1997). TNF-a was induced by UVA-I in this cell line but this was independent of the 
endogenous glutathione levels. The anti-inflammatory cytokine, IL-10, is also induced
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in normal human skin keratinocytes as well as in KB cells (Grewe et al., 1995). In 
HaCaT, another human keratinocyte cell line, a dose dependent decrease in IL -la  
mRNA was observed 24 h after UVA radiation (Park et al., 1997). Mitogenic factors 
such as vascular endothelial growth factor (VEGF) are induced in HaCaT cells and 
A431 cells (another human keratinocyte cell line derived from a vulvar epithelioma, 
Mildner et al., 1999) but not primary keratinocytes. Granulocyte macrophage-colony 
stimulating factor (GM-CSF), a growth factor for epithelial cells, was induced by UVA 
in HaCaT cells (Park et al., 1997). ICAM-1 was induced by UVA radiation in 
keratinocyte (Krutmann and Grewe, 1995). There is indirect evidence (based on 
arachidonate release) that UVA radiation can activate phospholipase A2 (PLA2) in 
human keratinocytes (Hanson and deLeo, 1990).
Fibroblasts: HO-1 is strongly induced by UVA radiation in human skin fibroblasts 
FEK4 (Keyse and Tyrrell, 1989). HO-1 is clearly a redox-regulated gene (see section 
1.7.6). Interstitial collagenase or MMP-1 is a neutral metalloproteinase that degrades 
extracellular matrix proteins including type I, type III and type IV collagen. UVA 
radiation increases the production of collagenase by cultured skin fibroblasts (reviewed 
by Tyrrell, 1997). UVA radiation induced type II collagen (a matrix protein that is a 
major component of anchoring fibrils) but does not alter the mRNA levels of fibronectin 
(another dermal matrix protein) in cultured skin fibroblasts (Chen et al., 1997). The 
protein phosphatase, CL100, is up-regulated by UVA irradiation of fibroblasts (Keyse 
and Emslie, 1992).
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1.7. 5 UVA induced lipid peroxidation and membrane damage
Although all classes of macromolecules are susceptible to radical attack, poly 
unsaturated fatty acids (PUFAs) are extremely susceptible to oxidation owing to their 
conjugated double bond structures. Higher levels of PUFAs in biomembranes contribute 
to preserve membrane fluidity at low temperatures and thereby ensure functioning of 
integral membrane proteins. At the same time a higher degree of lipid unsaturation 
could exacerbate membrane susceptibility to lipid peroxidation.
Lipid peroxidation of the biological membranes is highly detrimental to cell membrane 
structure and function (reviewed by Bucala, 1996). This process has been linked to 
effects such as i) increased ion permeability ii) loss of fluidity iii) cross-linking of 
aminolipids and polypetides, and iv) inactivation of membrane enzymes and receptors 
(reviewed by Girotti, 1990). Lipid peroxidation is an autocatalytic, uncontrolled process 
started by the abstraction of a hydrogen atom (H) from PUFA’ double carbon-carbon 
bond to form lipid radical (L*) -  ‘Initiation’
LH + oxidant -> L*
Then L* is combined with oxygen to give a peroxyl radical (LOO*). LOO* abstracts a 
hydrogen atom from neighbouring PUFAs, thus producing a lipid hydroperoxides 
(LOOH) on the original PUFAs and a new lipid radical L*. The break down of LOOH to 
form new LO* or LOO*, thus allowing the chain of lipid peroxidation to continue -  
‘Propagation’
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L* + 0 2 LOO*, LH + LOO* -» LOOH + L* 
LOOH -» LO* + OH*
LOOH breakdown is important for two reasons: it generates radicals to propagate lipid 
peroxidations, and it also generates non-radical fragmentation products, such as 
aldehydes, e. g. Malondialdehyde or hydroxynonenal, many of which are biologically 
active. Ultimately, the extent of LOO* and L* cycling is governed by various competing 
‘Termination’ reactions.
L* + L* -> non-radical species 
L* + LOO* -> non-radical species 
LOO* + LOO* -> non-radical species
Iron can catalyse the formation of OH* and the decomposition of LOOH to produce LO* 
which are capable of abstracting hydrogen atoms from PUFAs and LOOH, producing 
LO* and LOO* which can continue to propagate lipid peroxidation.
UVA irradiation has been shown to induce lipid peroxidation in a number of studies 
(reviewed by Tyrrell, 1994). UVA radiation has been shown to cause a linear increase in 
liposomal lipid peroxidation in the absence of photosensitisers (Bose et al., 1989 and 
1990). There are a number of studies showing that lipid peroxidation and membrane 
damage occur in cultured human cell lines such as fibroblasts and keratinocytes after 
UVA radiation (Morliere et al., 1991; Punnonen et al., 1991; Moysan et al., 1993:
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Gaboriau et al., 1993; Vile and Tyrrell, 1995; Applegate et al., 1995; Clement-Lacroix 
et al., 1996). UVA induced lipid peroxidation was detected by thiobarbituric acid- 
reactive species (TBARs) and was decreased by vitamin E treatment in most of the 
studies. Membrane damage was measured by the lactate dehydrogenase (LDH) leakage 
assay. The UVA induced lipid peroxidation process and LDH leakage in human skin 
fibroblasts can be prevented by vitamin E or DFO (Gaboriau et al., 1993; Vile and 
Tyrrell, 1995). UVA radiation induced lipid peroxidation was found to be dependent on 
the “chemical” composition of membrane, enrichment of human keratinocytes with 
PUFAs increased the lipid peroxidation (Quiec et al., 1995).
UVA radiation induced membrane damage has been shown to be directly correlated 
with cell death in normal human skin fibroblasts from patients with the ‘photosensitivity 
dermatitis/actinic reticuloid syndrome’ (Applegate et al., 1994). It has also been shown 
that cell membranes are peroxidised by UVA radiation and become rigid and lose their 
integrity and selective permeability (Gaboriau et al., 1993). UVA radiation decreases 
both receptor-mediated and non-specific uptake of exogenous molecules (e.g. LDL) and 
sucrose in a dose dependent manner (Djavaheri-Mergny et al., 1993). UVA induces 
membrane damage in yeast and changes in permeability correlate well with lethality and 
are strongly oxygen dependent (Ito and Ito, 1983). UVA irradiation of skin fibroblasts 
of both human and mouse or human skin keratinocytes leads to the release of 
arachidonic acid (AA) metabolites and cyclooxygenase from the membrane (Hanson 
and de Leo, 1989 and 1990). This may be involved in the biosynthesis of eicosanoids. 
The released AA may contribute to UVA induced inflammation.
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In culture systems, the two main skin cell types, keratinocytes and fibroblasts, react 
differently when challenged with oxidative stress. The epidermal keratinocytes, which 
are the major targets for carcinogenic events, are more resistant to UVA-mediated 
membrane damage, compared with dermal fibroblasts (Tyrrell and Pidoux, 1988; 
Applegate et al., 1995; Moysan et al., 1996; Leccia et al., 1998). UVA radiation caused 
apoptosis of fibroblasts but not keratinocytes of human skin reconstructed in vitro 
(Bemerd et al., 1998). Primary human epidermal keratinocytes are radiation resistant 
when compared with human fibroblasts (Kasid et al., 1987). This resistance was 
retained in the immortalised as well as the transformed cell lines. The mechanism 
behind this surprising finding has yet to be clarified. Cultured keratinocytes have a 
higher level of antioxidant defence pathways than fibroblasts (see section 1.4). So it was 
proposed that the different sensitivity to UVA radiation may link to different 
antioxidant capacities. Other endogenous chromophores and membrane PUFA 
composition or even passage, media, buffer composition (calcium), and confluence also 
contribute.
Epidermal tissue of humans has a higher antioxidant level than the dermis (Shindo et 
al., 1994 and 1997). The skin cells derived from sun-exposed areas always have higher 
ferritin levels and it is proposed that they sustain less membrane damage than non­
exposed skin cells (Applegate et al., 1996).
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1.7.6 UVA and FEK4 fibroblasts
It has been found in our laboratory that primary human skin keratinocytes possess high 
basal levels of HO (provided by HO-2), and this has been proposed as a form of cellular 
defence against oxidative stress. The HO-1 mRNA levels are strongly inducible in 
primary dermal fibroblasts but barely inducible in human primary epidermal 
keratinocytes following oxidative stress (UVA radiation and H2 O2) (Keyse and Tyrrell, 
1990). Interestingly, constitutive HO-2 mRNA, HO-2 activity and ferritin levels are 
higher in primary keratinocytes when compared with matching fibroblasts. This higher 
ferritin level would enhance the cellular iron sequestering capacity and this may 
increase the resistance to oxidative stress (Balia et al., 1992; Vile et al., 1994). Both 
fibroblasts and keratinocytes derived from the same biopsy are sensitised to UV 
radiation by GSH depletion, however, the keratinocytes are sensitised to a much lesser 
extent, an observation which agrees quantitatively with the higher residual levels of 
cellular glutathione remaining after maximum depletion by BSO (approximately 25% 
for keratinocytes vs. 5% for the fibroblasts). GSH levels in the keratinocytes are 
approximately three times higher than in the fibroblasts (Tyrrell and Pidoux, 1988). 
UVA radiation damages membranes of the keratinocytes to a much lesser extent than 
those of the fibroblasts (Applegate et al., 1995). In cultured skin FEK4 fibroblasts, UVA 
radiation has shown short term effect (earlier events, immediately following UVA 
radiation up to 2 h) and long term effect (14 h to 48 h following UVA radiation).
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Table 1.2 Summary of the effects of UVA radiation on cultured FEK4 cells
Short term effect Long term efect
GSH depletion HO-1 activity increase
Ferritin degradation, free iron increase Microsomal heme decrease
Microsomal heme release Ferritin level increase
Lysosome damage Adaptive response
Lipid peroxidation in plasma membrane
Short term effects (0 h to 2 h after UVA irradiation): immediately after UVA 
radiation, lipid peroxidation increases in a dose-dependent manner (Vile et al., 1994 
and 1995). GSH is increasingly depleted as a function of UVA fluence (Lautier et al., 
1992). ‘Free’ iron is released in the cells immediately following UVA radiation 
(Pourzand et al., 1999a). UVA also induces lysosomal damage as measured by leakage 
of the fluorescence lysoSensor dye in a dose dependent manner as detected by 
epifluorescence microscopy and by measuring the level of lysosomal chymotrypsin 
activity (Pourzand et al., 1999a). It also releases heme within microsomal membranes 
(Kvam et al., 1999) and the release of heme from hemeproteins appears to determine 
the degree of induction of HO-1 transcription in human fibroblasts after oxidative 
stress.
Long term effects (14 to 48 h after UVA radiation): UVA (250 kJ/m2) radiation of
FEK4 cells led to an increased HO-1 activity between 14 and 48 h post radiation (Vile
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and Tyrrell, 1993 and 1994) and decreased microsomal heme content (Kvam et al., 
1999). Heme recovered to 90% of control level 22 h post-irradiation. UVA irradiation 
also increased ferritin levels and this may provide protection of cells challenged with a 
second dose of UVA radiation (see next section).
Adaptive response in FEK4 cells
The ability of a cell, tissue, or organism to develop a better resistance to damage 
following exposure to the same or related stress is known as an adaptive response. In 
FEK4 cells, the increased ferritin level (22-46 h after UVA radiation), which was 
dependent on HO-1 protected FEK4 cells from subsequent UVA-induced oxidative 
damage to the cellular membrane (Vile et al., 1994). FEK4 cells that had been pre­
irradiated showed a 2-fold increase in ferritin, leaked less LDH (which reflects cell 
membrane integrity) and showed less lipid peroxidation (as measured by thiobarbituric 
acid-reactive species, TBARs) when compared with sham-pre-irradiated cells when they 
were challenged with a second dose of UVA radiation. Treating cells with HO-1 
antisense oligonucleotide inhibited UVA radiation dependent induction of ferritin and 
HO-1 and abolished the protective effect of UVA pre-radiation. DFO, an iron chelator, 
blocked the increase in ferritin (but not HO-1) and also abolished the protection (Vile et 
al., 1994).
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The objectives of the project
The main objective of this project was to examine changes in labile iron following 
single or repeated exposures of human skin keratinocytes and fibroblasts to UVA 
radiation and to correlate the changes with critical biological end points such as 
lysosomal and plasma membrane damage. The overall aim was to gain a clearer 
understanding of the factors controlling the susceptibility of skin cells to solar 
ultraviolet radiation. Furthermore an attempt was made to identify the key reactive 
oxygen species that may play a role in UVA-mediated iron release. Finally the role of 
ferritin as a potential source of iron release was also examined in FEK4 cells.
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2. Materials and methods
2.1 Chemicals
All the reagents were from Sigma Chemical Co. (Poole, UK) unless otherwise 
specified. All the cell culture materials were obtained from Life Sciences Technologies 
(Paisley, UK), except the foetal calf serum (FCS) which was obtained from PAA 
(Austria). Calcein (CA) and its acetoxymethyl ester (CA-AM) and LysoSensor DND- 
153 were obtained from Molecular Probes (Leiden, Netherlands). Salicyladehyde 
isonicotinoyl hydrazone (SIH) was kindly provided by P. Ponka (Lady Davis Institute, 
Canada). Desferrioxiamine mesylate (DFO) was from Ciba-Geigy (Basel, Switzerland). 
See Fig. 2A for their structures. MilliQ water used to prepare phosphate buffered saline 
(PBS) and other stock solutions were issued from a Millipore purification system 
(MilliQ cartridge: Millipore, Bedford, MA) in order to minimize the presence of trace 
elements such as transition metals. Deuterium oxide (D2O) solution was prepared by 
dissolving one PBS tablet in 100 ml of 100% D2O. Protease inhibitors 
(phenylemthylsulfonyl fluoride: PMSF, Leupeptin and Chymostatin) were from 
Boehringer, Mannheim, Germany).
2.2 Cell culture
All the cell lines outlined below were cultured routinely and incubated in a humidified 
atmosphere at 37°C with 5% CO2 .
FEK4 (human primary skin fibroblasts derived from infant foreskin):
The medium was 15% FCS (heat-inactivated at 56°C for 45 min before use)-EMEM 
(Earle’s modified minimum essential medium) with 0.25% sodium bicarbonate, 2 mM 
L-glutamine, 50 IU/ml of each of penicillin/ streptomycin (P/S). Cells were passaged by
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Fig. 2 A  Chemical structures of CA (a), SIH (b) and DFO (c)
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trypsinisation once a week and were used for experiments between passages 11 and 16 
as follows: 3.5 x 105FEK4 cells were seeded and grown in 10-cm plastic plates to reach 
80-85% confluency for three days, and to 95% confluency for 4 days. In some cases, 
cells were further cultured for one more day (5 days in culture) to reach 100% 
confluency. In order to study the effects of confluency on the results obtained, some 
cells were kept for 2 additional days after reaching 100% confluency (i.e. 7 days in 
culture).
1BR3 (human primary skin fibroblasts derived from adult arm)
The medium was 15% FCS-EMEM, the same as used for FEK4 cells. For experiments, 
3.0 x 105 cells were seeded and grown in 10-cm plastic plates to reach 80% confluency 
for 4 days, and to 90% confluency for 5 days. The cells were passaged by trypsinisation 
once a week and were used for experiments between passages 10 and 16.
HaCaT (spontaneously immortalised human skin keratinocyte cell line derived from an 
adult back). This cell line maintains fully epidermal differentiation capacity, but 
remains non-tumorigenic. See Boukamp et al., 1988). The medium was 5% FCS- 
DMEM (high-glucose Dulbecco’s modified eagles medium) containing 50 IU/ml P/S. 
For experiments, 1.8-2 x 105 cells were seeded and grown in 10-cm plastic plates for 3 
days to reach 80% confluency, and to 90-95% confluency for 4 days. In some cases, 
cells were cultured for an additional day (5 days in culture) to reach 100% confluency.
HFK-SV61 (human foetal skin keratinocyte cell line transformed with a recombinant 
plasmid pSV6i, which contained an origin defective SV4 0 genome). This immortalised 
human cell line may lead to the acquisition of a malignant phenotype. See Parkinson
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and Newbold, 1980). The medium was 10% FCS-EMEM containing (0.2 pg/ml) 
hydrocortisone. For experiments, 3 x 105 cells were seeded in 10-cm plastic plates and 
grown to 75%-80% confluency for 4 days, and to 90% confluency for 5 days.
2.3 Treatments
2.3.1 Chemical treatments 
Hemin treatment
Stock solution: 20 mM in dimethyl sulfoxide (DMSO)
Cells were treated with 10, 20 or 50 pM (final concentration in conditioned medium in 
which cells had been grown) for 18 h at 37°C prior to treatments (e. g. UVA- 
irradiation).
Iron citrate treatment
Stock solution: 10 mM in PBS
Iron citrate was freshly made by mixing 100 mM of iron chloride with 100 mM tri­
sodium citrate (in H2O), then diluted to 10 mM in PBS and filtered. Cells were then 
treated with 50 pM or 100 pM iron citrate (final concentration in conditioned medium) 
for 18 h at 37°C prior to experiments.
DFO treatment
Stock solution: 150 mM in H2O
DFO treatments were usually performed with 10, 50, or 100 pM (final concentration in 
conditioned medium) for 18 h at 37°C. In some experiments 1 mM DFO pre-treatment 
was undertaken (final concentration in conditioned medium) for 2 h at 37°C. For 
experiments involving DFO treatment following UVA radiation, DFO was added at the
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final concentration of 100 pM in conditioned medium for 20 h at 37°C. The treatment 
was usually followed by a second challenge dose of UVA radiation.
H?Q? treatment
Stock solution: 25 mM H2O2 in PBS
Prior to the experiment, monolayer cells were rinsed twice thoroughly with pre-warmed 
serum free EMEM medium (SFM), in order to remove any trace of catalase from the 
medium. The cells were then incubated with H2O2 in SFM at the final concentrations of 
20, 50, 100, 250, 500 and 1000 pM for 30 min at 37°C.
ATZ (3-amino-1.2.4-triazole 1 treatment
Stock solution: 2 M in water
Monolayer cells were washed as described above (as for H2O2 treatment). Cells were 
incubated with 50 mM ATZ in SFM at 37°C for 90 min, shaded from direct light. For 
H2O2 + ATZ treatment: H2O2 was added during the last 30 min treatment at the desired 
concentrations.
Deuterium oxide (D?CD treatment
Stock solution: made with 100% D2 O instead of H2O
Cells were washed with D2O and irradiated in PBS and Ca2+/Mg2+ based D2O solution. 
That means using D2O instead of water as a solvent during the procedure.
q-tocopherol succinate treatment
Stock solution: 20 mM in methanol
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Cells were incubated with 10, 20 and 40 pM a-tocopherol succinate, respectively, in 
conditioned medium for 18 h at 37°C.
Butvlated hvdroxvtoluene (BHT) treatment
Stock solution: 100 mM in ethanol
Cells were incubated with 100 and 200 pM BHT, respectively, in conditioned medium 
for 2 h 37°C.
Protease inhibitor treatment
Stock solutions: Chymostatin, 50 mg/ml in DMSO; Leupeptin, 20 mg/ml in H2O 
FEK4 cells were treated with 50 pg/ml Chymostatin and 20 pg/ml Leupeptin for 18 h in 
conditioned medium. These protease inhibitors were present during the experiment 
except the step in which cells were detached with cell dissociation solution (Sigma).
The final concentration of DMSO, ethanol or methanol in the cultured medium did not 
exceed 0.2%.
2.3.2 UVA irradiation: 
Irradiation of cells in plates
Prior to irradiation, the medium was removed from the plates, and cells were washed 
thoroughly with PBS. Cells were then covered with PBS (4 ml for 6-cm, 10 ml for 10- 
cm plates) containing 5 ppm Ca2+ and Mg2+. This was followed by irradiation of cells at 
doses of 100, 250 and 500 kJ/m2. The incident dose was between 300-350 W/m2. The 
UVA doses were measured using an IL1700 radiometer (International Light, Newbury, 
MA). The lamp emits primarily UVA radiation (significant emission in the range of
60
350-400 nm, see Fig. 2B). Irradiation was carried out in an air-conditioned room at 
18°C in order to maintain the temperature of the cells to approximately 25°C throughout 
the irradiation procedure. In challenge dose experiments, following the first irradiation 
(i.e. pre-irradiation), the irradiation solution was aspirated and replaced by the saved 
medium (the retained medium in which cell had been grown). After the appropriate 
incubation time (e. g. 24 or 48 h) at 37°C, the cells were detached by trypsinization then 
the cell suspension was irradiated with a second dose of UV as outlined below.
Irradiation of cells in suspension
In many cases, cells were irradiated in suspension. For this purpose, the medium was 
first removed from the plates, and then the cells were rinsed with PBS. Next, cells were 
detached with 0.125% trypsin made in PBS, and then transferred to 14 ml Falcon tubes. 
After addition of 3% bovine serum albumin (BSA) the cell suspension was centrifuged 
at 1000 rpm for 1.5 min in a Jouan B 3.11 centrifuge at room temperature (RT). The 
supernatant was then aspirated, and PBS containing 3% BSA was added. At this point, 
cells were counted, and centrifuged at 1000 rpm for 1.5 min in a Jouan B 3.11 
centrifuge. The supernatant was then aspirated and the pellet re-suspended in PBS 
containing 5 ppm Mg2+ and Ca2+ (density: 5 x 10 5 cells/ml). The irradiation of cells in 
suspension was performed in quartz cuvettes (Scientific Laboratory Supplies, UK) 
under constant swirling on a mixing platform (IKA Laboratechnik, Germany). Sham- 
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Fig. 2B The spectrum of the UVA lamp
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2.4 Fluorescence calcein assay (CA-assay) and LIP measurement
2.4.1 CA-assay
CA has been used as a vital dye and has a high affinity for iron. It can be loaded easily 
to cells via its esterified acetomethoxy precursor (CA-AM) to produce intracellular CA 
fluorescence. A portion of the CA binds iron to form a CA bound iron complex (CA-Fe) 
which then has iron-quenched fluorescence. Based on this iron chelation property of 
CA, the group of Cabantchik (Epsztejn et al., 1997) set up a methodology to measure 
the CA-Fe and free iron. This method consists of measuring the magnitude of CA 
fluorescence dequenching by addition of a lipophilic, high affinity chelator such as SIH 
and allows non-invasive measurements of iron in intact living cells. By taking into 
account the Kd of CA-Fe, the free iron concentration can be obtained (see section 
1.5.6). The method is not cytotoxic to cells. In our original CA-assay, the procedure was 
long, with several centrifugation steps. Thus, it had a high and variable cell loss; poor 
cell recovery and decreased cell viability. The base line of CA was also variable and 
erratic. CA leakage from cells was high (up to 30%). Under these conditions, FEK4 
fibroblasts gave a very small response or no response to SIH at all. Therefore, the CA- 
assay was modified as follows (unpublished results, this laboratory):
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The schematic presentation of the steps for measuring CA-Fe by CA-assay
Step I









Cell counting & measuring 
fluorescence leakage
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Step I: CA loading
In order to get intracellular CA, cells were loaded with CA-AM.
Immediately after treatment, cells were harvested by trypsinization (unless the cells had 
already been irradiated in suspension) and transferred to 14 ml Falcon tubes. BSA was 
then added to the cell suspension at a final concentration of 3% in PBS to keep the 
osmotic integrity of the cells. The cell suspension was then centrifuged at 1000 rpm for 
1.5 min in a Jouan B 3.11 centrifuge. The supernatant was aspirated and the cells were 
loaded with 0.05 pM CA-AM in 1 ml of loading buffer (20 mM Hepes in bicarbonate 
free EMEM, pH 7.3) for 15 min at 37°C.
Step II: washing
This step allows the elimination of the excess CA-AM from the cell suspension. After 
loading, BSA (3% in PBS) was added to the cells followed by centrifugation at 1000 
rpm for 1.5 min in a Jouan B 3.11 centrifuge. The supernatant was then aspirated and 
the cells were re-suspended in 4 ml of PBS containing 3% BSA centrifuged at 1000 rpm 
for 1.5 min in a Jouan B 3.11 centrifuge. The supernatant was then aspirated.
Step III: fluorescence monitoring
This step allows the measurement of basal fluorescence intensity of free CA, CA-Fe 
and total CA. After washing, the cell pellet was re-suspended in 1 ml of fixing buffer 
(10 mM Hepes in EMEM, pH7.3 with 150 mM NaCL and 2 mM diethylenetriamine
0*7pentaacetic acid, DTPA which is a non-permeable iron chelator, affinity > 10 ). At this 
point cells were transferred to a quartz spectrofluorometer cuvette. Steady state 
fluorescence was then measured in the thermostated (37°C) cuvette with a magnetic
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stirrer in a Kontron (SMF-25, Zurich) spectrofluorometer (parameters set up excitation 
at 480 nm, emission at 517 nm, 10 nm slit). Fig. 2.1 shows a schematic presentation of 
the CA-fluorescence measurement in the spectrofluorometer. As you can see, the initial 
level of fluorescence (F) attained represents the amount of free CA present in the cells. 
Upon additional of SIH (final concentration 40 uM) the level of fluorescence increases 
(i.e. dequenching). The increase in fluorescence (AF) resulting from addition of SIH 
(which has a greater affinity for iron than CA) provides an in situ measurement for the 
CA-Fe. The total fluorescence of CA (Ft) contains F plus AF. The AF can also be 
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Fig. 2.2 CA-Fe estimation
CA-loaded cells (see CA-assay) were re-suspended in fixing buffer supplemented with DTPA to chelate 
extracellular Fe. After fluorescence (F, free CA) signal stabilisation, permeable iron chelator SIH (40 |iM final 
concentration) was added, causing an increase in fluorescence signal (AF), which represent CA-Fe and can be 
expressed as fractional changes of the total fluorescence (free CA + CA-Fe). That is Ff = AF/Ft =10.6/117 = 
0.0906
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Step IV: cell counting and the estimation of the fluorescence leakage
This step allows the normalisation of both intracellular and extracellular fluorescence. 
Cells were counted under the microscope and then the suspension was transferred to a 
14 ml Falcon tube and centrifuged at 1000 rpm for 2 min in a Jouan 3.11 centrifuge. 
The supernatant was then transferred to the cuvette and fluorescence was recorded in a 
spectrofluorometer, as mentioned above, and calculated by reference to the fluorescence 
of total CA, as the percentage of CA leakage. The CA leakage was normally below 10% 
of the total CA, demonstrating an improvement with methodology. So the total 
fluorescence measured (including a small part of extracellular CA fluorescence) in the 
cuvette can still represent the major fluorescence inside of the cell. Treatment that 
causes significant injury to cells may result in an unstable basal CA fluorescence during 
measurement and high leakage of CA because of damaged cell membranes. In our 
experiments, the basal and total CA fluorescence were stable during measurements 
except when cells were treated with higher concentrations of H2O2 (e. g. 500 pM or 1 
mM). Such experiments increased the leakage of CA to more than 40% of the total 
fluorescence.
Significance of the fluorescence curves in the CA-assav
In order to ascertain that the response to SIH is entirely due to the chelation of 
intracellular CA-Fe, CA-Fe dequenching by SIH was performed in a fixing buffer 
supplemented with DTP A, which is an impermeable chelator, so it can be determined 
that the response to SIH is entirely due to the chelation of iron of intracellular CA-Fe. In 
the experiments, this chelator did not cause a gradual dequenching of CA that would be 
indicative of membrane leakage. The basal and total (after adding SIH for 10-20 min)
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CA fluorescence are stable so the mobilisation of iron from macromolecular sources 
such as ferritin is unlikely. Therefore the method differentiates well between the small 
pool of cellular chelatable iron and the bulk of iron, which is bound to enzymes and 
proteins.
In CA-loaded cells, CA is relatively well retained inside the cells (Parish et al., 1999), 
has no detectable effect on a range of cellular function, e. g. In K562 cells: CA pre- 
loading or post-loading did not change transferrin iron uptake, indicating the cell 
integrity is not disturbed by CA-loading (Breuer et al., 1995a). The CA competes 
weakly with intracellular ligands for Fe2+ entering the cytoplasm (Breuer et al., 1995; 
Epsztejn et al., 1997), so there is a minimum disturbance to LIP itself (Breuer et al., 
1995).
Cells can be easily loaded with CA via its non-fluorescent esterified acetomethoxy 
precursor CA-AM. For example, loading of cells with 0.5 pM CA-AM for 5 min can 
lead to an intracellular concentration of the de-esterified CA up to 10 pM, while cells 
retain full viability (Cabantchik et al., 1996). The concentration of free CA inside of the 
cells was found to be directly proportional to the incubation time and CA-AM 
concentration.
2.4.2 Calibrations: In order to obtain the relationship between the changes in 
fluorescence elicited by SIH and LIP in cells, all fluorescence intensities were to be 
converted to an intracellular CA concentration and CA-loaded cells were titrated with 
FAS.
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The schematic presentation of the steps for calibration of LIP:
Free CA standard in cell suspension
i
Calculation of total CA concentration 
of CA- loaded cell suspension
1r
Calculation of total intracellular CA 
and [CA-Fe] concentration
r
Titration of CA- loaded cells with FAS
1
Determination of Kd for CA-Fe
1




Free CA standard curve in cell suspension
In order to convert the arbitrary fluorescence intensity value to free CA concentration, 
incremental amount of non-permeable free CA were added to the non-treated cell 
suspension to monitor the subsequent change in fluorescence.
Procedure: A stock of 10 pM free CA (commercial powder) was prepared in water and 
diluted to either 0.1 pM (used to check the fluorescence) or 1 pM (used for a free CA 
standard). In this procedure, an original auto-fluorescence of cell suspension (in Hepes- 
EMEM) was observed. SIH (at a final concentration of 40 pM) was then added to 
chelate iron or other metals that could be bound to free CA. Next, a 1 nM or 2 nM free 
CA solution was cumulatively added into the cell suspension in order to obtain a steady 
increase in the fluorescence signal (see Fig. 2.3a). The fluorescence intensity (y) can 
then be plotted against free CA concentration (x) from the curve as exemplified in Fig 
2.3a. The resulting plot is illustrated in Fig. 2.3b which shows that the fluorescence 
intensity is proportional to the concentration of free CA. By using linear regression, the 
relationship between fluorescence (Y) and the free CA concentration (x) can be 
obtained and expressed as Y = A + Bx, where A is cell auto-fluorescence and B is the 
proportional constant (slope). Table 2a shows the free CA standard curves for all the 
cell lines.
Table 2a Free CA standard of the cell lines:
Cell line Fluorescence (Y) = A + Bx
FEK4 10.2 + 7.3x
HaCaT 11.4 + 7.3x
HFK-SV61 10.7 + 8.3x













Fig. 2.3a Free CA titration of FEK4 cells
FEK4 cells were re-suspended in Hepes buffer supplemented with SIH (40 
pm final concentration). 1 or 2 pM of free CA solution was added 
cumulatively to produce steady increase in fluorescence.
Free CA standard of FEK4
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Fig. 2.3b Calibration curve for CA standard
The fluorescence intensity (Y) is converted to free CA concentration (X) 
using the linear regression. Y = A + Bx, e.g. FEK4 cells, Y = 10.2 + 7.3x
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Total CA concentration of CA-loaded cells in suspension: fCAl^
Once the relationship between the fluorescence intensity and the concentration of free 
CA was obtained by the CA standard curve, the total CA concentration of CA-loaded 
cell suspension can be calculated by the total fluorescence intensity (Ft) measured by 
CA-assay. The conversion formula is very simple, since it only requires the 
rearrangement of Y = A + Bx to x = (Y - A)/B. For example, the Ft for FEK4 is 117 mv, 
therefore, the free CA concentration can be calculated as x = (Y -  10.2)/7.3. Therefore 
the concentration of total CA in FEK4 cell suspension [CA]SUS will be (117-10.2)/7.3 = 
14.63 nM.
Total intracellular concentration of CA in CA- loaded cells: 1C Ah
After obtaining the total CA concentration in cell suspension, it is necessary (for 
calibration purposes) to determine the total intracellular CA concentration: [CA]t. The 
[CA]t of CA-loaded cells can be worked out using the material conservation 
relationship. The total amount of CA in the cell suspension, [CA]SUS x Vsus, must be 
equal to the total amount of CA inside the cells, [CA]t x (Vc x Nc). Here [CA]SUS is the 
total CA in suspension, Vsus is the total volume of the suspension, Vc is the volume of 
unit cell and Nc is the total number of cells in the suspension. That is:
[CA]susx Vsus= [CA]t x (Vc x Nc)
So the intracellular CA concentration can be expressed as:
[CA]t = [CA]SUS x Vsus /(Vc x Nc)
The unit cell volume, Vc, can be measured (see below) and Nc is obtained by counting 
cells under microscope. When [CA]SUS is known, the [CA]t can be easily obtained from 
the above formula e. g. FEK4 cells, 1 ml of cell suspension is used.
Nc is 1.62 x 106 and Vc is 5.7 pi, and [CA]SUS is 14.63 nM, so
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[CA]t = [CA]SUS x Vsus /(Vc x Nc) = 14.63 nM x lm l/(1.62x 106 x 5.7/ j/) 
= 14.63 x 10'3hM x 1 m l/(1.62 x 106x 5.7x 10'9ml) = 1.58 (iM.
Cell volume measurement
The unit cell volume was measured by spinning down a certain amount of cell 
suspension (e. g. 4 ml x l06FEK4) at 1000 rpm for 1.5 min in a Jouan 3.11 centrifuge. 
The pellet was then re-suspended in 200 pi PBS and transferred into an eppendrof tube, 
then transferred into the capillary tubes with Cristasel to seal them and centrifuged at 
1000 for 1 min in a Haematocrit centrifuge GIBA-GEIGY TH12. The volume of 
supernatant and packed cells was measured using a Haematocrit reader or a ruler. The 
cell volume (Vc) was calculated by using the percentage of cell packed volume divided 
by the number of cells, e.g. for FEK4:
Vc = 11.4% x 200 jj.1/4 xlO6 = 11.4% x 200xl06p //4  x 106 = 5.7p i (picoliter).
The cell volumes of all the cell lines used in this study were measured using this 
methodology as follows:
1) FEK4: 5.7 ± 0.73 pi
2) HaCaT: 3.2 ± 0.32pi
3) HFK-SV61: 3.3 ±0.32/7/
4) 1BR3: 6.5 ±0.97/7/
5) Confluent FEK4: 4.0 ± 0.3 pi
6) Confluent HaCaT: 2.6 ± 0.2 pi
(n = 5-8)
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The intracellular concentration of CA-Fe in CA- loaded cells
The concentration of the CA-Fe, which is corresponding to the change in fluorescence 
(AF) from each CA-assay fluorescence curve, elicited by adding SIH, can be expressed 
as the fraction of total concentration of CA as follows:
Ff = AF/Ft = [CA-Fe]/[CA]t 
[CA-Fe] can then be worked out when Ff and [CA]t are known from the above 
concentrations. The concentration of CA-Fe is equal to Ff x [CA]t. 
e. g. for FEK4, Ff = 0.09 and [CA]t = 1.58 pM, So [CA-Fe] = 0.09 x 1.58 = 0.14 pM.
Titration of CA- loaded cells with FAS
In order to investigate the relationship between fluorescence intensity of CA and 
intracellular iron concentration, the CA-loaded cells need to be titrated with a certain 
amount of ferrous ammonium sulphate (FAS). Since FAS is a source of Fe2+, a divalent 
metal ionophore A23187 was used to internalise the compound. Ionophore A23187 
allows the equilibrium the metal between cells and medium. Incremental amounts of 
doses of FAS were added, and the change in the fluorescence intensity corresponding to 
each step increase was recorded.
Procedure
A stock of FAS was prepared by dissolving the compound in argon treated MilliQ water 
and the solution maintained under argon to prevent oxidation of the ferrous iron. Non­
irradiated FEK4 cells were loaded with CA via CA-AM as described above and re­
suspended in 20 mM Hepes-EMEM, 150 mM NaCL without DTP A, pH 7.3 and 
transferred to the cuvette in the spectrofluorometer. Next, the cells were treated with 10 
pM divalent metal ionophore A23187 (from a 5 mM stock solution in DMSO), which 
increased the permeability of divalent metal ions to the cell membranes, and also caused
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around 5% increase in the original fluorescence due to the metal gradient. A stable basal 
line of the fluorescence signal was obtained, which corresponds to the concentration of 
free CA in the cell suspension. Next, a 0.5 or lpM FAS (final concentration in cell 
suspension) was added cumulatively to the cell suspension, and the discrete decreases in 
fluorescence (CA-Fe) were monitored and recorded until a plateau was reached, where 
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Fig. 2.4a A schematic diagram for a FAS titration curve in the cell suspension
FAS titration
76
Fig. 2.4a shows schematically a curve for titration of the cells with ferrous solution. The 
concentration of the free CA, was normalised as Fn = [CA]/[CA]t. It is worthy of the 
notion that this titration relies on the assumption that in the presence of ionophore 
A23187, ion channels are fully open and that ferrous ions can freely move in/out the 
cell membrane. See Fig. 2.9a for FEK4 cells.
Determination of the dissociation constant (Kd) of CA-Fe
As mentioned earlier, LIP in cells is operationally defined as
LIP = [Fe] + [CA-Fe]
Indeed, upon addition of CA-AM to cells, [CA] and [Fe] rapidly reach equilibrium, i.e.
Kd
CA-Fe CA + Fe (1)
at time 0 0 [CA]t 0
at equilibrium [CA-Fe] [CA] [Fe]
The concentrations of intracellular [CA] and [CA-Fe] can be obtained by the method 
described in previous sections. However, in order to calculate the level of free iron in 
the cells (i.e. [Fe] unbound to CA, the Kd of CA-Fe needs to be calculated. In
quantitative terms, the formation of CA-Fe in cells will depend on the relative 
concentrations of free C a nd free Fe and the apparent Kd of CA-Fe. At equilibrium, the 
Kd of CA-Fe can be calculated as follows:
[CA]t = [CA] + [CA-Fe] (3)
[Fe]add = [Fe] + [CA-Fe] (4)
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Where [CA], [Fe], and [CA-Fe] are concentrations of CA, Fe and CA-Fe in solution at 
equilibrium, and [Fe]add is the concentration of Fe added to reach new equilibrium into 
cell suspension after starting the titration. The concentrations of CA and CA-Fe can be 
expressed as a function of concentration of CA by simple transformation from (3) and 
(4). They are
The substitution of equations (5) and (6) into equation (2) will yield the equation (7) as 
follows:
[CA] ~ {[Fe]°M ~ [CA]‘ - [ C A l + K d }2 + AKd[CAl .
[CA-Fe] = [CA], - [CA] (5)
[Fe] = [Fe]add - [CA-Fe] = [Fe]add - [CA],+ [CA] (6)
[CA]{[Fe]add -  [CA], +[CA]} 
[CA], -[CA] (?)
So have
Kd [CA],- Kd [CA] = [CA] {[Fe]add -  [CA],}+ [CA]2 
[CA]2 + [CA] {[Fe]add -  [CA],} + Kd [CA] - Kd [CA], = 0 
[CA]2 + {[Fe]add -  [CA], + Kd}[CA] -  Kd [CA], = 0 (10)
(8)
(9)
Equation (10) can be easily solved and its solution can then be expressed as
2
The dimensionless parameter, Fn, can be defined in the case as
(12)
Dividing [CA]t in the two sides of equation (11) and therefore have
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^ , l^ l , M + K d + [ C A ] t } ± ^ [ F e ) add +[CA}l + K d ) 2 - 4 [F e\dd[CA\l
2 [CA],
If set Y = Fn; PI = [CA]t, the total CA concentration; P2 = Kd, the CA-metal 
dissociation constant; X = [Fe]add, the concentration of free metal Fe in solution. The 
above equation then becomes
Y= 1 -  {PI + P2 + X -  [(PI + P2 + X)2 -  4*Pl*X]1/2/2 P l} (14)
This equation is a general form for titration of Fe in solution and is identical to the one 
cited in the literature (i.e. Epsztejn et al., 1997). In our experiments, Kd of CA-Fe was 
obtained by non-linear fitting of the curve using the Origin program (version 6).
Significance of the Kd value in CA-assav
It can be seen that when the concentrations of CA and CA-Fe are obtained by the 
methods above, and the Kd is determined, the free iron concentration in the cells can be 
worked out. Both Kd and the concentration of the CA are unknown; Kd is the property 
of the system studied, therefore, by addition of a known amount of Fe (i.e. FAS) into 
the system and monitor the fluorescence intensity changes (F) of the CA versus the 
metal concentration, which is termed as titration, the Kd of CA-Fe could be obtained.
Analysis of the titration curves for determination of cell dependent Kd values
First the titration curve is estimated when Kd is given with a 5 pM intracellular CA 
solution. Fig. 2.5 and Fig. 2.6 show a range of Kd from 1000 to 2 pM and 1 to 0.01 
pM, respectively. Those curves will shift up or down when different initial CA 
concentrations are used but their shapes will remain the same under a chosen Kd. This 
is difficult for comparison, so that normalised concentrations of free CA which are
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defined as [CA]/[CA]t, are used. Fig. 2.5 and Fig. 2.6 are then therefore re-plotted as 
Fig. 2.7 and 2.8. It can be seen from Fig 2.7 and Fig. 2.8 that the Kd is greater than 20 
or smaller than 0.1, the titration method is not sensitive enough for the determination of 
the Kd. This is because the change in the concentration of free CA is either too small or 
too big to be identified. That also means that the best values of Kd analysed by titration 
method are those between 0.1 and 20. Kd can be estimated using above predicted 
curves form the original shape of titration curve. Values of Kd analysed by titration 
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Fig. 2.5 Titration curves of Fe2+ calculated by equation (2) 
in a 5 \xM CA solution under different Kd ranged from 1000 to 2 gM
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Fig. 2.6 Titration curves of Fe2+ calculated by equation (2)

















0 1 2 3 4 5 6
FAS concentration (jjM)
Fig. 2.7 Titration of Fe2+ in a 5 jiM CA solution.
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Fig. 2.8 Titration of Fe2+ in a 5 jiM CA solution.
This one is the same as Fig. 2.6 but [CA]/[CA]t instead of [CA]
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Fig. 2.9a Titration of CA-loaded FEK4 cells with FAS
Ionophore (final concentration 10 pM ) was added to CA-loaded cells to allow 
permeabilization of cells to divalent metal FAS. Each 2-3 min, 0.5-1 pM FAS was 
added (from a 0.5 or 1 mM stock) to cell suspension and the fluorescence quenching 
by metal concentration was recorded. For each metal concentration, the fluorescence 
intensity of free CA was then expressed as the fractional of the original fluorescence, 
e.g. 2 pM FAS, Fn = F/FO
0 .9
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0 2 6 84
pM of FAS
Fig. 2.9b Estimation of Kd of CA-Fe of FEK4 cells
From the titration of Fig. 2.9a, the free CA fluorescence intensity was first normalised 
to the initial fluorescence value (Fn), and then plotted against the metal concentration. 
The curve through the experimental points represents the non-linear least-squares best 
fit yielding Kd = 9.49 pM, as described under materials and methods.
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The Kd value for the cell lines
FEK4: 12.7 (median, n = 20)
1) HaCaT: 9.8 (median, n = 12)
2) HFK-SV61: 4.5 ± 0.6 (n = 6)
3) 1BR3: 19.6 ± 1.23 (n = 5)
Free iron fFel of the cells
Kd = [CA] x [Fe]/ [CA-Fe], so
[Fe] = Kd [CA-Fe]/{[CA]t -  [CA-Fe]}
i.e. for FEK4, [Fe] = 12.7 x 0.14/(1.58-0.14) = 1.23 \iM
LIP of the cells
LIP = [CA-Fe] + [Fe], for FEK4 cells:
LIP = 0.14+ 1.23 = 1.37 \iM
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2.5 Ferritin ELISA
The objective of the study was to quantitatively determine the level of ferritin after 
specified treatments using a polyclonal (anti-ferritin) enzyme-linked immunosorbent 
assay (ELISA) kit known as the Enzyme-Test ® Ferritin kit (Roche, UK). Principles of 
the method: Cytosolic extracts are prepared and added to a streptavidin tube along with 
biotinylated (monoclonal, mouse anti-ferritin antibodies) and monoclonal, mouse anti­
ferritin antibodies labelled with peroxidase (the incubation solution), [one-step 
sandwich]. The antibodies bind to streptavidin, thus anchoring the ferritin/antibody 
complexes to the tube. Excess antibodies are then removed by a washing step. Next, the 
substrate-chromogen solution, ABTS ® (di-ammonium 2, 2’-azino bis 3- 
ethylbenzothiazoline-6-sulphonate), is added. ABTS® is a peroxidase substract and is 
cleaved by the peroxidase to produce a characteristic green coloured product, which is 
measured spetrophotometrically. This is intended to provide a quantitative 
determination of ferritin present in the sample’s cytosolic extract.
Preparation of cytoplasmic extracts for ferritin analysis
Immediately after the treatments, cells were collected from plates by trypsinization (or 
directly collected when cells were in suspension) and re-suspended in ice-cold PBS and 
centrifuged at 1500 rpm for 5 min at 4°C in a Jouan CR412 centrifuge. The supernatant 
was then removed and cells were suspended in 1 ml of fresh ice-cold PBS. Next, cells 
were counted and centrifuged as above. The supernatant was then aspirated and the cells 
were re-suspended in ice-cold (IX) Munroe lysis buffer containing 10 mM Hepes pH 
7.5, 3 mM MgCL2 , 40 mM KC1, 5% glycerol and chymostatin (50 pg/ml), leupeptin (20 
pg/ml), and 0.3% NP-40 (Merck, UK) and lysed on ice for 10 min (30 pi of IX Munroe
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lysis buffer/1 xlO6 cells). Lysates were then centrifuged at 2500 rpm for 7 min at 4°C in 
a Jouan CR412 centrifuge. Next, the cell extract (supernatant) was removed and placed 
in a 1.5 ml tube for flash freezing in a mixture of dry ice and 95% methanol. Extracts 
were then stored at -70°C till use.
Protein measurement
Quantification of cytosolic proteins: The extracts were thawed and protein concentration 
was determined by Bradford assay with the BioRad reagent kit, UK (Bradford, 1976). A 
series of concentrations of BSA (100 mg/ml stock, Roche, UK) were made from 0 to 20 
pg/ml for standard calibration curve and absorbance measurements obtained using a 96- 
well microplate reader (Dynatech MR5000) at 595 nm. Measurements were performed 
in duplicate on 2-10 pi aliquots of the extracts and the mean values were obtained from 
duplicate experiments.
Procedure for ferritin :
Cells extracts were prepared for the measurement of ferritin content. All reagents were 
brought to room temperature before use. Ferritin standards and cell extracts were added 
to separate streptavidin-coated tubes. Incubation buffer (containing the anti-ferritin 
antibodies) was added to each tube and incubated at room temperature for 30 min. The 
tube contents were then aspirated, and rinsed with the washing solution followed by 
aspiration. The chromogen-substrate solution was then added to each tube. The tubes 
were incubated for 15 min at RT and the absorbance was determined immediately at 
420 nm using the spectrophotometer (UVIKON 922). The concentration of ferritin 
protein in each extract was determined against the ferritin standards. This value was
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then normalised using the total cytosolic protein content obtained from the Bradford 
assay and expressed as ng of ferritin per mg of protein (ng ferritin/mg).
2.6 Epifluorescence microscopy studies
The LysoSensor Green DND-153 dye was used to monitor the integrity of lysosomal 
membrane in both the fibroblasts and keratinocytes following UVA radiation treatment 
using epifluorescence microscopy. The LysoSensor dyes are pH indicators which 
partition into acidic organelles (lysosomes and Golgi apparatus). These acidotropic 
probes accumulate in acidic organelles as a result of protonation. This protonation also 
relieves the fluorescence quenching of the dye by its weak base side chain, resulting in 
an increase in fluorescence intensity. They freely permeate to cell membranes and 
typically concentrate in spherical organelles.
LysoSensor treatment (loading)
Cells grown on coverslips (inside 10-cm plates) for 3 days (80% confluency) were 
irradiated and then incubated for 2 h with fresh medium containing 1 pM LysoSensor 
probe. Then the medium (with the excess dye that was not taken up by the cells) was 
aspirated. Next, the coverslips (on which the stained cells were growing) were removed 
and placed on microscope slides suspended in approximately 20 pi of fixing medium 
(EMEM without phenol red supplemented with 5% FCS and glutamine). Coverslips 
were then fixed to the slides using nail vanish, and were viewed under the 
epifluorescence microscopy (Nikon, Japan; Excitation at 443 nm and emission at 505 
nm). Photographs were taken (using a 35 mm Nikon camera) at 400 x magnifications at 
a range of exposure times from 10 to 45 seconds.
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2.7 Cathepsin B (Cath B) ELISA
The objective of the study was to quantitatively determine the level of either total Cath 
B present in cells or in cytosol devoid of intact membrane (cytosolic S-100 fraction, see 
Dignam et al., 1988). Cath B test (supplied by KRKA, d.d. Jozef Stefan Institute, 
Ljubljana, Slovenia) is a sandwich immunoassay for the quantitative measurement of 
human Cath B (HCB) in tissue, cytosols and body fluids. Microtiter strip wells are 
supplied as a solid phase coated with rabbit polyclonal antibodies specific for HCB.
During the first incubation period antigens present in samples, controls or calibrators are 
bound to the antibodies at the solid phase. Unbound material is removed by a washing 
step. In the second incubation sheep anti-HCB antibodies, conjugated with horseradish 
peroxidase (HRP) are added into each well resulting in the formation of a sandwich 
complex:
Immobilised rabbit anti-HCB IgG*cathepsinB*sheep anti-HCB IgG-HRP
The unbound conjugate is removed by the second washing step. Enzyme-linked 
complex is then detected by incubation with TMB substrate solution (i.e. 3,3,5,5, - 
tetramethylbenzidine and H2O2). The developed blue colour is changed into yellow by 
stopping the reaction with 2 M sulphuric acid. The intensity of the colour developed is 
read at 450 nm using microtiter plate reader (Dynatech MR5000) and is proportional to 
the concentration of Cath B in the specimen, within the working range of the test. The 
Cath B concentration of the specimen and control was then determined from the 
calibration curve obtained by plotting the Cath B concentration of the calibrators versus 
the absorbance at 450 nm. Cath B concentration is expressed as nmol/1.
Preparation of S-100 cytoplasmic extracts
Immediately after treatment (i.e. UVA irradiation), cell suspension was transferred to 14 
ml Falcon tube and centrifuged. Cell pellets were re-suspended in 5 ml of ice-cold PBS 
and spun at 1500 rpm for 5 min at 4°C in a Jouan CR412 centrifuge. Supernatants were 
aspirated and cell pellets were re-suspended in five packed cell pellet volumes of 
Dignam (1983) buffer A (10 mM Hepes, pH 7.9, 1.5 mM MgCL2 , 10 mM KCL) and 
incubated on ice for 10 min. Cells were collected by centrifugation as before and 
resuspended in 4 packed cell pellet volumes. Cell suspension were transferred to glass 
homogeniser tubes and lysed by 10 to 12 strokes to obtain 90% cell lysis (depends on 
cell lines). Alternatively, the homogenisation step was replaced with mild detergent 
lysis (i.e. 0.3% NP-40). Cells were transferred to 14-ml Falcon tubes and centrifuged at 
1850 rpm for 10 min at 4°C in a Jouan CR412 centrifuge. Supernatant were then 
carefully transferred into eppendorf tubes (avoid mixing with the unwanted nuclei) and 
mixed with 0.11 volumes of Dignam buffer B (300 mM Hepes, pH 7.9, 30 mM MgCL2 , 
1.4 M KCL). This was followed by centrifugation at 35,000 rpm for 1 h in a Beckman 
L8-M Ultracentrifuge (rotor type ILI 70,000). Supernatant were then transferred to fresh 
eppendorf tubes (i.e. to avoid the contamination with the pellet) and flash-frozen and 
kept at -70°C till use.
Total protein was measured according to the Bradford assay. The concentration of the 
extracts for the Cath B was adjusted to 0.06 and 0.12 or even 0.2 mg/ml protein 
(depends on the cell lines) with Cath B standards.
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Prepartion of total cell extracts
FEK4 cells grown on 10-cm plates to 80-85% confluency were washed with PBS, then 
scraped in cold PBS (3 ml/plate) and collected in 14-ml Falcon tubes. Cells were spun 
at 1500 rpm for 7 mins in a Jouan CR412 centrifuge at 4°C. Supernatant was aspirated 
and cells were re-suspended in 1 ml PBS and counted. Cells were then spun as above. 
The supernatant was aspirated, cells were lysed in solubilisation buffer (50 mM Tris- 
HCL, pH7.5, 150 mM NaCL, 10% Glycerol, 5 mM EDTA, freshly supplied with 1% 
NP-40 and 1 mM PMSF) at 30-50 pl/lxlO6. The lysate was transfer to an eppendorf 
tube and spun at 13,000 rpm for 2 min in Heraeus Bio-fugel3 at 4°C. Supernatants 
were transferred to clean tubes for the Bradford assay.
Procedure for Cath B
Calibrators (standard, 100 pi), diluted cytosol S-100 or total cell extracts were pipetted 
into selected wells which coated with rabbit anti HCB IgG; 100 pi of dilution buffer 
was used as for the substrate blank (0 nmol/1 calibrator). After 2 h incubation at 37°C 
(under dark condition), the content of the wells was aspirated and the wells were 
washed 3 times with 400 pi of washing solution. Then the remaining fluid was removed 
by tapping the microtiter strips on absorbing paper. Next, 100 pi of sheep anti HCB IgG 
conjugate with HRP solution was dispensed into the wells and incubated 2 h at 37°C 
(under dark condition). The solution was then aspirated and the wells were washed 3 
times with 400 pi of washing solution as before. Next, 200 pi of IB M  Reagent plus 
Substrate (3,3,5,5, -tetramethylbenzidine and H2O2) was added into the wells and the 
microtiter was incubated 15 min at RT in the dark. The enzymatic reaction was stopped 
by adding 50 pi of stopping solution (2 M sulphuric acid) to all the wells after which, 
the absorbance was measured at 450 nm with a plate reader (Dynatech MR5000).
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2.8 Cath B immunohistochemistry
Antibody coupled to Fluorescein Isothiocyanate (FITC) was used to visualise the 
lysosomal enzyme, Cath B.
Cells were grown on coverslips for the LysoSensor experiments. After treatments, cells 
were re-incubated in conditioned medium for 1 h. Medium was aspirated, cell 
coverslips were rinsed with cold PBS 3-4 times and fixed with methanol for 5-6 min at 
RT, and kept at -20°C till use. Cells were rehydrated by soaking the coverslips for 10 to 
15 min in PBS at RT (checked under microscope), and drained gently with absorbing 
paper. Next, cells were blocked (to decrease non-specific binding) for 10 min at RT 
with 40 pi of Buffer X (BSA, 0.4 g; 100% Triton 20 pi; PBS, 20 ml) for each coverslip. 
Next, cells were drained of excess liquid and incubated with the polyclonal rabbit anti­
human Cath B IgG (supplied by KRKA, d.d. Jozef Stefan Institute, Ljubljana, Slovenia) 
in 1:25 dilution Buffer X for 1 h at RT. Thereafter, the coverslips were washed gently 
with PBS at RT (coverslips were soaked in the buffer for 3 min). After washing, cells 
were incubated with the goat anti-rabbit IgG antibody coupled to FITC (dilution: 1:80) 
for 1 h at RT under dark conditions. Coverslips were then drained as before and 
mounted on slides with 20 pi of 4-Diazabicyclo[2.2.2]octane (DABCO). Excess liquid 
was drained with absorbing paper and sealed with nail vanish and dried for 10 min on 
the bench. Slides were analysed by epifluorescence microscopy as described before for 
lysoSensor experiments. It is critical to avoid letting the cells dry and cells should be 
covered with parafilm during incubation.
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2.9 LDH assay
Lactate dehydrogenase (LDH) reflects cell membrane integrity, which catalyses 
pyruvic acid reduced to lactic acid in the presence of NADH. The reaction scheme used 
is as follows:
LDH
Pyruvic Acid + NADH ------------> Lactic Acid + NAD
The objective of the LDH assay was to measure the integrity of cell membranes by 
monitoring the leakage of LDH into the extra cellular media following different 
treatments. For this purpose, the LDH activity was spectrophotometrically determined 
by measuring the rate NADH disappearance at 340 nm during the LDH-catalysed 
conversion of pyruvic acid to lactic acid. The maximum wavelength of absorption of 
pyruvic acid is at 340 nm and this wavelength was used in our measurements. The LDH 
activity was expressed as arbitrary units (Vile et al., 1994).
LDH measurements
1) LDH of supernatant: immediately after UVA irradiation (the first or the second dose), 
irradiation buffer was aspirated and cells in 6-cm plates were incubated in 2 ml 
Minimum essential medium (MEM) containing glutamine and P/S for 2 h, after which 
aliquots of medium were removed and spun at 13,000 rpm for 2 min in a Heraeus Bio- 
fugel3 to remove any cells present.
2) Total LDH: after LTV A irradiation, cells were incubated with MEM for 2 h at 37°C. 
Then 0.025% NP-40 detergent was added during the last 30 min incubation period (Vile 
et al., 1994) in order to lyse the cells and measure the total LDH. The percentage of 
LDH leakage was expressed as LDH of supernatant/total LDH.
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2.10 Survival assay
Cell survival was judged by the ability of a cell to divide and form colonies, which is a 
good indication of cytotoxity.
Procedure: Cells were grown to 80-90% confluency then irradiated as described 
before. Immediately after the irradiation, cells were detached by trypsinization, and 
counted. After a serial of dilution of the cells, 400, 1600 and 6400 cells were seeded for 
each condition in 10-cm plates in triplicate. Cells were incubated in a sealed box 
containing 5% CO2 at 37°C with no further medium changes for 14-21 days. The 
medium was removed and cell clones were stained with 2 ml of 1% crystal violet in 
methanol for 2-3 min and then washed with tap water. Clones were counted. Clone- 
efficiency was calculated as number of clones formed /per total number of cells seeded 
in control plates.
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2.11 Neutral red assay
This assay measures the function of the ATP-dependent HsO+ pump which maintains 
the lysosomal pH gradient responsible for the uptake of the lysosomotopic neutral red. 
It is therefore related to both the energy state of the cells and lysosomal membrane 
integrity.
Procedure: Neutral red stock solution was prepared by thoroughly dissolving 0.02 g 
neutral red powder in 5 ml Milli Q water. After dissolution, 500 pi of the solution was 
transferred to 39.5 ml of 15% FCS-EMEM to get the final concentration of 0.005%. 
This solution was kept in the dark overnight at RT. The following day the solution was 
filtered through a 0.2 pM filter and spun at 3000 rpm for 10 min in a Jouan CR412 
centrifuge. Cells were irradiated in plates as described before. After irradiation, cells 
were incubated for 30 min at 37°C in conditioned medium. Then the medium was 
aspirated, cells were rinsed once with PBS and 2 ml of 0.005% neutral red medium was 
added to a 3-cm plate and re-incubated at 37°C for 1.5 h. Then the neutral red medium 
was aspirated, cells were washed 3 times in PBS. Then cells were lysed with 1 ml of a 
solution containing 50% ethanol, 1% acetic acid in water. The plates were swirled for a 
few min. Then 100 pi solution from each plate was transferred into a 96-well plate and 
the absorbance was measured at 560 nm in a plate reader (Dynatech MR5000).
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2.12 Explanations of the experimental design and symbols
I. Dose-response and Kinetic experiments
• In both dose-response and kinetic experiments, cells were cultured to 80% 
confluency and then irradiated at the indicated dose (250 or 500 kj/m2). In dose- 
response experiments, the CA-assay was performed immediately following 
UVA irradiation of the cells (0 h, in bold):
General formula for dose-response experiments:
Y 0h
Where “X ” is the dose of UVA used in kJ/m2 and “Oh” is the time (h) at which 
the CA-assay is performed following UVA irradiation of cells.
•  To study the effect of DFO on UVA-induced iron release, cells were treated with 
DFO (100 pM, final concentration) in conditioned media 20 h prior to UVA 
radiation treatment.
General formula for DFO treatment in single-dose experiments:
DFO + X0h
Where “X ” is the dose of UVA used in kj/m2 and “Oh” is the time (h) at which 
the CA-assay is performed following UVA irradiation of cells.
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• In Kinetic experiments, following irradiation, the irradiation buffer was replaced 
with conditioned-media and the cells were incubated for the indicated time (h in 
bold) at 37°C prior to CA-assay:
General formula for kinetic experiments:
Where “X” is the dose of UVA in kJ/m2 and “ah” is the time (h) at which the 
CA-assay is performed following UVA irradiation of cells.
Ia Dose-response
0°h: Cells were sham-irradiated i.e. Cells were kept under dark in irradiation buffer for 
the time of irradiation.
250°h: Cells were irradiated with UVA dose of 250 kj/m2.
500°h: Cells were irradiated with UVA dose of 500 kj/m2 
lb  Effect of DFO on UVA-induced iron release
DFO + 0°h: Cells were pre-treated with 100 pM DFO for 20 h in conditioned media. 
The next day cells were sham-irradiated i.e. Cells were kept under dark in irradiation 
buffer for the time of irradiation.
DFO + 250°h: Cells were pre-treated with 100 pM DFO for 20 h in conditioned 
media. The next day cells were irradiated with UVA dose of 250 kJ/m2.
DFO +  500°h: Cells were pre-treated with 100 pM DFO for 20 h in conditioned 
media. The next day cells were irradiated with UVA dose of 500 kJ/m .
96
Ic Kinetics
2 6h0 ’ : Non-irradiated control for the following 2 samples.
2jj *
250 : Cells were irradiated with a UVA dose of 250 kJ/m and then incubated for 2 h 
in conditioned media prior to CA-assay.
2506h: Cells were irradiated with a UVA dose of 250 kj/m2 and then incubated for 6 h 
in conditioned media prior to CA-assay.
024h: Non-irradiated control for the next sample:
25024h: Cells were irradiated with a UVA dose of 250 kJ/m2 and then incubated for 24h 
in conditioned media prior to CA-assay.
048h: Non-irradiated control for the next sample.
25048h: Cells were irradiated with a UVA dose of 250 kJ/m2 and then incubated for 48h 
in conditioned media prior to CA-assay.
II. Challenge dose experiments
In challenge dose experiments, cells were cultured to 80% confluency, and then 
irradiated at the indicated dose (day 0, in bold). After the first irradiation, the irradiation 
buffer was replaced with conditioned media and cells were incubated for one (day 1, in 
bold) or two (day 2, in bold) additional days. The second challenge dose with UVA was 
performed either in 24 h (day 1) or 48 h (day 2) after the first irradiation performed on 
day 0. The CA-assay was performed immediately following the second irradiation 
(either in day 1 or day 2).
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General formula for challenge-dose experiments:
Where “X ” is the dose of UVA used in kj/m2 for the first irradiation and “Y ” is 
the dose of UVA used in kJ/m2 for the second irradiation. “dO” is the day at 
which the first irradiation was carried out. “d l” or “d2” are the days at which the 
second irradiation was performed. is the 20-48 h incubation period between 
the first and second irradiation treatments.
To study the effect of DFO on UVA-induced iron release, cells were treated with DFO 
(100 pM, final concentration) in conditioned media 20 h prior to the second irradiation 
in challenge dose experiments
General formula for DFO treatments in challenge-dose experiments:
Xd0 + DFO / Ydl"2
0d° / 0 dl
Cells were sham-irradiated during both the first and second irradiations in “day 0” and 
“day 1”. After the first sham-irradiation, the irradiation buffer was replaced with 
conditioned media and cells were incubated for an additional day at 37°C.
0d#+ DFO / 0dl
Cells were sham-irradiated during the first and second irradiations in “day 0” and “day 
1”. After the first sham-irradiation the irradiation buffer was replaced with conditioned 
media supplemented with DFO and cells were incubated for an additional day at 37°C.
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Od# / 250dI
Cells were sham-irradiated during the first irradiation. After a day of incubation in 
conditioned media, cells were irradiated with a UVA dose of 250 kJ/m2 in “ day 1”.
0d°+ DFO / 250dl
Cells were sham-irradiated during the first irradiation (i.e. in day 0). After a day of 
incubation in conditioned media supplemented with DFO, cells were irradiated with a 
UVA dose of 250 kJ/m2 in “day 1”.
250do / 0dI
Cells were irradiated with a UVA dose of 250 kJ/m2 in “day 0” and then incubated in 
conditioned media for an additional day. Cells were then sham-irradiated in “day 1”.
250do + DFO / 0dl
Cells were irradiated at 250 kj/m2 in “day 0”. The irradiation buffer was then replaced 
with conditioned media supplemented with DFO and cells were incubated at 37°C for 
an additional day. Cells were then sham-irradiated at 250 kJ/m2 in “day 1”.
250d°/250dl
Cells were irradiated with a UVA dose of 250 kJ/m2 in “day 0”. After a day of 
incubation in conditioned media, cells were re-irradiated with a UVA dose of 250 kJ/m2 
in “day 1”.
250d°+ DFO/ 250 dl
Cells were irradiated in “day 0” at 250 kj/m2 and then incubated in conditioned media 
supplemented with DFO for an additional day. Cells were then re-irradiated with a 
UVA dose of 250 kJ/m2 in “day 1”.
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0 d0/  0 d2
Cells were sham-irradiated during the first and second irradiations in “day 0” and “day 
2”. After the first sham-irradiation, the irradiation buffer was replaced with conditioned 
media and cells were incubated for two additional days at 37°C.
250do / 0d2
Cells were irradiated with a UVA dose of 250 kJ/m2 in “day 0” and then incubated in 
conditioned media for two additional days. Cells were then sham-irradiated in “day 2”.
0d°/ 250d2
Cells were sham-irradiated during the first irradiation. After two days incubation in 
conditioned media, cells were irradiated with a UVA dose of 250 kJ/m2 in “day 2”.
250d0/ 250d2
Cells were irradiated with a UVA dose of 250 kJ/m2 in “day 0”. After two days 
incubation in conditioned media, cells were re-irradiated with a UVA dose of 250 kJ/m2 
in “day 2”.
2.13 Statistical analysis
Paired or unpaired Student’s two-tailed /-test was used as appropriate to test differences 
between groups of data. Note that the rejection p value is 0.05. The statistical analyses 
were performed using the Origin program (version 6).
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3. Results
3.1 Characterisation of LIP release in cultured human skin cells 
following single or repeated exposures to UVA radiations
It has been shown in our laboratory that UVA radiation induces chelatable iron release 
in a human primary skin fibroblast cell line, FEK4 (Pourzand et al., 1999a). The 
objective of the present study was to characterise this phenomenon further in a series of 
human skin fibroblasts and keratinocytes following single or repeated exposures to 
UVA radiation. Using the Calcein (CA)-assay, first the dissociation constant (Kd) of 
calcein-bound iron (CA-Fe) was determined in CA-loaded cells, the results were then 
expressed as “LEP” which is operationally defined as the sum of free CA-unbound iron 
[Fe] and [CA-Fe] (see M aterials and Methods and Epsztejn et al., 1997). In order to 
estimate the extent of LIP release following irradiation treatment, both fibroblasts and 
keratinocytes were exposed to a range of doses of UVA irradiation at natural exposure 
levels (i.e. 150, 250 and 500 kj/m2, see Dose-response). Furthermore, the kinetics of 
UVA-induced increase in LIP were monitored up to 48 h (LIP levels of 1BR3 and HFK- 
SV61 were monitored only up to 24 h) post-irradiation time with UVA doses of 250 
kj/m (see Kinetics). To investigate whether UVA-induced LIP release also occurs 
following a second irradiation, the UVA-irradiated cells (i.e. 250 kJ/m2) were 
challenged with a second dose of UVA (i.e. 250 kJ/m2), 24 or 48 h after the first 




The fibroblasts used in this study were FEK4 (human foreskin fibroblast cell line) and 
1BR3 (human skin fibroblast cell line). Table 3.1 summarises the basal level 
concentration of LIP ([CA-Fe] + [Fe]), in both FEK4 and 1BR3, as determined by the 
Kd values with CA-assay for each cell line (see Materials and Methods). These results 
demonstrated that the basal level of LIP in 1BR3 fibroblasts is 1.7 fold higher than that 
of FEK4 fibroblasts.
Table 3.1 Determination of basal LIP in FEK4 and 1BR3 cells
Cell line [Fe] [CA-Fe] LIP=[Fe]+[CA-Fe]
pM pM pM
FEK4 0°h 1.07 ±0.41 0.1410.05 1.21 ±0.45
1BR3 0°h 1.79±0.38 0.21 ±0.07 1.9910.41
Note: Kd of CA-Fe for FEK4 and 1BR3 were 12.7 and 19.1 pM, respectively (n=6-20). 
The concentrations of Fe, CA-Fe and LIP are expressed as the mean ± SD (n = 3-6).
3.1.1a Dose response
The LIP levels were measured using the CA-assay immediately after irradiation of 
fibroblasts with UVA doses of 150, 250 and 500 kJ/m2. The results (Table 3.2) revealed 
that the levels of LIP in both 1BR3 and FEK4 cells are increased in a dose-dependent 
manner up to 2.8 fold of the control values. For FEK4 cells, the threshold of UVA-dose 
necessary for induction of iron release was determined, which was found to be around 
150 kJ/m2. These results illustrated that although LIP release occurs in both cell lines, 
the UVA-induced LIP concentration in 1BR3 remains 1.7 fold higher than in FEK4 
cells.
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Table 3.2 Modulation of the LIP levels following a range











0°“ 0 0 1.21 ±0.45 1
150oh 150 0 2.23 ±0.51* 1.61 ±0.28
250oh 250 0 2.46 ± 0.67* 2.14 ±0.51
500oh 500 0 3.08 ± 0.71* + 2.79 ±0.51
1BR3 UVA dose Time (h) LIP Fold increase
Samples (kJ/m2) post-UVA (pM) compared to control
o0h 0 0 1.99 ±0.41 1
2500h 250 0 4.06 ± 0.44* 2.11 ±0.52
500°h 500 0 5.02 ± 0.45* + 2.60 ± 0.57
Note; Kd of CA-Fe for FEK4 and 1BR3 were 12.7 and 19.1 pM, respectively (n=6-20). 
Measurements were performed at indicated times (h) after UVA irradiation.
The concentrations of LIP are expressed as the mean ± SD (n = 3-6).
* : Significantly different from the sham-irradiated control (00h),p < 0.05.
+ : Significantly different from 250 kJ/m2-irradiated sample (2500h),/? < 0.05.
3.1.1b Kinetics
The kinetics of iron mobilisation in FEK4 cells was followed using the CA-assay up to 
48 h post-irradiation time with a UVA dose of 250 kJ/m2. The results (Table 3.3) 
showed that the immediate increase in LIP is sustained up to 2 h after irradiation with a 
UVA dose of 250 kJ/m2 and returns to around the control value at 6 h post-irradiation. 
The CA-assay performed 24 or 48 h after UVA irradiation of both FEK4 and 1BR3 
cells revealed no further change in LIP concentration.
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Table 3.3 Modulation of the LIP levels following UVA
250 kJ/m irradiation in FEK4 and 1BR3 cells
FEK4 UVA dose Time (h) LIP Fold increase
Samples (kJ/m2) post-UVA (pM) compared to control
o*h 0 - 1.21 ±0.45 1
2500b 250 2 2.46 ± 0.67* 2.14 ±0.51
q2,6Ii 0 - 1.04 ±0.12 1
2502h 250 2 1.71 ±0.33* 1.68 ±0.29
250<b 250 6 1.01 ±0.28 0.95±0.23
024b 0 — 1.13 ±0.22 1
25024h 250 24 1.07 ±0.28 0.95 ±0.12
048h 0 — 1.27 ±0.30 1
25048b 250 48 1.08 ±0.27 0.89 ± 0.04
1BR3 UVA dose Time (h) LIP Fold increase
Samples (kJ/m2) post-UVA (pM) compared to control
o o C
P
0 0 1.99 ±0.41 1
250oh 250 0 4.06 ± 0.44* 2.11 ±0.52
024b 0 — 1.92 ±0.35 1
25024b 250 24 1.64 ±0.45 0.85 ±0.13
Note: Kd of CA-Fe for FEK4 and 1BR3 were 12.7 and 19.1pM, respectively (n=6-20). 
Measurements were performed at indicated times (h) after UVA irradiation.
The concentrations of LIP are expressed as the mean ± SD (n = 3-6).
* : Significantly different from the sham-irradiated controls,/? < 0.05.
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3.1.1c Effect of confluency on UVA-induced LIP release in FEK4 cells
It is known that confluent human skin fibroblasts are more resistant to both UVA- 
mediated membrane damage (Gaboriau et al., 1993) and cytotoxicity (unpublished data, 
this laboratory). Furthermore, Pourzand et al. (1999a) have reported that confluent 
FEK4 fibroblasts have significantly less chelatable iron than exponentially growing 
cells by IRP/IRE binding. The extent of UVA-induced iron release in confluent 
fibroblasts was therefore investigated. For this purpose, FEK4 cells were grown to 
confluency and incubated for 2 to 4 additional days in the incubator. The levels of LIP 
were then measured by CA-assay immediately after UVA irradiation of confluent cells 
(UVA doses of 250 and 500 kJ/m2). The results (Table 3.4) showed that although the 
basal level o f LIP in confluent fibroblasts was similar to that of exponentially growing 
cells (i.e. 80% confluent fibroblasts), the level of UVA-induced LIP was much lower in 
confluent cells. For example with a UVA dose of 250 kJ/m2, the level of LIP increased 
up to 2.46 pM in growing cells and only up to 1.80 pM in confluent cells. Nevertheless 
the immediate release of LIP in confluent cells following UVA radiation appeared to be 
dose-dependent and significantly different from the sham-irradiated controls.
Table 3.4 Effect of UVA on the LIP levels in confluent FEK4 fibroblasts
FEK4 UVA dose Time (h) LIP Fold increase
(kJ/m2) post-UVA (pM) compared to control
Ooh 0 - 1.2210.11 1
250oh 250 0 1.8010.28* 1.4810.23
500°h 500 0 2.4010.25* 1.9710.12
Note: Kd oj' CA-Fe for confluent FEK4 was 12.7 pM (n == 20).
Measurements were performed at indicated times (h) after UVA irradiation. 
The concentrations of LIP are expressed as the mean ± SD (n = 3-4).
* : Significantly different from the sham-irradiated control (00h),p < 0.05.
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3.1.Id The second challenge dose
The phenomenon of UVA-induced iron release was investigated following repeated 
exposures of fibroblasts to UVA radiation. This was achieved by designing experiments 
to monitor the release of LIP with a second challenge dose of UVA 24 or 48 h after the 
first irradiation.
The results (Table 3.5) showed that a second challenge dose of UVA 24 or 48 h after 
the first treatment, still promotes LIP release within fibroblasts. Indeed in both FEK4 
and 1BR3 fibroblasts, the pre-irradiated samples (250d0 / 250dl or 250d° / 250d2) 
yielded the same increase in LIP as the corresponding non-pre-irradiated samples (Od0 / 
250dl or Od0 /  250d2). Furthermore in FEK4 cells, the irradiation of pre-irradiated 
samples 24 or 48 h after the first dose (250d0/ 250dl and 250d°/ 250d2, respectively)
triggered a similar amount of LIP release. Also, in agreement with dose-response 
experiments, the sham-irradiation of pre-irradiated cells 24 or 48 h after the first UVA 
irradiation (250d0/ 0dl or 250d0 /  0d2) did not modulate the level of LIP as compared 
to the corresponding sham-irradiated control (Od0 /  0dl or Od0 /  0d2). This is presumably 
due to the fact that the UVA-induced increase in LIP returns to around the control value 
by 6 h post-irradiation time and does not further change for the next 24 or 48 h 
following irradiation treatment.
Taken together, these results suggest that UVA-induced iron release within fibroblasts 
is a general response to UVA since it occurs to the same extent following single or 
repeated exposure to radiation treatment.
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Table 3.5 Modulation of the LIP levels following a second dose

















od0/o dl 0 0 - 1.13 ±0.22 1
250d° /0 dl 250 0 - 1.07 ±0.28 0.95 ±0.12
0d°/250dl 0 250 - 2.42 ± 0.58* 2.16 ±0.40
250do/250dl 250 250 - 1.85 ±0.56* 1.65 ±0.31
od0/o d2 0 - 0 1.27 ±0.30 1
250do/0 d2 250 - 0 1.08 ±0.27 0.89 ± 0.04
0d°/250d2 0 - 250 2.21 ±0.52* 1.78 ±0.45

















0d(,/0 dI 0 0 - 1.92 ±0.35 1
250d° /0 dl 250 0 - 1.64 ±0.45 0.85 ±0.13
0d°/250dl 0 250 - 3.70 ± 1.01* 1.95 ±0.52
250d°/250dl 250 250 - 3.54 ± 0.74* 1.84 ±0.14
Note: Kd of CA-Fe for FEK4 and 1BR3 were 12.7 and 19.1pM, respectively (n=6-20). 
Measurements were performed 0 h after the second UVA irradiation.
The concentrations of LIP are expressed as the mean ± SD (n = 3-6).
*: Significantly different from the sham-irradiated controls (Od0/  0dl^ ) ,/?  < 0.05.
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3.1.1e Effect of DFO on the LIP levels following single or repeated exposure of 
fibroblasts to UVA radiation
Pourzand et al. (1999) have previously demonstrated that treatment of FEK4 cells with 
DFO, 18-20 h prior to UVA radiation could abolish both the basal and UVA-induced 
levels of chelatable iron. To study the effect of DFO on suppression of UVA-induced 
LIP release, the CA-assay was performed with both FEK4 and IBR3 cells that were 
either treated with the iron-chelator 20 h prior to the first irradiation or 20 h prior to the 
second irradiation. The results (Table 3.7) showed that in agreement with findings from 
Pourzand et al. (1999), DFO treatment prior to the first UVA radiation abolished both 
the basal and induced level of LIP in both FEK4 and 1BR3 cells. Furthermore the 
addition of DFO following the first irradiation also completely abolished the level of 
LIP release in both pre-irradiated and non-pre-irradiated samples following a second 
challenge dose of UVA radiation (Table 3.8).
These results emphasize the importance of iron-chelator treatment on the suppression of 
the harmful effects of UVA-induced iron release (see section 4).
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Table 3.7 Effect of DFO on the LIP levels following 
UVA irradiation in FEK4 and 1BR3








o0b - 0 - 1.21 ±0.45 1
DFO + 0ob 100 0 - 0 -
250#h - 250 0 2.4610.67* 2.1410.51
DFO + 250oh 100 250 0 0 -
500#h - 500 0 3.0810.71* + 2.7910.51
DFO + 500oh 100 500 0 0
1BR3 DFO UVA dose Time (h) LIP Fold increase
Samples
treatment
(HM) (kJ/m2) post-UVA (pM)
compared to 
control
o0h - 0 - 1.9910.41 1
DFO + 0°h 100 0 - 0 -
250oh - 250 0 4.0610.44* 2.1110.52
DFO + 250°h 100 250 0 0 -
500#h - 500 0 5.0210.45* + 2.6010.57
DFO + 500#h 100 500 0 0 -
Note: Kd of CA-Fe for FEK4 and 1BR3 were 12.7 and 19.1juM, respectively (n=6-20). 
DFO treatments were performed for 20 h prior to UVA radiation treatment. 
Measurements were performed at indicated times (h) after UVA irradiation.
The concentrations of LIP are expressed as the mean ± SD (n = 3-6).
Oh* : Significantly different from the sham-irradiated control (0 ) ,p  < 0.05
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Table 3.8 Effect of DFO on the LIP levels following a second dose 

















od0/ o dl 0 - 0 1.13±0.22 1
0d°+ DFO / 0d! 0 100 0 0 -
250d#/ 0 dl 250 - 0 1.07±0.28 0.9510.12
250d° + DFO / 0dl 250 100 0 0 -
0d#/2 5 0 dI 0 - 250 2.4210.58* 2.1610.40
0d°+ DFO / 250dl 0 100 250 0 -
250do/2 5 0 dl 250 - 250 1.8510.56* 1.6510.31
250d#+DFO/ 250dI 250 100 250 0 -
1BR3 UVA dose DFO UVA dose LIP Fold increase
(kJ/m2) (pM) (kJ/m2) OiM) compared to
Samples Day 0 Day 0 Dayl control
od0/ o dl 0 - 0 1.92±0.35 1
0d° + DFO / 0dl 0 100 0 0 -
250d° /0 dl 250 - 0 1.6410.45 0.8510.13
250do+ DFO/ 0dl 250 100 0 0 -
0d°/2 5 0 dl 0 - 250 3.7011.01* 1.9510.52
0d# + DFO/250dl 0 100 250 0 -
250d#/250dl 250 - 250 3.5410.74* 1.8410.14
250d#+DFO/250dl 250 100 250 0 -
Note; Kd of CA-Fe for FEK4 and 1BR3 were 12.7 and 19.1 pM, respectively (n=6-20). 
DFO treatments were performed for 20 h prior to UVA radiation in fibroblasts. 
Measurements were performed 0 h after the second UVA irradiation. The 
concentrations of LIP are expressed as the mean ± SD (n = 3-6).
* : Significantly different from the sham-irradiated control (Od0/  0dl),/? < 0.05.
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3.1.2 Keratinocytes
The upper layer of skin (epidermis) is frequently exposed to UV radiation and therefore 
is thought to be a major target for the carcinogenic events in the skin. It is generally 
observed that skin keratinocytes are more resistant to UVA-mediated membrane 
damage (Morliere et al., 1997; Applegate et al., 1995) and cytotoxicity (Pidoux and 
Tyrrell, 1988). Since UVA-induced iron release might be an important factor for skin 
damage, it was hypothesized that higher resistance of human keratinocytes to UVA may 
be related to the lower level of UVA-mediated LIP release in these cells. The 
keratinocyte cell lines used in this study were HaCaT (transformed human adult skin 
keratinocytes) and HFK-SV61 (transformed human foetal skin keratinocytes). Although 
these cell lines are transformed, they maintain full epidermal differentiation capacity 
and are therefore suitable for use as models to study the effect of UVA on human skin 
keratinocytes. The basal LIP levels in these cell lines were measured using the CA- 
assay. Table 3.9 summarises the basal LIP levels of LIP ([CA-Fe] + [Fe]) in both 
HaCaT and HFK-SV61, as determined by the Kd values for each cell line (see 
Materials and Methods). These results demonstrated that although the basal LIP levels 
in these two cell lines are similar, the basal LIP level in keratinocytes is 2-4 fold lower 
than in fibroblasts.
Table 3.9 Determination of basal LIP in HaCaT and HFK-SV61 cells
Cell line [Fe] [CA-Fe] LIP= [Fe]+ [CA-Fe]
pM pM pM
HaCaT 0°h 0.34±0.05 0.16±0.04 0.50±0.06
HFK-SV61 0°h 0.32±0.09 0.20±0.07 0.52±0.17
Note: Kd of CA-Fe for HaCaT and HFK-SV61 were 9.8 and 4.5 pM, respectively (n=5- 
12). The concentrations of Fe, CA-Fe and LIP are expressed as the mean ± SD (n=3-6).
i l l
3.1.2a Dose response
The LIP levels were measured using the CA-assay immediately after irradiation of 
keratinocytes with UVA doses of 250 and 500 kJ/m2. The results (Table 3.10) revealed 
that the phenomenon of UVA-induced immediate release of LIP occurs also in a dose- 
dependent manner in keratinocytes. However, the UVA-induced LIP concentration in 
these cells still remained 2-4 fold lower than for fibroblasts.
Table 3.10 Modulation of the LIP levels following irradiation of 
HaCaT and HFK-SV61 cells with a range doses of UVA
HaCaT UVA dose Time (h) LIP Fold increase
(kJ/m2) post-UVA (pM) compared to control
0 * 0 0 0.50 ± 0.06 1
2500h 250 0 0.97 ±0.10* 1.93 ±0.23
500oh 500 0 2.01 ± 0.44* + 3.99 ± 0.64
HFK- UVA dose Time (h) LIP Fold increase
SV61 (kJ/m2) post-UVA (pM) compared to control
o o c
r
0 0 0.52 ±0.17 1
250ob 250 0 0.92 ± 0.30* 1.78 ±0.16
500#h 500 0 1.42 ± 0.39* + 2.81 ±0.57
Note: Kd of CA-Fe for HaCaT and HFK-SV61 were 9.8 and 4.5 pM, respectively 
(n = 5-12). Measurements were performed at indicated times (h) after UVA irradiation. 
The concentrations of LIP are expressed as the mean ± SD (n = 3-6).
* : Significantly different from the sham-irradiated control,/? < 0.05.
+: Significantly different from 250 kj/mz-irradiated sample (250°h),/? < 0.05
3.1.2b. Kinetics
The kinetics of iron mobilisation in HaCaT cells were followed using the CA-assay up 
to 48 h post-irradiation with a UVA dose of 250 kJ/m2. The results (Table 3.11) showed 
that 2 h after UVA radiation, the LIP level was significantly higher than that of the non- 
irradiated control, however, at 6 h post-irradiation time, the LIP level returned to the
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control value. The CA-assay performed 24 h or 48 h after UVA irradiation of both 
HaCaT and HFK-SV61 cells revealed no further change in LIP concentration. These 
results illustrated that the kinetics of LIP release in UVA-irradiated keratinocytes was 
similar to fibroblasts.
Table 3.11 Modulation of the LIP levels following irradiation 
of HaCaT and HFK-SV61 cells with UVA 250 kJ/m2
HaCaT UVA dose Time (h) LIP Fold increase
(kJ/m2) post-UVA (pM) compared to control
0 " 0 - 0.50 ± 0.06 1
250#h 250 0 0.97 + 0.10* 1.93 ±0.23
Q2,6h 0 - 0.54 ± 0.20 1
2502h 250 2 0.84 ±0.35* 1.60 ±0.33
2506h 250 6 0.53 ±0.12 1.07 ±0.37
024h 0 - 0.65 ±0.16 1
25024h 250 24 0.57 ±0.13 0.88 ±0.18
048h 0 - 0.53 ±0.17 1
25048h 250 48 0.51 ±0.20 0.95 ±0.15
HFK- UVA dose Time (h) LIP Fold increase
SV61 (kJ/m2) post-UVA (pM) compared to control
o0h 0 0 0.52 ±0.17 1
250°h 250 0 0.92 ± 0.30* 1.78 ±0.16
024h 0 - 0.52 ± 0.09 1
25024h 250 24 0.52 ±0.12 1.04 ±0.40
Note: Kd of CA-Fe for HaCaT and HFK-SV61 were 9.8 and 4.5 pM, respectively 
(n = 5-12). Measurements were performed at indicated times (h) after UVA irradiation. 
The concentrations of LIP are expressed as the mean ± SD (n = 3-6).
*: Significantly different from the relevant sham-irradiated controls,/? < 0.05.
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3.1.2c The second challenge dose
The levels of LIP in keratinocytes were also monitored following a second challenge 
dose with UVA 24 or 48 h after the first treatment. The results (see Table 3.12) 
confirmed that the UVA-induced immediate increase in LIP in pre-irradiated 
keratinocytes (250d0 / 250dl or 250d0 / 250d2) occurred to the same extent as in the 
corresponding non-pre-irradiated samples (Od0 / 250dl or Od0 / 250d2). Furthermore in 
HaCaT cells, the irradiation of the pre-irradiated samples 24 or 48 h after the first dose 
(250d0 / 250dl and 250d° / 250d2 respectively) triggered a similar amount of LIP 
release. Also, in agreement with dose-response experiments, the sham-irradiation of 
pre-irradiated cells 24 or 48 h after the first UVA dose (250d0 /  0dl or 250d0 /  0d2) did 
not modulate the level of LIP as compared to the sham-irradiated controls (Od0 /  0dl or 
od0/ o d 2), since the UVA-induced increase in LIP returns to around the control value by 
6 h post-irradiation time and does not change further for the next 24 or 48 h. This was 
similar to the observations previously made in fibroblasts.
Taken together, these results indicate that iron release within skin fibroblasts and 
keratinocytes is an immediate response to UVA-induced oxidative stress and could 
occur following single or repeated exposure to radiation treatments.
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Table 3.12 Modulation of the LIP levels following irradiation

















od0/ o dl 0 0 - 0.65±0.16 1
250d#/ 0 dl 250 0 - 0.57±0.13 0.8810.18
0d°/2 5 0 dl 0 250 - 1.36±0.16* 2.1510.45
250do/2 5 0 dI 250 250 - 1.1810.23* 1.8410.29
od0/ o d2 0 - 0 0.53±0.17 1
250d° /0 d2 250 - 0 0.51±0.20 0.9510.15
0d°/250d2 0 - 250 1.07±0.49* 1.9710.39
250 d0/ 250d2 250 - 250 0.9710.38* 1.8010.17
HFK-SV61 UVA dose UVA dose UVA dose LIP Fold increase
(kJ/m2) (kJ/m2) (kJ/m2) compared to
Samples Day 0 Day 1 Day 2 (M-M) control
od0/ o dl 0 0 - 0.5210.09 1
250d#/ 0 dl 250 0 - 0.5210.12 1.0410.40
0d°/250dl 0 250 - 0.9210.17* 1.7710.28
250d°/250dl 250 250 - 0.8010.19* 1.5210.23
Note: Kd of CA-Fe for HaCaT and HFK-SV61 were 9.8 and 4.5 pM, respectively 
(n = 5-12). Measurements were performed 0 h after the second UVA irradiation. 
The concentrations of LIP are expressed as the mean ± SD (n = 3-7).
*: Significantly different from the sham-irradiated controls (Od0/ 0dl^ ) ,/?  < 0.05.
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3.1.2d Effect of DFO on the LIP levels following single or repeated exposure of
keratinocytes to UVA radiation
The effect of DFO treatment was tested in keratinocytes either prior to a single exposure 
to UVA or following the first dose of UVA in challenge dose experiments. The results 
(Table 3.13) showed that DFO treatment prior to UVA radiation abolished both the 
basal and induced level of LIP in both HaCaT and HFK-SV61 cells. In the second 
challenge dose experiments, the addition of DFO following the first irradiation also 
completely abolished the level of LIP release in both pre-irradiated and non-irradiated 
samples (Table 3.14). This was similar to the observations previously made in 
fibroblasts.
Overall these results indicate that iron-chelator treatment could suppress the UVA- 
induced iron release in both fibroblasts and keratinocytes.
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Table 3.13 Effect of DFO on the LIP levels following UVA
















o0h - 0 — 0.50± 0.06 1
DFO + 00b 100 0 - 0 -
250#h - 250 0 0.9710.10* 1.9310.23
DFO + 250oh 100 250 0 0 -
500°h - 500 0 2.01±0.44* + 3.9910.64

















- 0 - 0.5210.17 1
DFO + 0#b 100 0 - 0 -
250°" - 250 0 0.9210.30* 1.7810.16
DFO +  250°h 100 250 0 0 -
500ob - 500 0 1.4210.39* + 2.8110.57
DFO + 500°h 100 500 0 0 -
Note: Kd of CA-Fe for HaCaT and HFK-SV61 were 9.8 and 4.5 pM, respectively 
(n = 9-12). DFO treatments were performed for 20 h prior to UVA radiation treatment. 
Measurements were performed at indicated times (h) after UVA irradiation.
The concentrations of LIP are expressed as the mean ± SD (n = 3-6).
*: Significantly different from the sham-irradiated control (0°h),/? < 0.05.
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Table 3.14 Effect of DFO on the LIP levels following irradiation of

















0d#/ odl 0 - 0 0.65±0.16 1
0d°+ DFO/ 0dl 0 100 0 0 -
250do / 0dl 250 - 0 0.57±0.13 0.88±0.18
250d#+ DFO/ 0dl 250 100 0 0 -
0d#/2 5 0 dl 0 - 250 1.36±0.16* 2.15±0.45
0d°+ DFO/250dl 0 100 250 0 -
250do/250dI 250 - 250 1.18±0.23* 1.84±0.29
250do+DFO/250dl 250 100 250 0 -
HFK-SV61 UVA dose DFO UVA dose LIP Fold increase
(kJ/m2) (pM) (kJ/m2) compared to
Samples Day 0 Day 0 Dayl (pM) control
o a o O a 0 - 0 0.52±0.09 1
0d° + DFO/ 0dl 0 100 0 0 -
250d° /0 dl 250 - 0 0.52±0.12 1.04±0.40
250do+ DFO / 0dl 250 100 0 0 -
0d°/2 5 0 dl 0 - 250 0.92±0.17* 1.77±0.28
0d° + DFO / 250dl 0 100 250 0 -
250do/250dl 250 - 250 0.80±0.19* 1.52±0.23
250do+DFO/250dI 250 100 250 0 -
Note: Kd of CA-Fe for HaCaT and HFK-SV61 were 9.8 and 4.5 pM, respectively 
(n = 5-12). DFO treatments were performed for 20 h prior to UVA radiation. 
Measurements were performed 0 h after the second UVA irradiation.
The concentrations of LIP are expressed as the mean ± SD (n = 3-6).
*: Significantly different from the sham-irradiated control (Od0/  0 dl),/? < 0.05.
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3.1.3 Range of other cell-types
Additional experiments from this laboratory (Watkin, R., Holley, P., Yiakouvaki, A., 
Brown, J. E and Hejmadi, V.) show that in addition to fibroblasts and keratinocytes, the 
increase in LIP also occurred following UVA irradiation of cell lines A532 (human skin 
derived transformed endothelial cell line), Jurkat (human T cell lymphoma cell line), 
Hela (HtTAl, human cervical cancer cell line), murine R6 (transformed rat embryo 
fibroblast) and C57 IFy -/- cells (primary skin fibroblasts derived from “Interferon 
gamma” knock out mouse). These results (not shown here) strongly suggest that the 
phenomenon of iron release is a general response of cells to UVA-induced oxidative 
stress.
3.2 The role of ROS on the UVA-mediated LIP release in FEK4 cells
It is known that UVA radiation generates ROS in cells via interaction with intracellular 
chromophores (reviewed by Tyrrell, 1991). !02 and H2O2 are thought to be the most 
important ROS generated intracellularly by UVA, promoting biological damage in 
exposed tissues via iron catalysed oxidative reactions (Vile and Tyrrell, 1995). Since 
UVA triggers both iron release and ROS formation, an attempt was made to investigate 
the relationship between the level of ROS generated by UVA and the extent of UVA- 
induced increase in LIP. For this purpose the intracellular levels of ROS induced by 
UVA irradiation were modulated by various treatments. The FEK4 cell line was used as 
the model and the level of LIP was measured using the CA-assay as described in 
Materials and Methods. The results are summarized below.
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3.2.1 H20 2
H20 2 itself is an oxidising agent. Exposure of cells to this agent has been shown to 
promote biological damage due to its reactivity towards lipids, proteins and DNA 
(Shigenaga et al, 1994; Brunk et al, 1995). The toxicity of H20 2 within the cells is 
exacerbated by the presence of Fe2+, which reacts with the compound by Fenton 
chemistry to yield the highly reactive OH* (see section 1.5.1). Since UVA, the oxidising 
component of sunlight, promotes the release of LIP within the skin cells, an attempt was 
made to investigate whether H20 2 as an oxidising agent could also be a mediator of iron 
release within cells.
3.2.1a Exogenous H20 2
To mimic the deleterious effects of UVA radiation, in the first approach FEK4 cells 
were directly challenged with increasing concentrations of H20 2. The results (Table 
3.2a) showed that H20 2 induces a dose-dependent increase in LIP in FEK4 cells up to 
100 pM final concentrations. Treatment of cells with higher concentrations of H20 2 i.e. 
500 pM or 1 mM (data not shown) caused significant leakage of CA from CA-loaded 
cells, and therefore made the outcome of LIP data questionable. The CA leakage from 
CA-loaded cells is presumably due to cell membrane damage as a result of the cytotoxic 
concentrations of H20 2 applied.
The data indicate that in addition to UVA, H20 2, a well-characterised oxidising agent 
can trigger LIP release within human skin fibroblasts.
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Table 3.2a Modulation of the LIP levels following treatment







Control 1.21± 0.31 1
20 pM H20 2 1.43± 0.33 1.1610.21
50 pM H20 2 2.1110.33 * 1.8710.38
100 pM H20 2 2.831 0.83 * + 2.431 0.75
250 pM H20 2 2.8110.12 (n = 2) -
500 pM H20 2 3.411 0.59 * 2.7010.59
Note: Kd of CA-Fe for F EK4 was 12.7 pM (n = 20).
Measurements were performed 0 h after H2O2 treatment. The concentrations of LIP are 
expressed as the mean ± SD (n = 4-11) except when indicated.
*: Significantly different from the control,/? < 0.05.
+: Significantly different from 50 pM H2O2 sample,/? < 0.05.
3.2.1b Endogenous H2O2
The level of endogenous H2O2 can be increased in cells by inhibition of catalase activity 
with potent inhibitors such as 3-amino-l,2,4-triazole (ATZ). It has been shown that 
treatment of FEK4 cells with 50 mM ATZ for 90 min can inhibit the activity of catalase 
up to 95% of its control value (Reelfs, unpublished data, this laboratory). In order to 
find out whether increasing the level of endogenous H2O2 could exacerbate the level of 
exogenous H2O2- or UVA-induced LIP release, FEK4 cells were pre-treated with ATZ 
(under the conditions outlined above) and then the level of LIP was monitored 
immediately after treatment of cells with either increasing concentrations of exogenous 
H2O2 or with a UVA dose of 250 kJ/m2. The results (Table 3.2b) showed that ATZ pre­
treatment itself has no significant impact on LIP level. However pre-treatment of cells 
with ATZ slightly increases the effect of exogenous H2O2 on LIP release within
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fibroblasts. In the case of UVA, treatment of cells with ATZ prior to radiation treatment 
has no effect on the level of LIP release within the cells (Table 3.2c). Taken together 
these results strongly suggest that endogenous H2 O2 formation following oxidising 
treatments have a minor effect on modulation of oxidant-induced LIP release in FEK4 
cells.
Table 3.2b Modulation of the LIP levels by exogenous 







Control 1.17 ±0.23 1
50 mM ATZ 1.31 ±0.29 1.14 ±0.25
20 pM H20 2 1.32 (n = 2) -
ATZ + 20 pM H2O2 1.40 (n = 2) -
50 pM H20 2 2.11 ±0.42* 1.81 ±0.18
ATZ + 50 pM H20 2 2.31 ±0.34* 2.02 ± 0.44
100 pM H20 2 2.71 ± 0.94* 2.30 ± 0.47
ATZ + 100 pM H20 2 3.09 ± 0.96* 2.62 ± 0.58
Note: Kd of CA-Fe for FEK4 was 12.7 pM (n = 20).
Measurements were performed 0 h after ATZ/H2O2 treatments.
The concentrations of LIP are expressed as the mean ± SD (n = 4-6) except when 
indicated.
*: Significantly different from the control,/? < 0.05.
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Table 3.2c Effect of ATZ treatment on the LIP







Control 1.36± 0.22 1
UVA 250 kJ/m2 2.92± 0.70* 2.17± 0.46
50 mM ATZ + Control 1.47± 0.36 1
ATZ + UVA 250 kJ/m2 2.57± 0.49* 1.81+ 0.46
Note: Kd of CA-Fe for FEK4 was L2.7 pM (n = 20).
Measurements were performed 0 h following UVA irradiation.
The concentrations of LIP are expressed as the mean ± SD (n = 4-6) except when 
indicated.
*: Significantly different from the controls,/? < 0.05.
3.2.2 Singlet oxygen (*0 2 )
Singlet oxygen can be produced in cells upon UVA radiation, via the interaction of light 
with cellular chromophores, such as porphyrins (see section 1.7). Our purpose was to 
investigate whether *02 could be involved in UVA-mediated LIP release. The half-life 
of !02 can be enhanced in cells by the presence of deuterium oxide (D2O). By taking 
advantage of this system, the FEK4 cells were irradiated in irradiation buffer where H2O 
was replaced with D2O. The results (Table 3.2d) showed that enhancing the lifetime of 
!02 upon UVA treatment (250 kJ/m2) does not significantly change the level of UVA- 
induced LIP release in cells. This finding is consistent with the notion that ]02 is not a 
mediator in the release of LIP by UVA.
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Table 3.2d Effect of D2O treatment on the LIP







Control 1.41± 0.24 1
UVA 250 kJ/m2 2.98± 0.80* 2.15± 0.52
D2O + Control 1.31± 0.38 1
D20  + UVA 250 kJ/m2 2.51± 0.56 * 2.03± 0.76
Note: Kd of CA-Fe for FEK4 was 12.7 pM (n = 20).
Measurements were performed 0 h after D2O/UVA treatment.
The concentrations of LIP are expressed as the mean ± SD (n = 5).
*: Significantly different from the controls, P < 0.05.
3.2.3 Modulation by antioxidant, a-tocopherol succinate
Our approach to study the involvement of lipid peroxidation in UVA-mediated LIP 
release was to use the lipophilic chain-breaking antioxidant a-tocopherol succinate (a- 
Toco). This antioxidant has been shown to protect primary skin fibroblasts against 
UVA- induced peroxidative damage presumably as a result of stopping the propagation 
of the lipid peroxidation chain reaction (Gaboriau et al., 1993; Skoog et al., 1997).
For this purpose, FEK4 cells were treated with a-Toco for 18 h at concentrations up to 
40 pM and the threshold of toxicity was monitored prior to UVA-irradiation and the 
CA-assay. a-Toco at concentration of 40 pM showed some toxicity to the cells, so 10 
pM was chosen for the pre-treatment prior to UVA (250 kJ/m2) treatment. The results 
(Table 3.2e) showed that a-Toco treatment does not affect the level of UVA-induced
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LIP release, suggesting that LIP increase by UVA is not triggered by lipid peroxidation 
within cells (see section 4).
Table 3.2e Effect of a-tocopherol succinate treatment on 







Control 1.33± 0.50 1
UVA 250 kJ/m2 3.14± 0.56* 2.65± 1.23
a-Toco + Control 1.30± 0.37 1
a-Toco + UVA 250 kJ/m2 3.70± 1.17 * 2.84± 0.41
Note: Kd of CA-Fe for FEK4 was 12.7 pM (n = 20). 
Measurements were performed 0 h after UVA treatment.
The concentrations of LIP are expressed as the mean ± SD (n = 4). 
*: Significantly different from the controls,/? < 0.05.
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3.3 The role of ferritin on UVA-mediated LIP release in skin cells
It is known that the iron storage protein ferritin has a half-life of 24 h within the cytosol 
after which it is taken up by lysosomes and degraded by specific lysosomal proteases. 
The lysosomal degradation of ferritin molecules promotes the release of free iron from 
the protein shells to the lysosomal organelles. It has been shown that this iron can be 
transported across the lysosomal membrane either to stimulate the production of new 
ferritin molecules in human fibroblasts (Radisky and Kaplan, 1998) or to be utilized for 
haemoglobin synthesis in developing human erythroid precursors (Vaisman et al, 1997).
The proteolytic degradation of ferritin (as measured by immunoprecipitation of 35S- 
methionine labelled cytosolic protein extracts with a human polyclonal ferritin 
antibody) may also occur in the cytosol as a result of UVA-induced destabilisation of 
the lysosomal membrane and the subsequent leakage of proteolytic enzymes from these 
organelles (Pourzand et al., 1999). Since the UVA-mediated proteolytic degradation of 
ferritin molecules within the cytosol coincides with the phenomenon of UVA-induced 
immediate iron release, Pourzand et al. (1999) suggested that the release of iron from 
ferritin following its degradation might play a key role in UVA-mediated LIP release. 
However when the fibroblasts were pre-treated with specific lysosomal protease 
inhibitors (Chymostatin and Leupeptin), they could only partially recover the level of 
UVA-induced iron release (as monitored by the IRP/IRE bandshift assay), indicating 
that other sources of iron in addition to ferritin are responsible for the observed 
phenomenon.
The objective of the work described in this section was to investigate to what extent 
ferritin iron participates in the UVA-induced increase in LIP. For this purpose the basal
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level of ferritin was first modulated with various treatments and then the ferritin 
concentration was correlated with the level of UVA-induced LIP release in both HaCaT 
keratinocytes and FEK4 fibroblasts by the CA-assay. The results are summarised below.
3.3.1 Comparison of the basal level of ferritin in fibroblasts and keratinocytes
The results in sections 3.1.1 and 3.1.2 showed that the basal levels of LIP in HaCaT and 
HFK-SV61 keratinocyte cells were 2-4 fold lower than in FEK4 fibroblasts. In this 
section, the basal level concentration of ferritin was compared between keratinocytes 
and fibroblasts using a ferritin ELISA kit (Roche, UK). The results (Table 3.21) 
showed that the ferritin content of HaCaT and HFK-SV61 cells is approximately 5-fold 
lower than that of FEK4 cells.
Table 3.21 Determination of the basal level of







Note: Ferritin levels were measured using an ELISA kit as described in Materials 
and Methods. The concentrations of ferritin are expressed as the mean ± SD (n = 3), 
except when indicated.
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3.3.2 Modulation of ferritin levels in FEK4 and HaCaT cells
Several studies have shown that iron can be successfully supplied to cells either in the 
form of ferric heme (Hemin) or ferric iron (iron-citrate). These studies have also shown 
that an increase in iron supply within the cells causes an increase in ferritin synthesis as 
a result of inactivation of iron regulatory proteins (i.e. IRP1 and IRP2) leading to 
induction of ferritin mRNA translation (Eisenstein et al., 1991). It is also known that 
iron deprivation in cells by iron chelator treatment could significantly decrease the level 
of ferritin synthesis via activation of IRPs and the subsequent inhibition of ferritin 
mRNA translation (Cario et al., 2000).
To increase the intracellular level of ferritin, HaCaT and FEK4 cells were loaded with 
increasing concentrations of Hemin or iron-citrate for 18 h and then the level of ferritin 
accumulation was monitored using an ELISA kit. The results (Table 3.22) 
demonstrated that Hemin loading of cells at the maximum non-toxic concentration 
increases the level of ferritin up to 4-fold of the control values in FEK4 fibroblasts and 
up to 2-fold of control values in HaCaT keratinocytes. Iron citrate treatment at its 
maximum non-toxic concentration was less effective than Hemin, since the intracellular 
content of ferritin increased only up to 2.5-fold of the control values in FEK4 cells and 
up to 1.7 fold in HaCaT cells.
Since Vile and Tyrrell (1993) have previously shown that the level of ferritin can be 
enhanced in FEK4 cells 24 or 48 h following the UVA irradiation of cells (i.e. 1.8 fold 
of the control values), such experiments were performed and included as additional 
controls in the present study. The results (Table 3.22) confirmed the findings by Vile 
and Tyrrell, i.e. the level of ferritin doubled that of the control values within 24 or 48 h
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after UVA irradiation of FEK4 cells. In HaCaT cells, the same treatment increased the 
cellular content of ferritin only up to 1.6-fold of the control values.
In order to decrease the level of ferritin in cells, the cells were treated with the highly 
potent iron chelator Desferrioxiamine (DFO) that is known to scavenge not only the 
intracellular LIP (Pourzand et al., 1999a) but also ferritin iron as demonstrated by White 
and Jacob (1978). The overnight treatment of FEK4 cells with 100 pM DFO decreased 
the level of ferritin up to 5-fold of the control values (Table 3.22).
Table 3.22 Modulation of ferritin levels in HaCaT 
and FEK4 cells following various treatments
Treatment (ng ferritin /mg protein) 
FEK4
(ng ferritin/mg protein) 
HaCaT
Control 93.70±9.4 19.7±6.2
DMSO control 137.3±16.1 29.6±9.9
5 pM Hemin 217.5±22.3 37.2±12.9
20 pM Hemin 399.8±53.6 * + 44.3±8.3 *
50 pM iron citrate 214.5 (n =2) 31.1±6.1
100 pM iron citrate 253.6± 30.0 * 33.1±7.0
100 pM DFO 17.81±6.7*
250d° /0 dl 189.1±52.1 * 32.3±4.3
250d° /0 d2 173.1±24.4 * 30.3±3.9
Ferritin levels were measured using an ELISA. Hemin, iron-citrate and DFO treatments 
were carried out for 18 h in conditioned media. The concentrations of ferritin are 
expressed as the mean ± SD (n = 3) except when indicated.
*: Significantly different from control,/? < 0.05.
+: Significantly different from 100 pM iron-citrate sample,/? < 0.05.
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3.3.3 Effect of iron loading on UVA-mediated LIP release in FEK4 cells 
Table 3.3.3 shows the level of LIP in FEK4 cells following UVA radiation of cells that 
have been pre-treated for 18 h with either 20 pM Hemin or 100 pM iron-citrate. Hemin 
or iron-citrate treatments per se do not modulate the level of LIP in FEK4 cells. 
However UVA irradiation of Hemin pre-treated cells causes an immediate increase in 
LIP (i.e. 3.4-fold of the control values) that is significantly higher than the UVA- 
irradiated sample alone (i.e. 2.5-fold of the control values). Interestingly, UVA- 
irradiation of iron-citrate pre-treated FEK4 cells does not increase significantly the level 
of LIP when compared to the UVA-irradiated sample alone. These results suggest that 
since ferritin iron is only partially involved in the UVA-induced iron release, a 
significant increase in UVA-mediated LIP can only be detected in Hemin pre-treated 
cells, where the level of increase in ferritin molecules is substantially higher (around 4- 
fold) than that in control cells. In contrast, in iron-citrate pre-treated cells, where the 
enhancement of ferritin level is only around 2.5-fold control values, the CA-assay fails 
to detect a significant increase in LIP as compared to UVA-irradiated cells alone. The 
latter explanation seems also to be true for the samples involved in the UVA challenge 
dose experiments. Indeed, the level of ferritin increase only up to 2-fold control value 
24 h following the first irradiation (i.e. 250d0 /  0dl) and consequently the CA-assay 
performed immediately following the second challenge dose (i.e. 250d° / 250dl), fails 
to show a significant difference in LIP levels as compared to the corresponding non-pre- 
irradiated control (i.e. 0d° /  250dl).
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Table 3.3.3 Effect of iron loading on UVA-induced LIP release in FEK4 cells.
FEK4
Samples
[LIP] pM Fold increase compared to control
Control 1.33± 0.35 1
UVA 250 kJ/m2 3.05± 0.94* 2.01± 0.305
Iron-citrate + Control 1.54±0.53 1
Iron-citrate + UVA 250 kJ/m2 3.38±0.93* 2.24±0.32
DMSO + Control 1.20±0.29 1
DMSO + UVA 250 kJ/m2 2.53±0.24* 2.20±0.44
Hemin + Control 1.04±0.16 1
Hemin + UVA 250 kJ/m2 3.43+0.64* + 3.31+0.53
od0/ o dl 1.13±0.22 1
0d°/2 5 0 dl 2.42±0.58* 2.16±0.40
250d° /0 dl 1.07±0.28 0.95+0.12
250d°/2 5 0 dl
1.85±0.56* 1.65+0.31
Note: Kd of CA-Fe for FEK4 was 12.7 (n = 20).
Measurements were performed 0 h after UVA treatment.
The concentrations of LIP are expressed as the mean ± SD (n = 6-11).
*: Significantly different from the controls,/? < 0.05.
+: Significantly different from the control (DMSO + UVA 250 kJ/m2),/? < 0.05.
3.3.4 Effect of protease inhibitors on UVA-mediated LIP release in FEK4 cells
As noted above, Pourzand et al. (1999) have previously demonstrated that preventing 
UVA-mediated immediate ferritin degradation by pre-treatment of FEK4 cells with 
specific lysosomal protease inhibitors (Leupeptin and Chymostatin) could only partially 
recover the UVA-induced iron release (as determined by the IRP/IRE bandshift assay), 
indicating that ferritin iron is involved in the UVA-induced increase in LIP. In this
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section an attempt was made to measure the level of UVA-induced iron release by the 
CA-assay in FEK4 cells that have been treated with protease inhibitors Chymostatin (50 
pg/ml) and Leupeptin (20 fig/ml) for 18 h prior to UVA irradiation. The results (Table 
3.3.4) showed that although the level of UVA-induced LIP release was lower in FEK4 
cells treated with protease inhibitors as compared to UVA-irradiated sample alone, a 
statistically significant difference could not be established between those two 
conditions. These results suggest that, as previously suggested, ferritin iron is only 
partially involved in the pool of labile iron that was measured following UVA 
irradiation and that the IRP/ERE bandshift assay is a more sensitive assay for detecting 
subtle differences in intracellular chelatable iron pool than the CA-assay.
Table 3.3.4 Effect of protease inhibitor (PI) 




Fold increase compared 
to control
DMSO Control 1.29+0.42 1
DMSO + UVA 250 kJ/m2 2.40±0.38* 1.98+0.53
PI + Control 1.20+0.36 1
PI + UVA 250 kJ/m2 1.97+0.47* 1.71+0.46
Note: Kd of CA-Fe for FEK4 was 12.7 (n = 20).
Cells were pre-treated for 18 h with protease inhibitors (PI) Chymostatin (50 pg /ml) 
and Leupeptin (20 pg/ml). Control cells were pre-treated with DMSO (vehicle for 
Chymostatin) at the same concentration for 18 h. Measurements were performed 0 h 
after UVA treatment. The concentrations of LIP are expressed as the means ± SD (n = 
5).
*: Significantly different from the controls,/? < 0.05.
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3.4 The correlation between the level of UVA-induced iron release and 
the extent of lysosomal membrane damage
After characterisation of the phenomenon of UVA-induced LIP release in both 
fibroblast and keratinocyte cell lines, an investigation was performed to correlate the 
level of UVA-induced iron release and the extent of UVA-mediated lysosomal 
membrane damage in both fibroblasts and keratinoytes following single or repeated 
exposures to radiation treatment. Four independent assays were used for this purpose, as 
described below.
3.4.1 Epifluorescence microscopy studies
Epifluoresence microscopy was used in conjunction with an acidotropic fluorescent dye 
(LysoSensor DND-153) to assess the integrity of lysosomal membranes by monitoring 
the retention of the proton gradient across the membranes of the acidic vacuolar 
compartments. LysoSensor DND-153 is a weak base that enters the cells as uncharged 
species. Then the proton gradient between the cytosol and the lysosomal compartment 
allow the fluorescent dye to be trapped as protonated species in the acidic organelles. 
When excited by blue light, the highly concentrated LysoSensor DND-153 in lysosomes 
will emit a pH-dependent bright orange granular fluorescence (Molecular probes:
' r i #  T \ y f
LysoTracer and LysoSensor Probes). However the same dye when uncharged or 
diluted in the cytosol will emit a diffuse greenish fluorescence. Therefore the level of 
retention of this dye in the lysosomal compartment can be used to monitor the extent of 
UVA-induced lysosomal damage. For this purpose, the cells were first cultured on 
coverslips to 80% confluency and then irradiated with a range of doses of UVA (i.e. 250 
and 500 kJ/m ). Immediately after irradiation, the irradiation buffer was replaced with 
fresh media containing the LysoSensor DND-153 and the cells were incubated for 1 to 2
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h at 37°C. The integrity of lysosomal organelles was then monitored by epifluorescence 




Fig. 3F1 shows the intact lysosomal organelles in non-irradiated (control) cells. The 
appearance of orange/yellow fluorescent organelles was due to the accumulation of the 
acidotropic dye in the acidic lysosomal compartments, indicating that the lysosomal 
membranes were intact and that the proton gradient was not disturbed. Following UVA 
irradiation of cells with a moderate dose of 250 kJ/m (Fig. 3F2), the number of intact 
orange lysosomal organelles reduced significantly. Instead, the fluorescence of the 
lysosomal compartment was substantially lower indicating that the proton gradient of he 
lysosomal membrane was disturbed. Furthermore the loss of fluorescence in the 
lysosomal compartment was accompanied with the appearance of a diffuse and diluted 
greenish fluorescence in the cytosol. The latter is known to occur as a result of leakage 
of the dye from the acidic compartment to the cytosol due to the UVA-mediated damage 
to the lysosomal membrane. At a high dose of 500 kJ/m (Fig. 3F3), the image revealed 
only very few intact fluorescent lysosomes surrounded by a cytosolic compartment with 
a highly intense blurred greenish fluorescence. The latter observation indicates that a 
high dose of UVA could substantially damage the lysosomal membranes resulting in a 
significant leakage of the fluorescent dye from lysosomal organelles. The same dose- 
response experiments were also in 1BR3 fibroblasts. The results (Fig. 3B1-3B3) 
showed a similar pattern of lysosomal membrane damage following UVA radiation 
treatment.
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These results confirmed the observations previously made by Pourzand et al (1999) that 
in FEK4 cells, UVA triggers an immediate and dose-dependent damage to lysosomal 
membranes. The authors have also provided data showing that with a moderate dose of 
250 kJ/m2, the UVA-mediated immediate lysosomal damage could substantially recover 
by 6 h post-irradiation time. However at a high dose of 500 kJ/m , the damage to 
lysosomes could only partially recover 24 h following the radiation treatment.
Effect of DFO
DFO is a highly potent hydrophilic chelator. Several studies (e. g. Zdolsek et al., 1993; 
Cable and Lloyds, 1999) have shown that DFO (as a hydrophilic compound) can enter 
the cells via endocytosis and is first detected in the lysosomal compartments. Since 
lysosomal organelles are primarily the organelles that degrade both hemoproteins and 
ferritin, it is believed that these compartments contain a substantial pool of LIP. Studies 
from Ollinger and Brunk (1995) suggest that this pool of reactive iron could participate 
in the formation of highly reactive OH* following treatment of cells with H2O2 , resulting 
in an immediate burst of lysosomal membranes. The authors also demonstrated that pre­
treatment of cells with DFO prior to H2O2 exposure, could substantially protect the cells 
against the H202-mediated lysosomal membrane damage. To test the possibility that 
DFO treatment of fibroblasts prior to UVA irradiation, could also protect the lysosomal 
membranes against the UVA-mediated damage, the LysoSensor epifluorescence study 
was performed in FEK4 and 1BR3 cells that were pre-treated with DFO prior to UVA 
irradiation. The results (Fig. 3F4-F6 for FEK4 and Fig. 3B4-3B6 for 1BR3) were in 
agreement with the findings by Ollinger and Brunk (1997) since DFO pre-treatment 
significantly protected the lysosomal membrane against UVA-mediated damage in both 
studies.
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Fig. 3F. Effect of DFO on the UVA-mediated lysosomal damage of FEK4 cells
DFO treated or non-treated FEK4 cells were irradiated with UVA, then loaded with LysoSensor DND-153 for 2 h.
3F1 (0 kJ/m2), 3F2 (250 kJ/m2), 3F3 (500 kJ/m2);




Fig. 3Fb. Effect of BHT on the UVA-mediated lysosomal damage of FEK4 cells
BHT treated or non-treated FEK4 cells were irradiated with UVA, then loaded with LysoSensor DND-153 for 2 h.
3F1 (0 kJ/m2 ), 3F2 (250 kL/m2), 3F3 (500 kJ/m2);
BHT treated 3F7 (0 kJ/m2), 3F8 (250 kJ/m2 ), 3F9 (500 kJ/m2 )
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Fig. 3B. Effect of DFO on the UVA-mediated lysosomal damage of 1BR3 cells
DFO-treated or non-treated 1BR3 cells were irradiated with UVA, then loaded with LysoSensor DND-153 for 2 h.
3B1 (0 kJ/m2), 3B2 (250 kL/m2), 3B3 (500 kJ/m2);
DFO treated 3B4 (0 kJ/m2), 3B5 (250 kJ/m2), 3B6 (500 kJ/m2)
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Fig. 3H. Effect of DFO on the UVA-mediated lysosomal damage of HaCaT cells
DFO-treated or non-treated HaCaT cells were irradiated with UVA, then loaded with LysoSensor DND-153 for 2 h.
3H1 (0 kJ/m2 ), 3H2 (250 kL/m2), 3H3 (500 kJ/m2);
DFO treated 3H4 (0 kJ/m2), 3H5 (250 kJ/m2), 3H6 (500 kJ/m2 ).
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Effect o f BHT
BHT is a membrane antioxidant since it has the property to block the lipid peroxidation 
chain reaction. Ollinger and Brunk (1995) have demonstrated that antioxidant could 
also protect the cells against H202-mediated lysosomal membrane damage. To 
investigate whether BHT could also protect the FEK4 cells against the UVA-induced 
lysosomal membrane damage, the LysoSensor epifluorescence study was performed in 
FEK4 cells that were pre-treated with BHT prior to UVA irradiation. The results (Fig. 
3Fb(7-9) demonstrated that in contrast to DFO, BHT could only partially protect the 
organelles against the UVA-induced damage. The fact that this antioxidant in contrast to 
DFO could not significantly modulate both the basal and UVA-induced LIP levels (data 
not shown), strongly suggests that the pool of reactive iron either in lysosomes or at 
cellular level plays a role in promotion of lysosomal membrane damage by UVA.
3.4.1b Keratinocytes
Dose-response
The UVA dose-response experiments were also carried out with HaCaT cells. The 
results (Fig. 3H1-3) showed that UVA-induced lysosomal damage occurs also in a 
dose-dependent manner in this cell line. However the extent of lysosomal damage in 
keratinocytes was not as dramatic as fibroblasts. Indeed at UVA doses of both 250 and 
500 kJ/m , a substantial number of intact lysosomal organelles could still be detected. 




In contrast to fibroblast cells, DFO pre-treatment of HaCaT cells prior to UVA 
irradiation could only partially recover the UVA-induced lysosomal membrane damage 
(Fig. 3H4-6).
3.4.2 Cathepsin B ELISA
Lysosomal organelles are rich in proteases since they degrade and recycle several 
proteins such as ferritin. Cathepsin B (Cath B) belongs to the family of lysosomal 
cysteine proteases and is expressed at significantly higher concentration under certain 
pathological conditions such as malignancy. Two independent studies from this 
laboratory (Pourzand et al, 1999; Waltner et al, unpublished data, this laboratory, 
unpublished) have demonstrated that UVA-induced damage to lysosomal organelles 
promotes the leakage of potentially harmful lysosomal proteases into the cytosol. The 
latter has shown that following irradiation of FEK4 cells with a UVA dose of 250 
kJ/m , the level of lysosomal Cath B, L and D are increased up to 2.5-fold of the control 
values in the cytosolic fraction of cells devoid of intact organelles (i.e. cytosolic S I00 
fraction prepared as Dignam et al, 1983). Also Pourzand et al. (1999a) have shown that 
in the same cells and following the same dose of UVA, the level of lysosomal protease 
Chymotrypsin (i.e. the specific lysosomal protease responsible for the degradation of 
ferritin) is increased up to 2.7-fold of the control values. Therefore the Cath B ELISA 
kit was used in the present study to monitor the level of UVA-induced lysosomal 
damage in both fibroblasts and keratinocytes following single or repeated exposures to 
UVA radiation. The results are summarised below.
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3.4.2a Fibroblasts
Cells were first cultured to 80% confluency and then irradiated with UVA doses of 250 
and 500 kJ/m2. Immediately after irradiation, cells were detached from the plates by 
either mild trypsinization or using a non-enzymatic cell dissociation solution. Then, the 
outer cell membrane was either broken in a hypotonic buffer by cell homogenisation or 
alternatively by treatment of cells with a mild detergent (i.e. 0.1% Nonidet-P 40). This 
step was followed by a low speed centrifugation to pellet the cell membrane debris. 
The supernatant was then subjected to an ultra centrifugation to pellet the intact 
organelles and the nucleus. The resulting supernatant called the “Cytosolic S I00 
fraction” which was devoid of any intact organelle was used for the Cath B ELISA. 
The results are shown in Table 3.4.2a. The basal level of Cath B was similar in both 
FEK4 and 1BR3 fibroblasts, however following UVA irradiation the level of Cath B 
increased in both cell lines in a dose-dependent manner up to 2.3-fold of the control 
values. These results are in agreement with the data obtained by LysoSensor DND-153 
epifluorescence microscopy. It was also observed that the increase in Cath B in the 
cytosolic fraction of cells irradiated with a moderate dose of 250 kJ/m2 returned to 
control levels at 24 h post-irradiation time (i.e. 250d0 /  0dl). Furthermore, the UVA
irradiation of pre-irradiated cells 24 h following the first UVA challenge (i.e. 250d0 /
250dl) triggered the leakage of the lysosomal protease Cath B to the cytosol, although
to a lesser extent than the first irradiation treatment (i.e. 0d0 /  250dI).
DFO pre-treatment of cells prior to UVA irradiation slightly decreased the level of 
Cath B release, although a statistically significant protection could not be established. 
These results were in contrast to the previous study performed by LysoSensor DND- 
153. A possible explanation for this discrepancy is that perhaps during the procedure of
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preparation of the cytosolic S-100 fraction the lysosomal organelles were mechanically 
damaged. This physical damage could cause a contamination of the cytosolic 
preparations with a residual background Cath B protein and decrease the accuracy of 
our findings.








o « 8.96±4.2 11.2±1.92
250ob 14.84±5.6* 18.48±5.32*
500#h 21.28±5.6* 19.32±4.48*
DFO + 0oh 8.40±5.04 11.2±2.24
DFO + 250oh 13.44±4.48* 18.48±5.60*
DFO + 500oh 18.20±4.48* 19.60±6.16*
250d#/2 5 0 dl 12.88± 4.48 16.8±0.56 +
250d° /0 dl
8.12±1.12 9.80±5.04
Cytosolic Cath B levels were measured using an ELISA kit.
Protein extracts were diluted in the incubation buffer to the concentration of 0.06 
mg/ml. Cells were treated for 18 h with 100 pM DFO.
Data represent the mean ± SD (n = 3-6).
* Significantly different from the sham-irradiated control (00h), p  < 0.05.
+ Significantly different from 250d0/ 0dl,/? < 0.05.
3.4.2b Keratinocytes
HaCaT cells contain less lysosomal organelles than fibroblasts as determined by 
epifluorescence microscopy. Accordingly the level of cytosolic Cath B in HaCaT cells 
appeared to be much lower than in FEK4 and 1BR3 fibroblasts, in order to detect the 
Cath B levels by ELISA in this cell line, a much higher level of protein extract was 
used. The results (Table 3.4.2b) showed that in HaCaT cells, UVA could also trigger
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the lysosomal leakage of Cath B to the cytosol in a dose-increase manner. However the 
level of residual Cath B in non-treated HaCaT cells was substantially lower than in 
fibroblasts. Surprisingly, the DFO treatment did not affect the level of UVA-induced 
Cath B release. This result was in contrast to the findings with the LysoSensor 
epifluorescence study, where DFO pre-treatment could partially protect the HaCaT 
lysosomal organelles against UVA-induced membrane damage. These findings were 
similar to the observations made in fibroblasts. It was therefore proposed that, as for 
fibroblasts, the mechanical damage to lysosomes during the procedure of cytosolic 
extraction might have contaminated the cytosolic fraction with residual traces of Cath B 
consequently masking the protection by DFO. To test this hypothesis an in situ 
immunocytochemistry analysis was performed in both fibroblasts and keratinocytes 
using a polyclonal human Cath B antibody (see section 3.4.3).
Table 3.4.2b UVA-mediated Cath B release in HaCaT cells




DFO + 0oh 2.24±0.86
DFO + 2500h 4.98±2.46*
DFO + 500°h 5.94±1.79*
HaCaT Cytosolic Cath B levels were measured using an ELISA kit.
Protein extracts were diluted in the incubation buffer to the concentration of 0.2 mg/ml. 
Cells were treated for 18 h with 100 pM DFO.
Data represent the mean ± SD (n = 4-6).
* Significantly different from the sham-irradiated control (00h), p  < 0.05.
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Total Cath B of skin cells
The immunohistochemistry showed that HaCaT cells has very faint staining and the 
cytosol S-100 fraction showed that they have much lower level of Cath B. To further 
support that HaCaT cells have lower level of Cath B, the Cath B ELISA was determined 
in total protein of cell extracts. Table 3.4.2c showed that indeed in HaCaT cells have 
much lower intracellular level of Cath B compared with FEK4 and 1BR3 fibroblasts. In 
order to detect the Cath B levels by ELISA in this cell line, a much higher level of 
protein extract was used.
Table 3.4.2c Total Cath B levels of skin cells




Note: Cells total Cath B levels were measured using a Cath B ELISA kit. 
Protein extracts were diluted in the incubation buffer to the concentrations
of 0.02 mg/ml for FEK4 and 1BR3 cells and 0.2 mg/ml for HaCaT cells. 
Data represent the mean ± SD (n = 3-4).
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3.4.3 Cath B immunocytochemistry
Cells were grown on coverslips to 80% confluency and then irradiated with a range of 
doses of UVA (i.e. 250 and 500 kJ/m2). Following irradiation the cells were fixed with 
methanol and then incubated firstly with polyclonal rabbit anti-human Cath B antibody 
and secondly with polyclonal goat anti-rabbit IgG tagged with FITC antibodies. This 
was followed by epifluorescence microscopy using the appropriate excitation and 
emission wavelengths. Fig. 3F10 shows a representative example of a Cath B 
immunostaining in non-treated FEK4 cells. As you can see the Cath B proteases were 
mainly localised as bright green dots within the lysosomal organelles. However 
following UVA irradiation of cells with a dose of 250 kJ/m2 (3F11), a significant 
delocalisation of the proteases from the lysosomal compartment to the cytosol was 
observed. At a high dose of 500 kJ/m2, the delocalisation of the enzyme was even more 
apparent (Fig. 3F12). In 1BR3, the same dose-dependent pattern of Cath B 
redistribution was observed. In HaCaT cells however the immunostaining was very 
faint presumably due to the fact that this cell line contained much fewer lysosomal 
organelles (data not shown).
When fibroblasts were pre-treated with DFO and then UVA irradiated (Fig. 3F13-15 
and 3B10-12) a significant decrease in the redistribution of the Cath B from the 
lysosomal compartment to the cytosol could be observed, consistent with the notion that 
DFO has a protective effect on UVA-induced lysosomal membrane damage.
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Fig. 3F10-15 Effect of DFO on UVA-mediated delocalisation of lysosomal Cath B in 
FEK4 cells. Control (3F10), 250 kJ/m2 (3F11) and 500 kJ/m2 (3F12);




Fig. 3B7-12 Effect of DFO on UVA-mediated delocalisation of lysosomal Cath B in 
1BR3 cells. Control (3B7), 250 kJ/m2 (3B8) and 500 kJ/m2 (3B9);
DFO treated control (3B10), 250 kJ/m2 (3B11) and 500 kJ/m2 (3B12).
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3.4.4 Neutral red assay
The Neutral red assay was used to further reinforce the data showing that UVA induces 
dose-dependent lysosomal membrane damage and that DFO pre-treatment protects the 
organelles against UVA-mediated damage. This assay is based on the uptake of neutral 
red dye and retention of the dye in the lysosomes of cultured cells. For this purpose 
FEK4, 1BR3 and HaCaT cells were irradiated with a range of doses of UVA (i.e. 250 
and 500 kJ/m2) and then the cells’ ability to retain the neutral red compound were 
monitored. The results Fig. 3.4A, B and C (for FEK4, 1BR3 and HaCaT cells, 
respectively) confirmed that UVA induces a dose-dependent leakage of the dye from the 
lysosomes and that DFO pre-treatment prior to UVA radiation could significantly 
increase the retention of neutral red within fibroblast cell lines. However in HaCaT 
cells, the extent of UVA-induced lysosomal damage was significantly lower than 
fibroblast cell lines. These results strongly suggested a direct correlation among the 
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Fig. 3.4 A. B. C. Effect of DFO on UVA-mediated lose of neutral red dye retention of skin cells
Cells were pre-treated or non-treated with DFO, then irradiated at the indicated doses. The uptake o f  
neutral red dye was measured. Data were normalised by taking 100% as the retention o f  the dye o f  
controls. Values are the mean ± SD o f 3-5 independent experiments.
*: Significance level when compared with non-treated sample, p  < 0.05
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3.5 The correlation between the level of UVA-induced iron release and 
the extent of plasma membrane damage
After characterisation of the phenomenon of UVA-induced lysosomal damage, an 
attempt was made to correlate the level of UVA-induced iron release with the extent of 
UVA-mediated plasma membrane damage. For this purpose the level of leakage of 
intracellular LDH was used as a monitor for plasma membrane damage in both 
fibroblasts and keratinocytes following single or repeated exposures to UVA radiation. 
The results are summarised below.
3.5.1 UVA-induced LDH release in FEK4 cells
UVA is a strong membrane-damaging agent. Previous studies from this laboratory 
(Vile et al, 1994) and others (e. g. Morliere et al., 1991) have shown that UVA triggers 
lipid peroxidation of cellular membranes as evaluated by the formation of TBARs. 
Since the peroxidation of lipids in cell membranes will promote the leakage of the 
intracellular content (notably the cytosolic LDH enzyme), the quantification of the 
amount of LDH leakage from cells to the extracellular media could be used as a monitor 
for evaluation of the extent of UVA-induced membrane damage. Indeed in some studies 
the extent of UVA-induced cell membrane lipid peroxidation also directly correlated 
with the amount of LDH leakage (e. g. Vile et al, 1994). Using both TBAR and LDH 
assays, Vile et al (1994) have also demonstrated that UVA pre-irradiated (i.e. 250 
kJ/m ) FEK4 fibroblasts, sustain less membrane damage following a second high dose 
of UVA radiation (i.e. 750 kJ/m2) when compared with the corresponding non-pre- 
irradiated cells. Since UVA induces LIP release following either single or a second 
challenge dose of UVA, the observed adaptive response was sought in the fibroblasts 
following UVA irradiation of pre-irradiated cells (i.e. 250 kJ/m2) with a moderate dose
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of 250 kJ/m2 (i.e. conditions used for LIP measurements). The results (Table 3.5a) 
showed that pre-irradiated cells sustain similar LDH release of the corresponding non- 
pre-irradiated controls, consistent with the notion that the adaptive response (i.e. 
observations by Vile et al, 1994) does not occur in the conditions used in this study. 
Indeed, it appears that the extent of LIP release in the present study directly correlates 
with the amount of LDH leakage, suggesting that the cell membrane might be a primary 
target for LIP-mediated damage, since iron is a catalyst of lipid peroxidation.
Table 3.5a UVA-induced LDH release in FEK4 cells
Samples LDH activity of 
supernatant





od0/o dl 0.039±0.016 1
0d#/2 5 0 dl 0.0710±0.020 * 2.010.30
250do/2 5 0 dl 0.0921±0.071 * 2.810.53
250d° /0 dI 0.0415±0.010 1.210.12
0d° /  0d2 0.040410.010 1
0d°/2 5 0 d2 0.088610.044 * 2.110.22
250do/250d2 0.098010.037 * 2.410.13
250d° /0 d2 0.043110.021 1.110.11
Note: The level of LDH activity was measured in supernatant of cells following UVA 
treatments. The LDH values of the controls were arbitrary set to 1. Values are mean ± 
SD of 3 experiments.
* Significantly different from the sham-irradiated control,/? < 0.05.
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Although the total LDH activity of fibroblast cells, when normalized to the cell number 
was constant between the experiments, it was found that the total LDH of the UVA pre- 
irradiated samples were always lower than the non-pre-irradiated group. To investigate 
this phenomenon further, the total LDH activity of cells irradiated with a dose of 250 
kJ/m2 was followed up to 24 h post-irradiation time. The results (Table 3.5b) revealed 
that the total enzymatic activity of LDH decreases gradually following radiation 
treatment where at 24 h time-point this activity reaches half of its original value. These 
results strongly suggest that UVA mediates a direct damage to LDH protein resulting in 
a decrease of its enzymatic activity.
Table 3.5b UVA-mediated damage to LDH in FEK4 cells
Time post UVA (h) 0 3 6 10 16 20 24
LDH activity 
(% of control) 97 90 84 80 75 60 45
Note: LDH activity of the cells was measured at different time points following UVA 
irradiation. Total LDH activity was compared with relative control (n = 2).
In Table 3.5a the level of UVA-induced LDH release to supernatant was calculated 
relative to the control samples, which was arbitrarily set to 1. However in order to 
estimate the leakage of LDH in FEK4 cells, the LDH of supernatant this time was 
expressed as percentage of total LDH (LDH of supernatant + LDH remaining in the 
cells). This quantification (Table 3.5c) revealed that despite the UVA-induced damage 
to the LDH enzyme, the percentage of LDH leakage in the pre-irradiated sample (i.e. 
250d0 / 250dl) is much higher than in the non-pre-irradiated sample (i.e. Od0 / 250dl)
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consistent with the notion that exposure of cells to low split doses of UVA increases the 
susceptibility of the plasma membrane to UVA-induced damage.
Table 3.5c UVA induced LDH leakage of FEK4 cells
Sample LDH leakage (%)
Od0 /  odl 4.2±1.3
0d°/250dl 8.0±3.1
250d°/250dl 12.6±5.1
250d° /0 dl 5.7±2.7
Note: LDH leakage in the supernatant was expressed as a percentage of total LDH 
(supernatant + cell portion). Values are the mean ± SD of 3 independent experiments.
3.5.2 UVA-induced LDH release in HaCaT cells
The LDH assay was also carried out in HaCaT keratinocytes following either single or 
second challenge doses of UVA radiation. The results (Table 3.5d) showed that UVA 
also induces LDH release following both single and repeated exposures to UVA. 
Furthermore, as for fibroblasts, the fold increase in LDH induced in pre-irradiated 
HaCaT cells was similar to that of non-pre-irradiated cells, consistent with the notion 
that UVA-induced membrane damage occurs following single or repeated exposures to 
UVA radiation.
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Table 3.5d UVA-induced LDH release in HaCaT cells
Sample LDH activity of 
supernatant
Fold increase compared to control
o0h 0.014±0.005 1
250oh 0.027±0.013* 1.9±0.67
Odo /  0dl 0.020±0.007 1
0d°/250dl 0.035±0.016* 1.7±0.53
250do/250dl 0.039±0.014* 2.1±0.82
250d° /0 dl 0.024±0.003
1.2±0.28
Note: The level of LDH activity was measured in supernatant of cells following UVA 
treatments. The LDH values of the controls were arbitrarily set to 1. Values are the 
mean ± SD of 3 experiments. * Significantly different from the sham-irradiated control, 
p  < 0.05.
In Table 3.5e the LDH activity of the supernatant was also expressed as percentage of 
total LDH (LDH of supernatant + LDH remainingin the cells). These results showed 
that the percentage of LDH leakage in HaCaT cells is significantly lower than in 
fibroblasts, consistent with the notion that HaCaT keratinocytes are more resistant to 
UVA-induced membrane damage. Also, as for fibroblasts, the percentage of LDH 
leakage in the pre-irradiated sample (i.e. 250d° / 250dl) was significantly higher than
for the non-pre-irradiated sample (i.e. 0d° / 250dl), consistent with the notion that 
exposure of keratinocytes to low split doses of UVA also increases the susceptibility of 
plasma membrane to UVA-induced damage. Furthermore the fact that in HaCaT cells, 
both basal and UVA-induced levels of LIP were significantly lower than in fibroblasts, 
strongly suggests that the amount of intracellular LIP should play a role in the degree of 
susceptibility of cells to UVA-induced damage.
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Table 3.5e UVA induced LDH leakage in HaCaT cells





Od0 /  0dl 1.710.4
0d° / 250dl 3.111.6
250do / 250dl 6.514.1
250do / 0dl 2.511.0
Note: LDH leakage in the supernatant was expressed as a percentage of total LDH 
(supernatant + cell portion). Values are the mean ± SD of 3 independent experiments.
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3.6 Determination of colony-forming ability
It has been shown in this laboratory that UVA mediates dose-dependent inactivation of 
human skin cells in culture as monitored by colony-forming ability assay (Tyrrell and 
Pidoux, 1987 and 1988). In order to test whether the LIP is involved in the mechanism 
of cell killing by UVA radiation, UVA-induced cytotoxicity was determined by colony- 
forming ability curves for fibroblasts and HaCaT cells that were treated with DFO for 
18 h prior to UVA irradiation. The results (Fig. 3.6A, B and C for FEK4, 1BR3 and 
HaCaT cells, respectively) showed that DFO pre-treatment does not increase the cell 
survival, consistent with the notion that UVA-induced LIP release is not involved in 
long-term UVA-mediated cell killing. Furthermore, HaCaT cells that were much 
resistant to both UVA-induced lysosomal and plasma membrane damage, were found to 
loose their ability to form clones following UVA treatment. These results emphasize 
that the factors involved in short-term effects of UVA should be entirely different from 
those involved in long-term cell killing. In other words, the UVA-induced LIP release 
might play a role only in UVA-induced short-term damage.
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Fig. 3.6A. B. C Survival curves for FEK4, 1BR3 and HaCaT cells.
Inactivation o f cells by exposure to U VA  at the indicated doses with DFO-treated and non-treated cells. 
Data are plotted as fraction o f non-irradiated controls (which are taken as 100% survival).
The plating efficiency for FEK4, 1BR3 and HaCaT cells are 30%, 28% and 15%, respectively.
Values are log o f mean ± SD of 3 independent experiments.
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4. Discussion
4.1 The significance of UVA-mediated labile iron pool (LIP) release in skin cells
Although in humans, excessive exposure to solar ultraviolet radiation has been shown to 
be associated with increased risk of developing a number of pathologies, ranging from 
erythema, immunosuppression, hyperplasia, cataract, skin ageing to the development of 
melanoma and non-melanoma skin cancer, the cellular mechanisms underlying such 
risks are, at present, not fully understood. It is known that most of these effects are 
wavelength dependent and usually occur as a result of cumulative solar UV dose. The 
identification of specific cellular changes following irradiation with either UVA or 
UVB component of sunlight is therefore likely to provide clues as to the development of 
such pathologies. Most of the studies in the field of photobiology focus on the effect of 
acute i.e. single high dose rather than chronic i.e. repeated low doses of UVA and UVB 
exposures. Since skin is repeatedly exposed to solar UV radiation and long-term photo­
damage is a consequence of cumulative UV radiation injury, it is crucial to examine the 
effects of repetitive exposure of human skin cells to UV radiation in order to obtain 
clues as to the early alterations that lead to photo-aged skin and ultimately to 
carcinogenesis. The recent discovery that UVA radiation leads to immediate measurable 
increase in potentially harmful available iron in human dermal fibroblasts (Pourzand et 
al., 1999a), prompted us to characterise further this phenomenon in both skin fibroblasts 
and keratinocytes following single or repeated exposures to UVA irradiation, since iron 
is a catalyst of biological oxidations. The UVA doses used in this study were 250 and
9 • •500 kJ/m , which are equivalent to the amount the surface of skin would be exposed to 
over 70 or 140 min, respectively on a summer day around noon at a northern latitude of 
30-35° (Frederick and Albert, 1992), so that these doses mimic normal exposures to 
sunlight.
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The results of this study (Table 3.2, 3.5 3.10 and 3.12) clearly demonstrated that LIP 
release occurs immediately following UVA irradiation of both human skin fibroblasts 
and keratinocytes following either single or repeated exposure to UVA irradiation. 
These findings also emphasized the importance of repeated iron release in promoting 
cumulative UV radiation injury in the skin. Indeed, free iron, due to its bioavailability in 
biological systems, plays an essential role in the promotion of the prooxidant condition 
in cells since as a redox-cycling metal, iron catalyses the formation of ROS (see section 
1.5). The release of potentially harmful free ‘transit’ iron within cells should exacerbate 
the damaging effects of the UVA-induced oxidative stress and is likely to be of central 
importance to both the reversible and degenerative damage to skin cells that follows 
exposure to solar UVA, including the events that lead to skin ageing. Indeed daily 
exposures at low doses of UVA (50-100 kJ/m2) have been reported to promote the 
cumulative morphological alteration as well as ‘surbum cells’ in human skin as a result 
of cumulative UVA doses applied (Kumakirim et al., 1977; Lavker et al., 1995). 
Furthermore Bemeburg et al. (1999) have reported that repetitive UVA exposure of 
human fibroblasts to UVA irradiation (80 kJ/m2) results in mitochondrial DNA damage, 
which may contribute to skin ageing. It has also been demonstrated that UVA-induced 
increase in LIP has the potential role to promote mitochondrial membrane damage (this 
laboratory, unpublished data). Furthermore UVA induces the rapid proteolytic 
degradation of ferritin within both skin fibroblasts and keratinocytes (Pourzand et al, 
1999a and unpublished data, this laboratory). The lack of this critical iron storage 
protein ferritin during the first hour that followed irradiation is thought to further 
exacerbate the consequences of the UVA-induced iron release within human skin cells, 
since the excess of the highly reactive LIP cannot be withdrawn from the cells. Indeed, 
in the present study it was found that the UVA-induced immediate increase in LIP is
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sustained for at least 2 h following irradiation and only returns to basal levels 6 h 
following irradiation (Table 3.3 and 3.11).
The presence of excess iron has also been demonstrated in a variety of skin disorders 
such as psoriasis (Molin and Wester, 1973), venous ulceration (Ackerman et al., 1988) 
and atopic eczema (David et al., 1990), indicating the involvement of iron in the 
pathology of skin. Furthermore, Bissett and coworkers (1991) have reported that 
chronic exposure of mice to suberythemal doses of UV radiation led to an increased 
skin level of non-heme iron after 12 weeks of irradiation presumably as a result of TJV- 
induced increase in vascular permeability. They also observed that there were greater 
amounts of non-heme iron in sun-exposed sites of human skin biopsies (after sunburn) 
indicating that similar events occur in man (Bissett et al, 1992). Our in vitro findings are 
in good agreement with the in vivo studies of Bissett, suggesting that the phenomenon 
of UVA-induced iron release may also occur in human skin following exposure to the 
sunlight.
The findings of UVA-induced iron release in both fibroblasts and keratinocytes is of 
paramount importance to cancer studies, since iron may play a role in carcinogenesis. 
Over the past few decades, it has been shown that one of the dangers of iron is its ability 
to favour neoplastic cell growth (reviewed by Weinberg, 1996). The metal is 
carcinogenic due to its catalytic effect on the formation of highly reactive hydroxyl 
radicals, suppression of host defence cells and promotion of cancer cell multiplication. 
In both animals and humans, primary neoplasms develop at body sites of excessive iron 
deposits such as the skin. The body has already developed mechanisms to withhold iron 
from cancer cells via sequestration of the metal into newly formed ferritin. It is clear
161
that the fast proteolytic degradation of ferritin following UV radiation would have 
deleterious consequences. Furthermore, since skin is potentially the target of significant 
oxidative damage due to its constant exposure to high oxygen tensions, frequent 
exposure to UV light and the presence of considerable amounts of polyunsaturated fatty 
acids, it is clear that increased deposit of transit iron on the surface of skin will catalyse 
the formation of highly reactive radicals and could contribute to severe oxidative 
damage. High dietary iron has also been reported to induce skin cancer in mice (Hann et 
al., 1988). Taken together, a picture emerges suggesting that repeated exposures to 
UVA and the consequent mobilisation and deposit of iron might be a major factor in 
both the photoageing and photocarcinogenesis processes.
4.2 The source of UVA-induced iron release in skin cells
Although the present work clearly demonstrates that UVA radiation rapidly causes the 
release of free iron within cultured human skin fibroblasts and keratinocytes, the 
potential source of this transit iron has yet to be identified. This study (see also 
Pourzand et al., 1999) has shown that ferritin iron is only partially involved in UVA- 
induced LIP release since neither preventing the UVA-mediated ferritin degradation by 
protease-inhibitors nor enhancing the level of ferritin by iron-loading (e.g. iron citrate) 
could substantially modulate the level of UVA-induced LIP release (Table 3.3.3 and 
Table 3.3.4). Therefore it appears that sources of iron, in addition to ferritin, are 
responsible for the observed effect. One such source is the heme that is released from 
microsomal hemoproteins immediately after UVA irradiation of FEK4 cells (Kvam et 
al., 1999). Although heme itself is not a source of LIP, it is a substrate for heme- 
catabolizing enzyme heme-oxygenase (HO) which could release the heme iron.
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The UVA-induced immediate release of heme within microsomal membranes of skin 
cells could therefore contribute to the observed increase in LIP.
The other candidate source for LIP is the lysosomal organelles. Indeed, lysosomal 
organelles that are responsible for the degradation of ferritin and other hemoproteins in 
the cells are thought to contain significant levels of free iron (Ollinger and Brunk, 1995; 
Petrat at al., 2001) It therefore follow that the UVA-induced lysosomal membrane 
damage could release this source of free iron from lysosomal compartments to the 
cytosol again contributing to the increase in the LIP that is detected by the CA-assay.
Since damage to the lysosomal membrane and the consequent leakage of lysosomal 
proteases to the cytosol is responsible for the UVA-induced immediate degradation of 
ferritin, such proteases could also degrade other iron-containing proteins (i.e. 
hemoproteins) in the cytosol. Mitochondrial cytochrome c has been shown to be 
released from mitochondrial membrane immediately after UVA irradiation of FEK4 
fibroblasts (this laboratory, unpublished data) and could be a substrate for degradation 
and iron release. It is well known that the total protein content of the cells decreases 
dramatically and in a dose-dependent manner following UVA irradiation of skin 
fibroblasts and keratinocytes (this study and also unpublished data from this laboratory), 
consistent with the notion that several proteins are degraded following radiation 
treatment.
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4.3 The origin of UVA-induced iron release in skin cells
Pourzand et al. (1999) have suggested that the phenomenon of UVA-induced LIP 
release in fibroblasts originates from the immediate damage to the lysosomal membrane 
leading to the leakage of potentially harmful proteases in the cytosol, which in turn 
degrade ferritin in the cytosol and release iron. In this thesis it was also found that the 
LIP release (see section 4.1) and damage to plasma membrane (release LDH) occur both 
in fibroblasts and keratinocytes following single or repeated exposures to UVA 
radiation (Table 3.5a and 3.5d).
Two questions arise from these observations: Firstly what is the mediator of UVA- 
induced immediate lysosomal membrane damage and secondly is the lysosomal damage 
the origin of LIP release or is this a consequence of LIP release? Several studies have 
shown that during cellular injury by oxidative stress, lysosomal membranes could be 
destabilized through lipid peroxidation promoting lysosomal rupture and release of 
potent hydrolytic enzymes to the cytosol. It has been suggested that during oxidative 
injury, the presence of abundant redox active iron in lysosomes along with H2O2 
generation within the vicinity of such organelles could yield the formation of highly 
reactive hydroxyl radical leading to lysosomal rupture and cell damage (Ollinger and 
Brunk, 1995; Roberg and Ollinger, 1998).
Since UVA is a membrane-damaging agent, and it has been shown that iron and singlet 
oxygen contribute to the peroxidation of human skin fibroblast membranes (Vile & 
Tyrrell, 1995), it was hypothesized that UVA may also trigger the peroxidation of 
lysosomal membranes. However the pre-treatment of fibroblasts with membrane
164
antioxidants BHT (Fig. 3F7-9) and -Tocopherol succinate (unpublished data, this 
laboratory) could only partially protect the lysosomal membranes against UVA-induced 
damage, suggesting that membrane peroxidation is not the major mediator of UVA- 
mediated lysosomal damage. Furthermore the same treatment failed to modulate the 
level of UVA-induced LEP release (Table 3.2e) consistent with the notion that UVA- 
induced iron release is not related to peroxidation of lysosomal membrane.
To further ascertain that UVA-induced LIP release is not a consequence of UVA- 
mediated lipid peroxidation in cell membranes, the role of ROS in this process was 
investigated. Singlet oxygen has been shown to contribute to UVA inactivation of 
human skin FEK4 cells (Vile and Tyrrell, 1995) and is the primary effector in the UVA 
induction of HO in FEK4 cells (Basu-Modak et al., 1993). This reactive oxygen 
intermediate can also abstract hydrogen and initiate the lipid peroxidation in cell 
membranes. Also H2O2 appears to be generated in cultured human skin fibroblasts at 
micro-molar (pM) concentrations during UVA radiation (Peak et al., 1990a; Vile and 
Tyrrell, 1995) and is thought to participate in Fenton chemistry to yield the highly 
reactive hydroxyl radical, which is a known mediator of cell membrane damage. The 
results (Table 3.2d and 3.2c) demonstrated that neither enhancing half-life by 
deuterium oxide (D2O) nor increasing the level of UVA-induced endogenous H2 O2 by 
the catalase inhibitor amino-triazole, could significantly enhance the level of UVA- 
mediated LIP release in FEK4 cells, consistent with the notion that these reactive 
oxygen intermediates do not play a key role in UVA-induced lysosomal damage and 
LIP release.
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It appears that UVA-induced lysosomal damage is a consequence of LIP release and not 
the primary mediator of it. In addition to LIP, early release of lysosomal enzymes might 
activate feedback processes that cause further lysosomal rupture. Such feedback 
processes may be either LIP-mediated and/or due to activation of lytic cytosolic pro­
enzymes such as caspases.
The lysosomal membrane damage that occurs upon irradiation could also be due to the 
interaction of UVA radiation with an unknown chromophore present within lysosomal 
organelles that leads to an immediate burst of these organelles. The candidate 
chromophore could be a partially degraded hemoprotein with a protoporphyrin-IX-type 
structure. Further investigations are required to address such issues.
4.4 The link between intracellular LIP and the susceptibility of skin cells to the 
UVA-mediated oxidative damage
Although UVA promotes rapid release of potentially harmful free iron in both human 
fibroblasts and keratinocytes, it was observed that both the basal and UVA-induced 
levels of LIP were 2-4 fold higher in human skin fibroblasts when compared with 
keratinocytes. Since iron plays a crucial role in propagation of lipid peroxidation in 
cellular membranes, we hypothesised that the low level of LIP in keratinocytes could be 
responsible for the higher resistance of keratinocytes to UVA-induced membrane 
damage. The investigation of the correlation between the amount of UVA-mediated LIP 
release and the rate of membrane damage in different cellular organelles i.e. plasma 
(Table 3.5a and 3.5d), lysosomes (Fig. 3F1-15,) and mitochondria (unpublished data, 
this laboratory) demonstrated that UVA promotes membrane damage in both
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keratinocytes and fibroblasts, however the extent of damage in keratinocytes is not as 
dramatic as in fibroblasts.
In fibroblasts, DFO treatment, which is known to abolish the UVA-induced LIP release 
significantly, protected the cells from lysosomal membrane damage. Similarly, It has 
been shown that DFO treatment can also substantially protect the fibroblasts against 
both the mitochondrial membrane damage and the necrotic cell death (i.e. loss of cell 
membrane integrity: recent unpublished data, this laboratory) consistent with the notion 
that UVA-induced LIP release plays a key role in UVA-mediated membrane damage. 
Furthermore, based on the finding that hemin-loading of cells prior to radiation could 
increase the level of UVA-induced LIP release (Table 3.3.3), it has been shown that 
hemin treatment of FEK4 cells could dramatically increase the level of UVA-induced 
peroxidative damage in lysosomal, mitochondrial and plasma membranes (this 
laboratory, unpublished data). Taken together, these data indicate that the level of UVA- 
induced LIP release in fibroblasts is directly related to the extent of UVA-mediated 
membrane damage.
In the present study, DFO treatment of keratinocytes that have low LIP levels only 
partially protect them against UVA-mediated damage (Fig. 3H1-6). It also did not 
significantly protect cells against the effect of UVA irradiation by clone-forming ability 
(Fig. 3.6A,B,C). So in the long term, the starvation of cells by DFO may not protect 
UVA-mediated cell killing.
Comparison of the fibroblast data with the keratinocyte data reveals that in addition to 
the lower basal level of LIP, keratinocytes have 5 times lower ferritin level, far fewer
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lysosomal organelles and lower lysosomal Cath B level (Table 3.2, 3.10, 3.21 and 
3.4.2). We propose that a combination of low basal and UVA-induced intracellular LIP, 
low basal level of ferritin and low lysosomal organelle and low lysosomal Cath B 
content will all contribute to the higher resistance of keratinocytes to UVA-induced 
membrane damage.
Overall, the results demonstrate that UVA-mediated release of reactive iron immediate 
following radiation treatments plays a key role in the increased susceptibility of cells to 
UVA-induced damage and will almost certainly act to exacerbate damage caused by 
further exposure. UVA also liberates heme within microsomal membranes of skin cells. 
This will sensitise cells to further exposure to UVA. Although cells have mechanisms to 
remove iron (i.e. long-term increase in ferritin) and heme (heme-oxygenase activation 
within hours), these defence mechanisms develop over several hours and days. 
Therefore it appears that high intensity short-term exposures to UVA radiation are the 
most likely to be damaging. This is precisely the situation for exposure to sunlamps 
where people tend to expose themselves habitually for short high intensity periods. A 
clear role for iron in exacerbating UVA damage suggests potential pathways to 
protection through iron chelation or natural antioxidants with iron chelating properties 
(e.g. polyphenols found in most fruits and vegetables).
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5. Future projects
In the present study, the phenomenon of UVA-induced LIP release has been 
characterized in two cultured human skin fibroblasts and keratinocytes. However in 
order to gain insight into the in vivo relevance of such studies, it is necessary to measure 
the same phenomenon either in animal models (e.g. hairless mice) or in human skin 
biopsies (e.g. after sunburn). Also, the present study has only focussed on the effect of 
UVA component of sunlight, but it is clear that such investigations should also be 
monitored following UVB component of sunlight. As mentioned before, most of the 
effects of sunlight are wavelength dependent, so it is of particularly importance to 
investigate whether UVB also promotes LIP release both in vitro in cultured skin cells 
and in vivo in animal or human skin. Such studies will complement our knowledge 
about the immediate cellular effect of solar UV radiation and will therefore provide 
information pertinent to develop strategies for the delay of7or protection against UV- 
mediated damage to the skin.
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